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Abstract 
 
Described here is the synthesis and coordination chemistry of various ligands, 
L1 – L17. Some of the ligands presented form interesting supramolecular 
assemblies upon reaction with selected metal ions.  
 
Chapter 1 provides a general introduction to supramolecular chemistry and self-
assembly. 
 
Chapter 2 introduces a new class of potentially hexadentate symmetrical 
ligands, L1 – L5. These ligands consist of two tridentate binding sites separated 
by a 1,3-phenylene spacer unit. Reaction of L1 with Zn(II) ions results in the 
formation of a pentanuclear circular helicate [Zn5(L1)5]10+, within the structure all 
five zinc ions are six-coordinate arising from coordination of two tridentate 
domains from two different ligand strands. This structure was shown to exist in 
both the solid state and in solution. Incorporation of various enantiopure units 
allowed variation of the terminal functional group of the ligand, L2 – L5. These 
ligands, upon coordination with Zn(II) ions, were shown to from supramolecular 
assemblies analogous to the pentanuclear species observed for L1. Additionally 
these ligands were shown to be diastereoselective, controlling the resulting 
supramolecular architecture giving up to 80% diastereomeric excess. 
 
Described in Chapter 3 are a number of potentially hexadentate N-donor 
ligands, L6 – L14. Each ligand possesses the same thiazole-pyridyl-pyridyl 
tridentate domains, with variation of the spacer unit. Upon coordination with 
selected transition metal ions these ligands resulted in the formation of 
dinuclear species. Reaction of L9 with Cd(II) results in the formation of a 
dinuclear double helicate, in which the two tridentate domains coordinate each 
metal ion and the ligands twist in the centre generating an ‘over and under’ 
arrangement. However, reaction of L9 with Co(II) results in the formation of a 
dinuclear meso-helicate, in which the ligands adopt a side-by-side 
configuration. This difference in structure is attributed to unfavourable steric 
interactions which prevent the formation of the Co(II) double helicate. Reaction 
iii 
 
of two of these ligands L10, which possesses an ethylene glycol chain, and L11,  
containing an amine group, with Cd(II) and camphorsulfonic acid results in the 
formation of a heteroleptic one-dimensional chain. Hydrogen bonding 
interactions between the protonated amine of L11 and the glycol chains of L10 
results in a structure which contains both of these meso-helicate structures in 
an extended one-dimensional arrangement (([Cd2(L10)2][Cd2(L11-H)2])(ClO4)10)n. 
 
Chapter 4 reports the synthesis of three ligands, L15 – L17, each containing the 
same central phenol unit, and either a hydroxyl, pyridine or pyridine-N-oxide 
terminal unit. Reaction of each ligand with various trivalent lanthanide ions 
results in the formation of a dinuclear double helicate. In each structure the 
central phenol unit is deprotonated and bridges the two lanthanide ions giving 
[L2M2]4+. L17, which possesses the pyridine-N-oxide as the terminal group, 
effectively encompasses the cations minimising access for the coordination of 
any anions or solvent molecules. Photophysical measurements show that this 
ligand forms emissive complexes with a number of lanthanide ions, whilst the 
magnitude of the lifetime for [(L17)2Yb2]4+ ( = 21.0 s) suggests that both Yb(III) 
ions are well-shielded from excited state quenching phenomena. 
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1. Introduction  
1.1 Supramolecular chemistry 
 
Supramolecular chemistry is a vast area of research; as such it is difficult to 
give a precise definition. However, Jean-Marie Lehn, seen as one of the 
founding fathers of supramolecular chemistry, referred to it as ‘chemistry of 
molecular assemblies and of the intermolecular bond, more commonly quoted 
as ‘chemistry beyond the molecule’.1 This may seem simplistic but allows 
interpretation and adaptation to incorporate all possible architectures from the 
many disciplines (physical chemistry, inorganic chemistry, organic synthesis, 
computational chemistry and even biochemistry) which have contributed to this 
maturing research field.2 
 
The key feature of supramolecular chemistry is the use of reversible 
intermolecular interactions for the generation of the final architecture. In 
comparison to classical molecular chemistry, which is focused on the making 
and breaking of strong molecular bonds (covalent bond) providing new 
molecules,3 supramolecular chemistry takes these preformed molecules and 
through intermolecular interactions provides a structure which is greater than 
the sum of its parts.4  
1.1.1 Foundations of supramolecular chemistry  
 
The very beginning of supramolecular chemistry is hard to define exactly. It is 
generally accepted that the main developments were achieved in the 1960’s,5 
from this time research in this field has expanded exponentially. Early work 
focused on macrocyclic ligands for coordination of metal cations. The principles 
of these systems were researched by groups Curtis,6 Jäger,7 Busch8 and 
Pederson,9 providing the foundations for future development. Also worth a note 
here for their contributions to this emerging field are Cram and Lehn.  
 
2 
 
Pederson is known for creating crown ethers as well as Lehn who introduced 
the structurally similar cryptands.10 Cram further modified these systems to give 
ligands that were more pre-organised for cation binding becoming known as 
spherands11 (figure 1.1). This initial research introduced principles of selective 
recognition of cations based on ion and shape as well as pre-organisation of 
ligands. Pederson, Lehn and Cram were recognised for their contributions to 
this field being awarded the Nobel Prize in 1987.  
 
Pederson: 18-crown-6            Lehn; [2.2.2] cryptand10            Cram: Spherand11 
 
Figure 1.1 Early macrocyclic ligands in supramolecular chemistry 
 
1.2 Supramolecular interactions  
 
Reversible intermolecular interactions are implemented, as opposed to covalent 
bonds, in the assembly of components in supramolecular systems. 
Intermolecular interactions may be attractive as well as repulsive, which means 
for the most stable complex to form the components must possess a 
complementary arrangement of binding sites. There is an enormous range of 
forces which can potentially be employed by the supramolecular chemist. The 
main ones of note are electrostatic interactions (ion-ion, ion dipole and dipole-
dipole), hydrogen bonding and π-π stacking interactions. However the 
interactions between the components do not occur in isolation so other factors 
may also influence the system, for example solvation.12  
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1.2.1 Ion-ion interactions  
 
Ionic bonding is comparable in energy to covalent bonding. In basic terms the 
formation of an ionic bond results from the loss of an electron from a metal to a 
non-metal forming ions of opposite charge, leading to electrostatic attraction. A 
well-known example is NaCl, which is composed of an ionic lattice of Na+ ions 
surrounded by Cl- ions in the solid state (figure 1.2). This type of interaction is 
rarely seen in supramolecular chemistry. 
 
Figure 1.2 Ion-ion interactions13 
 
1.2.2 Ion-dipole interactions 
There are numerous examples in supramolecular chemistry of ion-dipole 
interactions. An ion-dipole force occurs when an ion interacts with a polar 
molecule. The complexes of crown ethers and alkali metal cations are a perfect 
example to illustrate this type of interaction (figure 1.3); here the oxygen lone 
pairs are attracted to the positive charge of the potassium ion.  
 
Figure 1.3 Example of ion-dipole interaction 
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1.2.3 Dipole-dipole interactions 
Association of one dipole with another can be useful for bringing molecules into 
alignment. Organic carbonyl compounds are good examples that exhibit this 
type of interaction (figure 1.4). 
 
Figure 1.4 Dipole-dipole interactions in carbonyls 
 
1.2.4 Hydrogen bonding 
Hydrogen bonding is considered as a special example of dipole forces. This 
occurs when a hydrogen atom which is attached to an electronegative atom (for 
example nitrogen) is attracted to a dipole in an adjacent molecule or functional 
group (figure 1.5). This bonding is highly directional and relatively strong which 
is why it is of some significance in supramolecular chemistry. There are a wide 
variety of bond lengths, strengths and geometries for hydrogen bonds; they are 
significant for the formation of proteins, the double helix of DNA and much more 
besides.  
 
Figure 1.5 Example of hydrogen bonding 
 
1.β.5 π-π stacking interactions  
These interactions occur within systems containing aromatic rings; it is believed 
that the interaction is a weak electrostatic interaction. This results when the 
negative charged π-electron cloud of one system is attracted to the positive σ-
framework of an adjacent molecule. More than one orientation of the rings 
A= F, Cl, O, S, N, π-system D= F, Cl, O, S, N, C
δ+ δ
+
δ-
δ-
5 
 
involved is possible giving rise to face-to-face or edge-to-face interactions 
(figure 1.6).14 
 
 
Figure 1.6 Possible orientations for π-π stacking interactions 
 
1.3 Host-guest chemistry 
As mentioned supramolecular chemistry is the binding of components using 
intermolecular forces, the next step is to identify what is partaking in the 
binding. Obviously for binding to occur at least two components are required, 
for host-guest chemistry one molecule binds another forming a complex or 
supramolecule. Generally the host is identified as the larger (higher molecular 
weight) component of the system.4 Cram identified the components of a 
complex as “The host component is the molecular entity whose binding sites 
converge in the complex... the guest component is any molecule whose binding 
sites diverge in the complex”.15  
 
A number of categories of host compounds have been identified based on the 
association between host and guest within the supramolecule. Two main 
categories that have been acknowledged are cavitands and clathrands (figure 
1.7). Cavitands are hosts which already possess intermolecular cavities, with 
the capability of encapsulating the guest. As the cavity is already present within 
the host these complexes exists both in solution and in the solid state. 
Clathrands produce extra-molecular cavities which form between two or more 
of the host molecules. As these cavities are not an instrinsic molecular property 
of the host component these cavities only exist in the solid or crystalline state. 5 
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Guest 
Host 
Cavitand 
Clathrand 
 
Figure 1.7 Illustration of the co-ordination difference between cavitands and 
clathrands 
The previous examples of host guest complexes illustrate the two extremes of 
the possible supramolecule. There exist a number of intermediate types for 
host guest coordination, based on the spatial arrangements of the guest and 
host when forming the complex, resulting in further subdivision of the two broad 
categories.  
Figure 1.8 Spatial arrangements between host and guest5 
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At first glance this area of supramolecular chemistry may seem simplistic; host-
guest chemistry is, however, extremely significant. The idea of the host-guest 
complex is reminiscent of the enzyme-substrate complex seen in biology. The 
principal ideas are effectively the same in each instance, the host (enzyme) 
must possess certain binding domains which are complimentary to those of the 
desired guest (substrate). This is more commonly known as the “lock and key 
principle” introduced by Emil Fischer in 1894.16 In this analogy, the lock 
(enzyme) and key (substrate) must be correctly sized to fit together to allow the 
lock to be opened. Incorrect geometric shape or size of a key (substrate) does 
not fit into the lock (enzyme); this forms the basis of molecular recognition. 
Therefore the shape and size of the host cavity must be complementary for a 
particular guest if the coordination is to be selective and specific. This plays a 
critical part in the formation of supramolecules leading to increased likelihood of 
coordination to the guest and increased stability of the complex. 
 
1.3.1 Crown ethers 
  
The serendipitous discovery of the first crown ether was due to an impure 
starting material being used in the synthesis of bis[2(o-hydroxy-
phenoxy)ethyl]ether (figure 1.9) by Pederson working for DuPont in New 
Jersey, USA. He was initially interested in making multidentate ligands for 
coordination of copper and vanadium. Pederson isolated a small quantity of 
white crystalline by-product (0.4 % yield) while attempting to purify the desired 
pentadentate ligand.17 
  
8 
 
 
Figure 1.9 Intended synthesis for bis[2(o-hydroxy-phenoxy)ethyl]ether4 
 
This unexpected by-product, a crystalline substance, was of some interest to 
Pederson due to the properties observed for the compound. It was sparingly 
soluble in methanol but was solubilised upon addition of sodium hydroxide. On 
further investigation it was actually identified that alkali metals solubilised the 
compound, thus the solubilisation was due to the sodium cation not the addition 
of base. The UV analysis was of a phenolic compound, with the spectrum being 
altered upon the addition of sodium.18 
 
The elemental analysis was consistent with the structure being benzo-9-crown-
3, a possible product of the reaction. However, the structure was finally 
identified after molecular weight determination; with the molecular weight being 
double that of benzo-9-crown-3 indicating the compound was actually dibenzo-
18-crown-6 (figure 1.10). As the chemical names of these compounds are 
enormous, a more trivial nomenclature was implemented.17 Eventually these 
compounds became known as crown ethers, supposedly due to the crown-like 
conformation of the complexes. It was observed by a space-filling model that 
the sodium cations sit in the cavity of the macrocyclic polyether by way of 
electrostatic ion-dipole interactions with the oxygen atoms.  
contaminant
H+
Et2O
NaOH
n-BuOH
H+/MeOH
n-BuOH
9 
 
 
Figure 1.10 Dibenzo [18]crown-6 (or 2,3,11,12-dibenzo-1,4,7,10,13,16-
hexaoxacyclooctadeca-2,11-diene) 
 
Before this there were no known examples of synthetic compounds capable of 
forming complexes with alkali metal cations. With this realisation of the 
significance of such a compound no time was wasted in producing a whole 
family of macrocyclic polyethers (figure 1.11), followed by in-depth 
determination of their interactions with inorganic cations.17, 19  
 
Figure 1.11 Examples of crown ethers 
 
Early research undertaken by Frensdorff20 provided information relating to the 
strength of complexation in solution dependent on the polyether structure, 
cation size and solvent. The stability constants of several cyclic polyethers with 
different cations in methanol and aqueous solution were determined using 
potentiometry. Frensdorff determined that the stability constants of 1:1 
complexes were significantly higher using methanol as solvent, due to the 
18-crown-614-crown-4 15-crown-5
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cation being more highly solvated in water. The main finding was that selectivity 
towards different cations depended on the polyether ring size, with the optimum 
ring size being the one that the cation just fits into the cavity. This relationship 
between cation size and ring size is clear from the results, for example, 
potassium ions (K+) form a more stable complex with 18-crown-6 than sodium 
(table 1.1). However, sodium (Na+), being a smaller ion, binds more strongly 
with the smaller 15-crown-5. 
 
This is further supported by structural data as the cavity size and cation 
diameter are most complementary between potassium and 18-crown-6 (table 
1.1). The 1:1 complexation is strongest when the host and guest are 
complementary; the cation (guest) when matched with the complementary 
crown ether (host) is able to fully sit in the cavity within the plane of the oxygen 
atoms where the charge density is highest. If the crown is too large there are 
insufficient interactions with all the available oxygen atoms. This relationship 
between cationic radius, cavity size and stability of the complex is a concept 
known as optimal spatial fit.  
 
 
Cation 
 
 
Ionic Diameter (Å) 
 
Polyether Ring  
 
Cavity Size (Å) 
Li+ 
Na+ 
K+ 
Rb+ 
Cs+ 
Ag+ 
1.36 
1.94 
2.66 
2.94 
3.38 
2.52 
14-crown-4 
15-crown-5 
18-crown-6 
21-crown-7 
1.20-1.50 
1.70-2.20 
2.60-3.20 
3.40-4.30 
 
Table 1.1 Cation ionic diameters with a selection of crown ether cavity sizes 
 
It should be noted that stoichiometries of cation to crown ether, other than 1:1, 
are also possible. A complex may still form even if the sizes are not 
complementary between the two components, this results in a “sandwich 
complex” where two “smaller” crowns coordinate a “larger” cation.21 
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Crown ethers, which have been shown to coordinate s-block cations, consist of 
a cyclic array of ether oxygen atoms linked by an organic spacer (commonly –
CH2-CH2-), mono-dentate ether molecules, for example diethyl ether, are very 
poor with regards to metal ion coordination. This leads to the question as to 
why this isn’t the case for crown ethers and even podands such as 
pentaethyleneglycol (acyclic ether). This ability to form a stable coordination 
complex is due to what is known as the macrocyclic effect and chelate effect, 
which are well established principles in coordination chemistry.22 
 
Following on from the work of Pederson, Lehn moved crown ethers into 3-
dimensions by introducing macro-bicyclic structures: the cryptands.23 This 
resulted in the guest interacting to a greater degree with the host, giving more 
stable complexes with group one and two metal cations than analogous crown 
ethers.24 The most common cryptand is the [222] cryptand (figure 1.1). Upon 
inspection of the crystal structures of the complexes produced by crown ethers 
and cryptands with s-block metal ions, Cram noticed that the binding sites 
within these macrocycles were not completely convergent. Thus for 
complexation to occur the ligands require some degree of rearrangement. This 
realisation prompted the idea to produce a rigid host which contains fixed 
binding sites in an octahedral arrangement around an enforced cavity, leading 
to the synthesis of the more pre-organised macrocycles the spherands.25 
These macrocycles showed enhanced binding constants in comparison to the 
aforementioned macrocycles due to the structure being more pre-organised 
towards the desired guest.26 
 
Since this pioneering research these macrocyclic ligands are now ubiquitous in 
supramolecular chemistry, with research groups introducing new functionalities 
and properties into the simple crown ether motif.27 The simplest variations are 
those which have substituted the heteroatom, using such atoms as nitrogen,28 
sulfur, or arsenic29 in place of the oxygen atoms, making up the family 
collectively known as corands. More drastic alterations have given other 
classes such as Lariat ethers,30 which are essentially crown ethers which 
possess a side arm with additional donor atoms for coordination to the guest 
giving desirable properties of both podands and crown ethers. These structures 
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have found a number of potential uses, such as building blocks in other 
supramolecular systems, for example, within rotaxanes and catenanes. 
1.4 Self-assembly 
 
The previous section focused on macrocycles, pre-organisation and molecular 
recognition: the origins of supramolecular chemistry. Another concept that has 
emerged within supramolecular chemistry is self-assembly. The definition of 
self-assembly is the spontaneous and reversible generation of well-defined 
supramolecular architectures from their component parts under a given set of 
conditions to provide the most thermodynamically stable assembly. The 
components, or tectons, contain intrinsic information which is used to direct the 
assembly.3  
 
A wide variety of biological systems and structures rely on self-assembly 
processes for their construction. Self-assembly is ubiquitous in nature; 
formation of the DNA double helix being the most common example. Natural 
systems exhibit efficient control over complex molecular assemblies using a 
number of relatively weak intermolecular interactions. It is from here that the 
supramolecular chemist gains inspiration to replicate such principles within 
synthetic systems, with the desire to produce assemblies with the same degree 
of selectivity, specificity and precision as those found in nature.31 
 
This area of supramolecular chemistry may allow access to molecular 
architectures which may be inaccessible using classical synthesis methods or if 
they are accessible the synthesis would be greatly time-consuming and non-
trivial.  The molecular architectures result when simple, appropriately designed 
sub-units combine under certain conditions, these complex assemblies may 
have a number of potential uses.2 A simple example is the production of 
catenanes; the first method of synthesis, “the statistical approach”, gave very 
small yields (< 1 %). The use of self-assembly techniques was subsequently 
implemented in their construction, providing improved yields and more reliable 
synthesis methods.32 Within nanotechnology it is desired that one day similar 
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principles will be applied to electronic devices, the bottom-up or engineering up 
approach, to provide access to the ever reducing size of electronic devices.33 
1.4.1 Rotaxanes   
These supramolecules acquire their name from Latin: rota (wheel) and axis 
(axle), as Rotaxanes consist of a long relatively linear component which is 
threaded through a macrocyclic ring, giving a similar result to threading a piece 
of cotton through the eye of a needle. A true rotaxane cannot be separated into 
its constituent parts without the breaking of a chemical bond, thus the reason 
why the linear chain is frequently terminated by bulky functional groups which 
are unable to fit through the macrocyclic component. The group of 
supramolecules which does not possess these barriers to stop the separation 
of the components, allowing unthreading of the structure, are known as 
pseudorotaxanes (figure 1.12).5 
 
Figure 1.12 Representation of a) [2]-rotaxane b) [2]-pseudorotaxane34 
 
There are a number of methods that have been employed for the assembly of 
these structures. The first method utilised in their initial synthesis was “the 
statistical approach”, this relies on there being a small chance that 
macrocyclisation may occur while a linear precursor is threaded through a 
macrocyclic component.35 The first example of a rotaxane using the “statistical 
approach” was reported by Harrison et al.36 In this it was suggested that the 
structure be called a hooplane, the method was to attach a cyclic ketone with a 
carboxylic acid functionality to Merrifield’s peptide resin.37 A column of this 
resin, bound to the macrocycle, was washed with decane-1, 10-diol and 
triphenylmethyl chloride a number of times (70 in total), after which the 
reagents and other materials were washed from the column leaving only the 
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reaction product to be hydrolysed from the resin support. This method was 
unreliable and initial reactions gave yields between 1-6 % (figure 1.13). Due to 
low yields of this approach other methods of synthesis were investigated.38 
 
Figure 1.13 Method of synthesis for the first [2]-rotaxane32 
 
The directed synthesis, self-assembly, of rotaxanes allowed more control over 
the process. A number of methods were produced for the successful synthesis 
of these interlocked structures. Three main methods were identified, threading, 
clipping39 and slipping. For threading, a molecule is threaded through a 
preformed ring, this is achieved by the two tectons containing complementary 
binding sites to assemble the sub-units, which is followed by stoppering of one 
or both ends of the linear section. Pseudorotaxanes produced by self-assembly 
followed by termination at one or both ends of the linear component by bulky 
groups gives the rotaxane, if however the linear component reacts intra-
molecularly (ring closure) then a catenane is produced, another family of 
supramolecules. Clipping is achieved by attaching a macrocycle onto a 
preformed dumbbell, and slipping is achieved by slipping the ring over the ends 
of a preformed dumbbell (figure 1.14).2  
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Figure 1.14 Illustration showing methods for rotaxane synthesis40 
 
Slipping is achieved as the bulky end groups may be able to slip through the 
axle as a result of elevated temperature. Harrison41 first demonstrated this by 
heating a mixture of macrocycles with 1,10-bis(triphenylmethoxy) decane  to 
1β0˚C which resulted in the formation of a small concentration of an interlocked 
[2]-rotaxane; this [2]-rotaxane structure was shown to decompose on heating. It 
was demonstrated here that the size of the macrocycle is important for slipping 
as if it is too small slipping will not occur and if it is too large only transient 
compounds are formed. This method has been used by other research groups 
to produce rotaxanes.42 
 
It is possible to produce [3]-rotaxanes which contain one axle and two 
macrocycles within the final structure.43 Further to this rotaxanes with 
interesting functions are known such as molecular shuttles, where the axle 
contains two ‘stations’ for the macrocycle and with manipulation of the system 
the macrocycle favours one of the ‘stations’.44 Rotaxane assembly may also be 
directed by means of coordination with metal centres.45 
 
1.5 Metallosupramolecular chemistry 
The use of transition metal centres for organising molecular building blocks into 
complex architectures is an area of study frequently seen in supramolecular 
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chemistry. There are a number of reasons why metal centres are employed. It 
is well known that metal ions are able to be coordinated by donor atoms or 
groups of atoms, through a form of ion-dipole interaction. Additionally these 
dative bonds are directional, thermodynamically strong, are available in a range 
of kinetic stabilities and have a variety of geometries depending on the metal 
centre, which add significantly to directing the self-assembly process. The 
formation of these coordination complexes can lead to architectures which may 
be one-, two-or three- dimensional.4 As this strategy has been vastly employed 
in self-assembly it has become known as metallosupramolecular chemistry. 
This term was first introduced in 1994 by Constable, describing the metal 
centres as a type of ‘glue’ holding the structure together.46 
 
There are numerous examples of supramolecular architectures which have 
taken advantage of metal ion centres for their self-assembly. For example 
grids, racks ladders, various polygons, rotaxanes and helicates to name a few 
(figure 1.15). Through careful selection of metal ion and ligand the 
supramolecular chemist is able to impart some control over the outcome of the 
assembly. The self-assembly processes are directed by the information 
encoded within the covalent framework, resulting in organisation of the 
components via interactions and recognition events. This concept of 
components containing molecular information which directs the assembly is 
analogous to an algorithm which controls a computer programme. The idea that 
information can be stored at the molecular level is a concept introduced by 
Lehn.3 
Figure 1.15 Examples of metal directed assemblies a) molecular square47, b) 
Helicate and c) a supramolecular cube48 
a) ď) Đ) 
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1.5.1 Grids 
Self-assembly of metal directed arrays are of particular interest such as racks, 
ladders and grids (figure 1.16), which have extensively been researched, 
particularly the latter due to potential use as molecular electronic devices.49 The 
grid architecture, denoted as [nxm]grid or [nxm]G, consists of square or 
rectangular tiles with metal ions as the corners. The ligands used within the 
assembly may be the same or different depending on the desired architecture. 
For construction of a square grid the n and m ligands must be equivalent, for 
the rectangular arrangement n and m must be different. The metal ions may be 
tetrahedral or octahedral; however the ligands must possess complementary 
binding domains for the assembly to be directed to the grid array.  
 
Figure 1.16 Schematic representations of A) racks, B) ladders and c) a grid50 
 
For the construction of a square grid architecture utilising tetrahedral metal ions 
(e.g. Ag+, Cu+) the n-topic linear rigid ligands would require bidentate binding 
sites for coordination to the tetrahedral ions. Within these structures the two 
ligand sets may be on opposite sides of the metal ions, one above and one 
below the plane of the metal. This can however become more complex by the 
ligands twisting and binding over and under the metal ions at opposite ends 
introducing the possibility of having chiral grids.4 
 
Grids have been extensively researched by Lehn et al. This is primarily due to 
the interesting reversible switching processes, optical, magnetic and redox, in 
response to changes from external parameters.51, 52 
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One of the early reported [2x2] grids reported by  Lehn et al.,53 was assembled 
using ligands containing pyridine and pyrimidine units to provide the donor 
atoms for coordination. Three ligands were used in this research with variation 
of substituents present on the central pyrimidine ring and the 5-position of the 
terminal pyridine rings (R = H or Me). The variation within the ligands was 
incorporated to allow possible further functionlisation to provide more complex 
architectures. Upon mixing equimolar quantities of cobalt acetate tetrahydrate 
with one of the ligands in methanol and heating at reflux temperature the 
[2x2]G tetracobalt(II) complex is formed in high yields. Elemental analysis and 
mass spectroscopy confirmed the formation of the desired structures. Single 
crystals were obtained after slow diffusion of methanol into a saturated solution 
of the complex in acetonitrile, allowing structural determination by X-ray 
crystallography (figure 1.17). The complex was shown to consist of four ligands 
and four cobalt metal cations in a [2x2]G array, with the metal centres 
displaying a distorted octahedral coordination to the perpendicularly orientated 
ligand fragments. 
Figure 1.17 Self-assembly of [2x2] grid architecture  
(CH3COO)2Co.4H2O (Co2+) 
La
La1 (R1=R2=H)
La2 (R1=Me, R2=H)
La3 (R1=R2=Me)
Ca
Ca1= [Co4(La1)4]8+
Ca2 =[Co4(La2)4]8+
Ca3 =[Co4(La3)4]8+
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1.5.2 Ladders 
 
Ladders are similar to grids, in that the self-assembly occurs due to the 
interplay between the polydentate ligand and coordination to metal ions. 
Ladders are described by using [2.n]L nomenclature, where 2 signifies the two 
sides of the ladder to which the “rungs” are attached and n refers to the number 
of “rung” ligands present.54 In these structures, unlike grids, a second ligand is 
always required, so in addition to a rigid rod like ligand to form the backbone of 
the structure an additional ligand for the “rungs” of the ladder is necessary. 
Such metal arrays have not been as extensively investigated as the related grid 
architectures.  
 
Common ligands which are instrumental in these self-assembled metal arrays 
are those containing pyridine and pyrimidine aromatic rings.55 An example of a 
[2.2] and [2.3] ladder has been reported by Lehn et al.56 which is produced 
upon mixing the preorganised ligands, Lb and Lc, with Cu(I) metal ions in the 
correct stoichiometries (figure 1.18). This is an example of a mixed-ligand self-
assembly, which requires some form of recognition between the components 
for the formation of the discrete complex to occur. The structure of complexes 
of Lb and Lc were unambiguously assigned based on 1H and 13C NMR, with the 
1H NMR spectrum being extremely simple indicating a single highly 
symmetrical species. Other analysis of the complexes was conducted (COSY, 
ROESY and ESMS) with these results also corresponding to the formation of 
the ladder type complexes (Cb1c and Cb2c 
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Figure 1.18 Self-assembly of two- and three-“rung” ladders 
1.5.3 Racks  
 
Racks are closely related to grids and ladders. Racks are designated by [n] 
Rack, where n represents the nuclearity of the species. These arrays consist of 
a single linear rigid poly-topic ligand and several monotopic ligands which upon 
coordination to metal ion linkers results in the monotopic ligand pointing 
perpendicularly away from the poly-topic ligand backbone. For this to be 
achieved the components must be complementary, therefore the ligands and 
metal centre must be appropriately selected. Thus if the metal ion selected is 
tetrahedral then binding domains of the ligand must satisfy this geometry, to 
achieve this each ligand requires bidentate donor moieties. These architectures 
can be assembled using octahedral or tetrahedral metal centres.54 
 
Lehn et al. have produced a number of different racks by using these simple 
principles for their self-assembly. One such example produced upon reaction of 
Cu(I) with oligobipyridine ligand Ld and ligand Le (figure 1.19) results in the 
formation of a rigid rack, with a slight rotaxane character due to the use of a 
Lb
Cu(I)
Cb2c = [Cu6(Lb2)2(LC)3]6+Cb1c = [Cu4(Lb1)2(LC)2]4+
Lb1 n = 0 
Lb2 n = 1
Lc
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macrocycle as one of the ligands. The structure of this rack has been 
determined through analysis of the crystal structure.57 
 
Figure 1.19 Self-assembly of a rack with rotaxane character57 
1.5.4 Cages 
 
The metal-directed self-assembled cage architectures fall into the category of 
molecular containers or capsules. Hydrogen bonded self-assembled capsules 
are known, which are also able to encapsulate guest species.4 A remarkable 
amount of progress in the construction of three dimensional structures has, 
however, been made since the incorporation of metal centres. There are two 
methods available for the construction of metallosupramolecular cages; these 
methods depend on the type of ligand(s) employed. The ligand selected may 
be one-dimensional or two-dimensional. Ligands which are one-dimensional 
are only able to bridge two metal centres. These ligands are equivalent to the 
straight edges of the structure. This method of forming self-assembled 
molecular capsules is known as molecular scaffolding (also known as edge-
directed self-assembly).58 One such example was reported by Thomas et al., in 
which a supramolecular cube was produced from 8 octahedral metal ions, the 
corners, and 12 ligands, the edges, via self-assembly (diagram c, figure 1.15).48  
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Additionally two-dimensional ligands may be employed in the production of 
molecular cages. In this case the ligand is able to bridge more than two metal 
ions and the ligands make up the faces of the structure. This approach is 
known as molecular panelling or face-directed assembly.59 An excellent 
example by Fujita and co-workers demonstrates the assembly of an octahedral 
3D structure.60 The idea to use 90° coordination angles of transition metals led 
to the production of a cis-protected square-planar metal (C*, figure 1.20). The 
prepared ethylenediamine-protected Pd(II) complex was shown to form simple 
2D square assemblies with 4,4’-bipyridine, a one-dimensional ligand. This 
structure was produced upon mixing equimolar amounts of cis-protected Pd(II) 
and 4,4’-bipyridine in aqueous solution, addition of ethanol to the reaction 
solution led to precipitation of the pure product. The tetranuclear square 
compound results due to the 180° divergence of the ligand and the nature of 
the cis-protected metal giving a 90° coordination angle. These architectures are 
now known as molecular squares (diagram a, figure 1.15).61 
 
The use of two-dimensional ligands with the square-planar protected metal ions 
afforded 3D assemblies. Fujita and co-workers47 have produced some 
fascinating self-assembled three-dimensional molecular cages, which show 
potential as synthetic receptors. When ligand Lf is exposed to C*, a symmetrical 
cage complex containing four ligands and six metal ions forms (figure 1.20). 
The cage has a large spherical central cavity with a diameter of ca. 11 Å, which 
is able to accommodate four molecules of adamantine carboxylate. This 
clathrate complex has been fully characterized by X-ray crystallography.62 
Further investigations of these cage complexes have dealt with such aspects 
as selective recognition of the guest species, as well as variation of the cis-
protected metal employed within the assembly. A Pt(II) containing complex was 
shown to be more stable upon exposure to harsh conditions, changes in pH 
and nucleophile addition, in comparison to a Pd(II) complex.63 The numerous 
examples which employ 2-dimensional organic components as molecular 
panelling illustrate that this is an efficient method in constructing large 3D 
architectures. 
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Figure 1.20 Three-dimensional supramolecular cage 
 
Ward et al.64-67 have also contributed a considerable quantity to the research of 
supramolecular cage complexes. This research focuses on multinucleating 
ligands all of which are based on pyrazolyl-pyridine chelating units linked to a 
central head-group. Initially the desire to extend the chemistry of the 
tris(pyrazolyl)borate ligand led to the incorporation of various substituents at the 
C3 position of the pyrazolyl rings.68 One such example was a hexadentate 
podand ligand hydrotris[3-(2-pyridyl)pyrazol-1-yl]borate. This derivative of 
tris(pyrazolyl)borate incorporates  2-pyridyl substituents at the C3 positions of 
the pyrazolyl rings giving a ligand which possesses three bidentate arms (Tppy) 
(figure 1.21). This was designed to encapsulate large metal ions, in many 
cases this is how the ligand behaves. Upon exposure to lanthanide metal ions 
mononuclear complexes result and the stoichiometries may be 1:1 or 1:2 
(metal: ligand).69   
Lf
C *
Pd=
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Figure 1.21 Ligand Tppy 
 
On reaction of the hexadentate ligand with Co(II) a mononuclear complex is 
formed, in contrast reaction with Mn(II) or Zn(II) forms tetrahedral clusters.70 
Reaction with Co(II) salts results in the formation of a 1:1 metal:ligand complex 
[Co(Tppy)][PF6], in which the Co(II) ion is coordinated in a trigonal prismatic 
geometry which is imposed by the steric constraints of the ligand strand, to give 
a relatively undistorted ligand. Reaction of Tppy with Mn(II) or Zn(II) salts and 
subsequent elemental analyses suggested a 1 : 1 metal: ligand ratio, however, 
the electrospray mass spectrum of each complex contained a weak peak 
corresponding to the presence of a tetranuclear species.  The crystal structure 
for each complex confirmed the formation of a tetranuclear complex cation 
[M4(Tppy)4][PF6]4 (M= Mn or Zn). The two complex cations display very similar 
structures, each ligand is spread out so each of the bidentate arms coordinates 
a different metal ion. In order for this to happen the tris(pyrazolyl)borate core 
adopts an inverted geometry such that the apical hydrogen is directed inwards. 
Each metal ion displays a pseudo-octahedral coordination geometry from three 
bidentate pyrazolyl-pyridine groups from three different ligands. It was realised 
that this was the only way in which an octahedral geometry could be produced, 
since it would not be possible for the three arms of one ligand to provide an 
octahedral donor set to encapsulate one metal ion.  
 
Following on from this initial research into the coordination behaviour of 
poly(pyrazolyl)borate ligands it was identified that extension of this class of 
_
Tppy
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bridging ligands through substitution of the spacer group would be valuable. 
Consequently aromatic hydrocarbon spacers provided a suitable alternative as 
a bridging unit to separate the two binding sites (figure 1.22).65-67, 71 
 
Figure 1.22 Examples of aromatic hydrocarbon spacer ligands 
 
1.6 Helicates  
Metallosupramolecular chemistry has provided access to architectures of 
higher complexity through self-assembly. There has been substantial 
contribution from numerous research groups to this area of chemistry, 
presenting a wide variety of eye catching and innovative architectures. 
Inspiration for such systems can be ascribed to nature. With the precision and 
accuracy of self-assembly and self-organisation observed in biological systems, 
it is no surprise chemists wish to mimic these processes to better understand 
them as well as to master non-covalent interactions within synthetic systems. 
The spontaneous association of complementary base pairs leading to the 
formation of the DNA double helix has been an area of intense interest. It has 
been shown that the entwining of the two strands for the formation of the 
Bp-phen
Bp-biphen
26 
 
double helix occurs in two stages. Initially there is nucleation; the two strands 
come together. This association is thermodynamically unfavourable due to the 
loss in entropy. However, subsequent hydrogen bonding between every 
additional base pair leading to the complete double helix more than 
compensates for this initial loss.5 This is just one of the many remarkable 
examples of self-assembly observed in a biological system. 
 
An example of an inorganic helix was reported by Lehn in 1987, with the 
introduction of the term ‘helicate’ to describe the polymetallic helical double-
stranded complex.72 The ligand strands used in the formation of a helicate are 
known as helicands, reaction of a helicand with an appropriate metal centre 
resulting in the formation of a complex gives a “helicate”.4 The formation of a 
helicate requires one or more organic strands, containing multiple binding sites, 
which are able to wrap around two or more metal centres defining a helical 
axis. A coiled spring is a good example of a helix, as helices can run in either 
right or left direction a special property of a helix is chirality.  
 
The successful assembly of a helicate from its components is dependent on the 
design of the ligands and metal ions selected, similar to the self-assembly of 
the metal-directed arrays seen previously. Helicates have similarities to the 
self-assembly of ladders in that they are assembled from linear molecular 
threads which coordinate a number of metal centres, however, helicates require 
more flexible ligands to allow twisting around the metal ions to form a helical 
structure. These structures are interesting as achiral ligands may be used for 
the assembly and a chiral architecture may result. 
1.6.1 Nomenclature   
To communicate clearly the components of a metallosupramolecular helicate 
some form of unambiguous naming of the structure is required. As new 
structures being produced display better control over the self-assembly and 
ever more interesting features this nomenclature can become complicated. 
Initially a few aspects can easily be determined for the naming process: i) the 
number of ligands ii) the number of metal centres. Following this a simple 
helicate can be identified from the number of ligands and the number of metal 
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ions. For example a helicate containing two ligands is a double helicate, three 
ligands a triple helicate, with each additional ligand adding to this naming. The 
number of metal ions is expressed by dinuclear, trinuclear, tetranuclear, 
pentanuclear... for two, three, four (and so on) metal ions. From this point other 
nomenclature can be introduced into the name depending on other features of 
the metal ions or ligand strands.  
 
Within a complex the ligand strands may be of one type (homoleptic or 
homostranded), use of different ligand strands provides heteroleptic or 
heterostranded helicates. The other possible difference between molecular 
strands for helicate formation is variation of binding domains. A ligand 
containing identical binding domains is a homotopic ligand, different 
coordination sites along a strand are known as heterotopic ligands. Two 
isomeric forms exist if a heterotopic ligand strand is employed. Depending on 
the orientations of the ligands upon coordination this may give a head-to-head 
(HH) or a head-to-tail (HT) configuration. Additionally these sections of 
helicates can be further divided to take into account the nature of coordination 
to the metal centre, giving saturated helicates when the coordination sites of 
the metal ion are fulfilled by the donor atoms of the ligand strands. Unsaturated 
helicates occur when other atoms (possibly from solvent molecules) are 
required to satisfy the coordination requirements of the metal centre.73 
 
1.6.2 Homotopic helicates 
There are many examples of homotopic helicates. These are produced from 
the self-assembly of molecular strands containing identical binding domains 
along the ligand strand and a suitable metal centre. Ideally homotopic helicates 
give complexes with a constant pitch (palindromic helices). One such example 
can be found in the early work published by Lehn et al.72 in which ligand 
strands containing two or three β,β’-bipyridine units separated by oxapropylene 
bridges and their coordination properties with metal ions was investigated. Of 
particular interest was the result produced upon complexation with copper(I). 
Determination of the crystal structure of the complex between ligand (Lg) and 
Cu+ was found to be a trinuclear double helicate (figure 1.23). This structure 
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results due to the intrinsic information provided by the metal ions and the 
structure of the ligand. The ligand is flexible enough to allow twisting of the 
strand around the metal ions but sufficiently rigid to prevent coordination to one 
metal ion. As the stereochemical requirements of the metal ion are fulfilled this 
is also an example of a saturated helicate. Bipyridine and oligobipyridine 
derivatives are now frequently employed in the formation of helicates. 
 
Figure 1.23 Trinuclear saturated homotopic double stranded helicate 
 
1.6.3 Heterotopic helicates 
 
As with homotopic helicates ligands focused on pyridine and bipyridine 
functionalities have been popular in the research of heterotopic assemblies. 
Heterotopic ligands contain different binding sites; this difference could be 
introduced by variation of the number or type of donor atoms present. This 
Cu(I)
Lg Cg = [Cu3(Lg)2]3+
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leads to the possibility of two isomeric forms depending on the various 
arrangement of the molecular strand, giving directionality to ligand strands. 
Constable et al. demonstrate this well with the coordination of asymmetrically 
substituted β,β’:6’,β’’:6’’,β’’’-quaterpyridine to copper(I).  Initial attempts to 
demonstrate selectivity for the formation of a single conformational isomer 
produced only a small excess of the less hindered isomer.74 Synthesis of other 
asymmetrically substituted β,β’:6’,β’’:6’’,β’’’-quaterpyridines however provided 
better results.75 As can be seen, two additional ligands were produced with 
variation in the substituent located at the 4 (R) and 4’ (R’) position of the 
pyridine rings (figure 1.24).  
 
Complexes of the ligands were obtained upon treatment of methanolic solutions 
of the ligand (Lh2 or Lh3) with excess metal ([Cu(MeCN)4][PF6]) under an 
atmosphere of argon, resulting in the formation of dark brown solutions from 
which the brown complexes [Cu2(L)2][PF6]2 (L = Lh2 or Lh3) could be obtained. 
Diffusion of diethyl ether into acetonitrile solutions of the complexes gave 
sufficiently pure crystals for structural analysis. It was determined from the data 
that a dinuclear species was present. From the NMR and subsequent COSY 
and NOESY assignment the data suggest a 1:1 mixture of the two 
conformational (HH and HT) isomers for Lh2, while only one isomer is present in 
the data for the other ligand Lh3. Problems with crystal formation, stability and 
disorder only allowed comment on the gross structural features; this did 
however confirm the presence of only one isomer (HH) for the Lh3 ligand. 
Through molecular modelling the reasoning for the preferential formation of this 
conformer was attributed to short contacts between the tert-butyl substituent in 
the other isomer.76 
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Figure 1.24 Directional helicates from asymmetrically substituted quaterpyridine 
 
Steric control over the conformational isomerism is not the only method which 
may be employed to direct the assembly; this may also be achieved by the 
careful selection of the metal centre and binding sites within the ligand.77-79 
 
1.6.4 Unsaturated helicates 
The previous examples have all been saturated helicates. This means the 
stereochemical requirements of the metal were satisfied by the coordination of 
the ligand atoms alone. There are, however, a few cases where additional 
species (anions or solvent molecules) are required to complete the coordination 
sphere of the metal centre. There are fewer unsaturated helicates that have 
been investigated and completely characterised, this is possibly due to the 
reduced selectivity of these assemblies.73 
 
These assemblies result when the number of donor atoms within a binding 
domain of the ligand strand is inconsistent with the coordination demands of the 
metal centre. An example of a heterotopic unsaturated helicate was reported by 
Constable et al. 80, in which the relatively simple β,β’:6’,β”:6”,β”’:6”’,β””-
Lh
Lh1 (R=Me, R'= SEt)
Lh2 (R=Me, R'= H)
Lh3 (R=But, R'= H)
H-H H-T
1
0
1
1
Ch
31 
 
quinquepyridine ligand (Li) was used. This ligand may be seen as a bipyridyl, 
bidentate unit, and terpyridyl, tridentate unit, joined together giving heterotopic 
binding domains. Reaction of the ligand with copper(II), cobalt(II), zinc(II) or 
nickel(II) acetate in boiling methanol followed by addition of [NH4][PF6] allowed 
isolation of the complex salt [M2L2]4+. From the copper(II) acetate reaction a 
number of species were isolated. These species contained a varying number of 
ancillary ligands. Analysis of a complex from the copper reaction shows the 
formation of a dinuclear unsaturated heterotopic double homoleptic helicate, 
with each ligand within the assembly acting as a bidentate donor to one metal 
and a tridentate donor to the other metal centre forming the head-to-head 
conformer. One copper ion has a distorted octahedral coordination geometry 
and the other copper centre has a highly distorted trigonal bipyramidal 
geometry. This second copper centre is coordinated by the two bidentate 
bipyridyl sections of the ligand and an oxygen atom from an acetate group 
(figure 1.25).79 
 
Figure 1.25 Dinuclear unsaturated heterotopic double stranded homoleptic 
helicate 
Cu(II)
Li Ci
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1.6.5 Heteroleptic helicates  
 
The helicates, discussed previously, have all contained identical ligand strands 
within the helicate i.e. are homostranded helicates. It is possible, however, to 
incorporate different strands within a helicate resulting in heterostranded or 
heteroleptic helicates. Hasenknopf et al. provided one example for the 
synthesis of a heteroleptic helicate.81 The assembly of a heteroleptic helicate 
through programming of the components was seen as the next step in the self-
assembly of helicates. The two ligands selected had previously been produced 
and shown to form homoleptic helicates, copper(I)72 with Lk and iron(II)82 or 
nickel(II)83 with Lj. Reaction of three equivalents of Cu(CF3SO3)2 (in acetonitrile 
solution) and one equivalent of each ligand strand in chloroform gave a blue 
green solution upon reaction completion. The crystal structure was obtained 
which confirmed the formation of the desired trinuclear heteroleptic helicate, in 
which each metal ion is pentacoordinated by one terpyridyl unit of Lj and a 
bipyridyl group from Lk (figure 1.26). This example demonstrates well how the 
self-assembly may be directed by the binding information within the ligand 
strands and metal ion selected. 
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Figure 1.26 Trinuclear saturated homotopic double stranded heteroleptic 
helicate 
 
1.6.6 Heteronuclear helicates 
It is clear from the previous examples that different metal ions can be used in 
the self-assembly of helicates. For the self-assembly to be successful the metal 
ions must be complementary to the ligand. Tetrahedral metal centres form 
double stranded helicates with molecular strands possessing multiple bidentate 
domains; octahedral metal ions forming double stranded helicates require 
molecular strands with tridentate sites. An octahedral metal ion can also form 
triple stranded helicates with ligands consisting of bidentate domains. These 
general rules for matching the intrinsic information to direct the self-assembly of 
a helicate may not be applicable to every system. For example copper(II) is 
known to display a number of distorted coordination geometries, with five-
coordinate complexes being a common occurrence.84 As seen within the 
section relating to unsaturated helicates the β,β’:6’,β”:6”,β”’:6”’,β””-
quinquepyridine ligand was shown to coordinate two copper ions, with each 
copper ion within the assembly displaying a different coordination geometry. 
Lj
Cu(II)
Lk
Cjk
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The different geometries within the complex were due to the binding sites 
available within the ligand strand. As this ligand is heterotopic, it possesses 
different binding domains, the ligand can be seen as being split into a bidentate 
and a tridentate domain.  
 
The examples so far have incorporated one type of metal ion within each 
complex i.e. a homonuclear helicate. Constable et al. have contributed a 
substantial amount of research into the self-assembly of metal ions with 
oligopyridines.75, 85, 86 By using helicates already known it was rationalised that 
it would be possible to convert a mono-helical cobalt(II) complex to a 
heterobimetallic double helicate upon exposure to a compatible metal ion such 
as copper(I) or silver(I).78 This research was conducted using a variety of 
β,β’:6’,β”:6”,β”’:6”’,β””-quinquepyridine derived ligands (Li). Reaction of 
solutions containing [Co(Li)(MeCN)2]2+ with half an equivalent of silver(I) or 
copper(I) resulted in the precipitation of solids after treatment with [NH4][PF6] or 
Na[BF4]. This initial research did not successfully produce good quality crystals. 
Subsequent investigation along the same lines resulted in the successful 
formation of heterodinuclear double helicates in the solid state upon reaction of 
one equivalent of β,β’:6’,β”:6”,β”’:6”’,β””-quinquepyridine with half an equivalent 
of each metal ion, cobalt(II) and silver(I) (figure 1.27).87  
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Figure 1.27 Representation of the first structurally characterized 
heterodinuclear double helicate 
So far only octahedral and tetrahedral metal ions have been considered for the 
formation of helicates. It is, however, possible to use other metal centres with 
higher coordination numbers, such as lanthanide metal ions.88 These metals 
can display a range of coordination geometries (generally 6-12). If a tricapped 
trigonal prismatic geometry (9 coordination geometry) is displayed then the 
metal centre has the potential to form triple stranded helicates with molecular 
strands possessing tridentate domains.89  
 
1.6.7 Chirality in helicates 
 
A helix is generated from the motion of a point around and along a line, the 
helical axis. The helix is characterised by its helical axis, a screw sense (i.e. 
chirality) and a pitch (rate of axially linear to angular properties). In an ideal 
example the axis is a straight line and the two kinds of motion, linear and 
circular, give a helix with a constant radius (constant distance from axis, r) and 
constant pitch (palindromic). The direction of the circular motion may be right 
Ci 2Li
Co(II)
Ag(I)
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handed (P, plus) or left handed (M, minus). So if the direction of the rotation of 
a helix is clockwise from the end closest to the viewer to the end which is 
distant this gives the P helix while a rotation anticlockwise gives the M helix 
(figure 1.28).90 
 
Figure 1.28 Illustration representing a right-handed (P-plus) and a left-handed 
(M-minus) helix (where I is the pitch and z gives the helical axis) 
 
Chirality operates at the molecular and supramolecular levels. As such 
supramolecules, as with molecules, can express chirality with enantiomeric and 
diastereomeric forms. Within the metal-directed assembly of helicates the 
helices are a racemic mixture of the plus (P) and minus (M) enantiomers. The 
ability to selectively form one of the helicates, P or M, shows a higher level of 
control over the assembly. This is of importance as chirality is seen in biological 
systems and has been an issue within medical research.  
 
Chiral ligands have been employed for the self-assembly of helicates. When 
chiral ligands are used the P and M forms are diastereomers. Enantiomers 
possess identical chemical and physical properties except for the direction they 
rotate plane-polarised light, whereas diastereomers express different chemical 
and physical properties. Thus one diastereomer could be more 
thermodynamically stable than others resulting in one isomer being produced in 
excess. The use of chiral ligands to direct self-assembly has been an area of 
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some interest. With contributions from numerous research groups some 
remarkable results have been produced.73 
 
Constable et al. have a background in the self-assembly of helicates using 
oligopyridine and oligobipyridine which is known as a robust method for helicate 
formation with carefully selected metal ions. With the use of chiral oligopyridine 
ligand strands Constable et al. have demonstrated the diastereoselective 
formation of helicates.91 A pair of enantiomeric 2,2’:6’β’’-terpyridine ligands (LL 
and Lm) was prepared by reaction of  6-bromo-6’’-methyl- β,β’ : 6’,β’’- 
terpyridine with the sodium salts of (1S)-(-) or (1R)-(+)-borneol (figure 1.29). It 
is known that the coordination of terpyridines to copper(I) produces dinuclear 
double species. In this example using the chiral terpyridine and copper(I) a 
number of possible double helicates may result. This ligand is directional so 
head-to-head and head-to-tail isomers are possible for the P or M conformers 
as the helicate itself is chiral. Reaction of the ligand, LL or Lm, with 
[Cu(MeCN)4][PF6] in acetonitrile gave an orange-red solution from which a 
precipitate was isolated upon addition of [NH4][PF6]. X-ray structural 
determination was achieved from crystals produced from the recrystallisation of 
the crude [Cu2(LL)2][PF6]2 or [Cu2(Lm)2][PF6]2 complexes from acetonitrile by 
slow diffusion of diethyl ether. This confirmed the formation of the head-to-tail 
isomer and the diastereoselective formation of (S)(S)-(M)-HT isomer for LL and 
(R)(R)(P)-HT isomer of Lm. The preferential formation of the HT helicate is due 
to reduced steric interactions between the chiral groups in relation to the head-
to-tail isomer. The reasoning for the preferential formation of a given 
diastereoisomer is not as clear cut. 
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Figure 1.29 a) Ligands LL and Lm b) schematic representation of the possible 
HH and HT diastereomeric dinuclear double helicates from the reaction of chiral 
ligands LL and Lm with Cu(I) (S*= homochiral compounds, (S,S) or (R,R))91 
  
LL
a)
Lm
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Following this research relating to the formation of diastereoselective helicates 
other ligands were produced which upon complexation to different metal ions 
displayed a greater level of diastereoselectivity. In the previous example the 1H 
NMR spectrum of each complex showed two species in solution with a d.e 
(diastereomeric excess) of 75%. Subsequent ligands (for example figure 1.30) 
produced by Constable et al. showed 95% d.e with silver(I)92 and 98.7% with 
copper(I).93 
 
Figure 1.30 Chiral ligand produced to control the chirality of helicates 
 
Another researcher within this area of chiral control of helicates is Von 
Zelewsky. Early research focused on ruthenium(II) complexes produced by 
coordination to a number of bridging chiral bisbipyridine ligands, becoming 
known as “chiragen” ligands.94 Von Zelewsky reports the application of 
chiragen-type ligands in the self-assembly of helicates.95 One of these 
chiragen-type ligands, 4,5-chiragen (LO, figure 1.31), has been shown to form 
complexes with a number of octahedral metal ions (Cd(II), Zn(II) and Fe(II)). 
Through analysis it was determined that the major species produced is a 
dinuclear triple helicate which shows preferential formation of one of the 
stereoisomers.96  
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Figure 1.31 4,5-Chiragen-type ligand produced for diastereoselective formation 
of helicates 
 
The research so far has involved double- or triple-stranded helicates; however, 
as chirality is an intrinsic property of a helix, single stranded helicates also 
exhibit chirality. Kwong et al. have reported the synthesis of a new chiral 
quaterpyridine ligand (LP) which forms a stereoselective single-stranded 
dinuclear helical complex with palladium.97 Each Pd atom adopts a distorted 
square-planar geometry. X-ray crystal structure and CD analyses confirm the 
complex structure to be stereoselective in the assembly giving the M-[Pd2(3-
C3H5)2(Lp)] complex (figure 1.32). 
 
Figure 1.32 Stereoselective self-assembly of a single-stranded helicate 
Lo
Lp
[Pd(η3-C3H5)Cl]2
C p
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1.6.8 Meso-helicates 
 
The term meso-helicate was introduced around 1995; also at the same time 
additional terms, ‘side-by-side complex’98 and ‘mesocate’, were introduced to 
describe the same kind of coordination array. In the formation of helicates the 
ligands within the assembly twist around the metal ions forming a helix, in 
meso-helicates the ligands adopt a ‘side by side’ arrangement. The ligands in a 
meso-helicate do not twist around the metal ion in a helical rotation and thus 
the meso-helicate gives an achiral product from the self-assembly.99 There has 
been some interest in the factors which drive the assembly toward the 
formation of the achiral meso-helicate in preference to the chiral helicate. 
Albrecht’s research led to the suggestion that the length of alkyl spacers 
between bidentate binding domains of alkyl bridged dicatechol ligands could be 
used to predict the selective formation of meso-helicates.100  
 
An interesting example of a mixed-ligand mesocate has been reported by Ward 
et al.101 Two bisbidentate  ligands  which possess two N,O-donor pyrazolyl-
phenol units (Lq and Lr) have been shown previously102 to form conventional 
double helicates with Co(II), Cu(II) and Zn(II) in which the metals adopt a 
distorted tetrahedral geometry. A 1:1 mixture of each ligand (Lq, Lr), with 
triethylamine to deprotonate the phenol donors, was treated with metal salts in 
methanol. The product formed was isolated by filtration and analysed to 
determine the distribution of the three possible structures. From the reaction 
between Lq, Lr and Zn(II) crystals were obtained; X-ray structural determination 
revealed the structure to be the ‘face to face’ arrangement of the two ligands 
giving an achiral heteroleptic mesocate (figure 1.33). 
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Figure 1.33 Illustration of the assembly of a dinuclear heteroleptic mesocate 
 
1.7 Circular helicates 
The principles for the successful formation of helicates are now generally well 
known. The self-assembly of these linear polynuclear structures results from 
the careful selection of complementary ligands and metal centres. Contributions 
from many research groups have produced a vast array of ligands which are 
able to coordinate a whole host of metal ions and through self-assembly lead to 
helicates. Numerous architectures from the simple dinuclear double helicates to 
other polynuclear double-, triple- and even quadruple-stranded helicates are 
now known.80-82, 84 As seen in previous sections these structures can be further 
controlled or varied through incorporation of different features within the ligand 
strand or variation of stereochemistry of the metal centres.  
 
In comparison to helicates the self-assembly of circular helicates, a higher 
nuclearity assembly, is less well understood. This is partially due to the design 
principles of these architectures which are essentially the same as their linear 
counterparts. For the self-assembly of helicates and circular helicates a ligand 
containing at least two suitable binding sites that coordinate different metal ions 
= Zn(II) Zn(BF4)2.H2O  
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is required. However, for the self-assembly of a circular helicate the entropically 
favoured linear assembly must be prevented. The assembly of linear helicates 
could be hindered through intermolecular interactions such as templation by 
anions or intramolecular interactions which stabilise the formation of a circular 
structure. The nomenclature employed in the identification of circular helicates 
is essentially the same as that used for linear helicates.  
 
1.7.1 Anion templation  
As with linear helicates the vast majority of circular helicates are produced 
using homotopic ligands, ligands which contain the same binding domains. The 
first example of a circular helicate was reported by Lehn and co-workers.103 
Reaction of tris-bipyridyl ligand (Ls) and an equimolar quantity of Fe(II)chloride 
in ethylene glycol gave a red-orange solution; addition of ammonium 
hexafluorophosphate afforded a red precipitate. This was separated and the 
structure confirmed using 1H NMR, mass spectroscopy and X-ray crystal 
structure determination. The structure was found to contain five Fe(II) ions, five 
ligands and a chloride ion [(Fe5Ls5)Cl]9+. Three bipyridine groups, belonging to 
three different ligands, are coordinated to each metal ion giving each Fe(II) a 
distorted octahedral coordination geometry. The short linkers between the 
bipyridyl groups prevent the terminal and central bipyridyl units coordinating the 
same metal ion; in addition to this the two terminal bipyridyl groups are unable 
to coordinate the same metal centre as this would distort the central unit. The 
metals almost lie in one plane and form the corners of a pentagon, with the 
ligands wrapped helically around the metals forming the sides of the pentagon. 
The structure has been identified as a pentanuclear circular helicate [5]cH 
(figure 1.34).The cavity of the structure is occupied by a chloride ion, with no 
exchange of anion occurring even with excess of other anions (PF6-, CF3SO3-) 
demonstrating ion selectivity of the receptor for Cl-. 
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Figure 1.34 Self-assembly of a pentanuclear circular helicate 
 
Further understanding of the factors controlling this self-assembly was required. 
Lehn and co-workers104 subsequently investigated how variation in the system 
components, such as metal salt and structure of the ligand, would affect the 
outcome of the self-assembly. With variation in the metal salt (FeSO4) a 
hexagonal circular double-helicate,[6]cH, was produced. The idea that the size 
of the circular double helicate could somehow be dependent on the anion 
prompted further inspection. Other metal salts employed produced circular 
helicates and it was determined that the charge of an anion had little influence 
on the structure (i.e. mono- or divalent). The important feature was shown to be 
FeCl2
CS
LS
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size of the anion; the size of the circular helicate was dependent on the size of 
the anion used, suggesting the role of the anion is to act as a template for the 
self-assembly of these circular helicates. As well as variation in anions a 
different ligand was also synthesised to identify the role of the ligand structure 
in the self-assembly. Exchange of the ethylene bridges for oxypropylene 
bridges gave a longer ligand (Lt) displaying a higher level of flexibility in 
comparison to the ethylene bridges. Reaction of this ligand with Fe(II) ions 
results in the assembly of a tetrameric circular assembly [4]cH. This structure is 
produced due to the increased length of the ligand, giving a larger cavity, and 
higher flexibility allowing more bending of the ligand to form a square (figure 
1.35).  
 
Figure 1.35 Self-assembly of a tetranuclear circular helicate from four Lt ligands 
and four Fe(II) ions 
FeCl2
Ct
Lt
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1.7.2 Alternatives to anion templation 
Following on from the initial research conducted by Lehn et al. other groups 
have reported circular helicates which are not dependent on anion templation. 
Thummel and co-workers produced ligands for coordination with metal ions 
which contained a pyrene unit which due to its ability to form well organised π-
stacked arrays dictates the nuclearity of the complex in this case forming a 
trimeric species.105 Hannon106 demonstrated that the coordination geometry of 
the metal ion employed can influence the self-assembly, showing that reaction 
of bis-pyridylimine ligands containing a 1,3-bis(aminomethyl) benzene spacer 
unit with tetrahedral metal centres gives linear dimers while coordination to 
octahedral metal ions produces a triangular circular helicate.  
 
An elegant example by Rice et al.107 demonstrates the self-assembly of circular 
helicates controlled by inter-ligand interactions, which is dependent on the size 
of the metal ion used. The ligand (Lu) consists of two tridentate domains, 
containing thiazole–pyridyl–pyridyl units, separated by a phenylene spacer 
(figure 1.36). Reaction with Cd(ClO4)2.6H2O in nitromethane produced crystals 
upon diffusion of dichloromethane. The structural determination showed a 
dinuclear double stranded helicate in which the cadmium(II) metal centres 
adopt a distorted octahedral coordination geometry due to coordination with 
one tridentate, thiazole–pyridyl–pyridyl, domain from each ligand strand. 
Reaction with Zn(CF3SO3)2 in acetonitrile gave a colourless solution which 
upon layering with ether resulted in the formation of crystals; structural analysis 
revealed  the formation of a pentanuclear cyclic helicate. The Zn2+ metal ions 
within the assembly are six-coordinate again due to the coordination with two 
tridentate domains, thiazole–pyridyl–pyridyl, from two different ligands. The 
ligands wrap around the metal ions in an ‘over and under’ conformation, giving 
the helical cyclic oligomer. To rule out the possibility that the difference in 
architecture could be due to use of different metal salts 1H NMR solution 
studies were conducted to monitor any effect upon addition of another anion. 
This showed, even with addition of an excess of the second anion, no 
observable influence.  The vast difference seen between the structures has 
been assigned to the difference in size between the metal ions, which causes 
unfavourable inter-ligand steric interactions.   
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Figure 1.36 Ligand, Lu, employed for the self-assembly of a circular helicate 
 
1.7.3 Directional and heteroleptic circular helicates   
 
As discussed above linear helicates may be programmed to express a variety 
of structural features, from the standard dinuclear double helicate to 
polynuclear double- , triple- and quadruple-stranded assemblies. They can also 
be programmed to give architectures which display a higher level of complexity, 
such as directionality and heteroleptic structures. The programming of such 
helicates is through the ligands selected and metal centres. To control the 
directionality of a helicate the ligand strand must contain at least two different 
binding domains, such as a tridentate and bidentate unit, which upon 
coordination gives a head-to-head or head-to-tail arrangement. The conformer 
which results may be controlled with the selection of metal ion, thus if a metal 
ion which possesses a geometry which forms five-coordinate species is 
employed the preferential coordination of one bidentate and one tridentate 
domain will give the head-to-tail isomer. The formation of the head-to-head 
isomer may likewise be programmed for self-assembly by using two metal ions 
one of which is tetrahedral, for binding the bidentate domains, and one which is 
octahedral, for the tridentate domains, assembling the ligand in a head-to-head 
conformation.  
 
Until recently these principles for directing structures of higher complexity had 
not been applied to the assembly of circular helicates. Rice et al.108 elegantly 
demonstrated the application of these simple principles for the formation of a 
Lu
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higher complexity circular helicate. The principles which govern the assembly of 
circular helicates are essentially the same as those which are applicable to 
linear helicates, with the additional proviso that the formation of the linear dimer 
must be hindered. A few methods for the stabilisation of the circular 
architecture have been reported,103, 104, 107, 108 in this instance the formation of 
the circular helicate was driven by repulsion between protons located on the 
central phenyl group within the ligand. 
 
The use of a phenyl spacer within the ligands has provided a reliable and 
robust method for the self-assembly of circular helicates. Variations in the 
structure of the ligand, Lu, led to the synthesis of Lv and Lw providing new 
structures for the investigation of higher complexity circular assemblies (figures 
1.37 and 1.38). Lv was used to probe the possibility of directionality within these 
higher nuclearity species.  Using similar design principles as those for the 
assembly of linear analogues a ligand containing a bidentate and tridentate 
domain separated by a 1,3-phenylene spacer was produced, reasoning that 
one bidentate and one tridentate domain is required to satisfy the 
stereochemical requirements for a metal ion displaying a pentacoordinate 
geometry, resulting in the assembly of a head-to-tail motif. Reaction of Lv with 
one equivalent of Cu(ClO4)2·6H2O in acetonitrile gave a crystalline solid after 
diffusion of chloroform. Structural analysis confirmed the head-to-tail 
pentanuclear circular helicate [Cu5(Lv)5](ClO4)10 (figure 1.37).  
 
 
Figure 1.37 Lv used in the self-assembly of a head-to-tail circular helicate. 
Cu(II)
Lv
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As expected the bidentate and tridentate domains of the ligand coordinate two 
different metal centres, with each centre adopting a distorted square-based 
pyramidal geometry. This is an excellent example of a head-to-tail circular 
helicate.  
 
In addition to demonstrating the possibility of producing a circular helicate 
displaying head-to-tail conformation, the assembly of a heteroleptic circular 
helicate was investigated.  For this experiment Lu, a bis(tridentate)ligand, and  
Lw,  bis(bidentate) ligand, were utilised. The arrangement of these ligands in a 
circular array has the potential to produce any number of different structures. 
Initial attempts using mixed metals to form a heteroleptic species were 
unsuccessful, which resulted in the use of copper(II) as it may display more 
than one coordination geometry. Reaction of Cu(II) with Lu and Lw in a 5:3:2 
ratio gave the desired pentanuclear heteroleptic complex [Cu5(Lu)3(Lw)2]10+, 
however, this reaction gave a mixture of other species as well as the desired 
heteroleptic circular helicate. In order to force the equilibrium towards a 
heteroleptic helicate the component ratios were altered giving a 2:1:1 ratio of 
Cu2+: Lu: Lw. ESI-MS of the complex in acetonitrile showed a number of peaks 
which potentially corresponded to a heteroleptic species. Crystallisation of the 
complex from nitromethane was achieved after slow diffusion of ethyl acetate. 
X-ray analysis confirmed the presence of a heteroleptic circular helicate in 
which five copper(II) ions are coordinated by three strands of Lu and two Lw 
strands. One of the metal ions is octahedrally coordinated by two tridentate 
domains and the remaining metal ions are bound by one tridentate and one 
bidentate domain making them five-coordinate (figure 1.38).   
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Figure 1.38 Lu  and Lw used in the self-assembly of a heteroleptic circular 
helicate [Cu5(Lu)3(Lw)2]10+ 
 
1.7.4 Diastereoselective circular helicates 
Circular helicates are also intrinsically chiral so the architectures which result 
within an assembly are a racemic mixture of the two enantiomers. In a similar 
way to the linear analogous the chirality may be influenced by incorporation of 
chiral centres within the ligand strands. An elegant example by Von Zelewsky 
and co-workers demonstrates the application of the principles used in the 
formation of linear helicates is applicable in the formation of circular assemblies 
to selectively provide one diastereomer. 
 
From previous research a family of ligands which incorporate a number of 
pinene-2,2'-bipyridine moieties into one ligand strand have been synthesised.95, 
96
 Due to steric constraints Lx (figure 1.39) is unable to coordinate in a 
tetradentate manner to one coordination centre. The interaction of Lx with labile 
coordination centres was tested for the possibility of producing polynuclear self-
assembled structures. A mixture of a 1:1 molar ratio of Lx and AgPF6 in 
Cu(II)
Lu
Lw
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acetonitrile solution followed by slow diffusion of diethyl ether provided crystals. 
X-ray diffraction analysis of the silver complex shows a hexameric single-
stranded circular helicate which displays a P handedness of the resulting helix. 
The silver centres are tetrahedrally coordinated by four nitrogen atoms from two 
different ligands. This is the first example of a self-assembled hexanuclear 
structure which is a circular helicate with a predetermined configuration.109 
 
Figure 1.39 Lx ligand utilised in the diastereoselective self-assembly of a 
circular helicate 
 
1.7.5 Circular meso-helicates 
 
In comparison to helicates the occurrence of circular and meso-helicates is 
rare, while examples of circular meso-helicates are even more uncommon. 
Gloe et al.110 have created some beautiful architectures, which present the first 
examples of circular meso-helicates. Using ligands Ly, Lz and LA’ (figure 1.40) 
the bis-pyridylimine ligands differ in the central linking component between the 
two binding domains. Previous studies have shown these ligands form a variety 
of supramolecular structures depending on the metal ion employed.111,112 
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= Cu(II) 
 
 
Figure 1.40 a) Ligands utilized for the self-assembly of circular mesocates b) 
Schematic representation of a hexanuclear mesocate with Cu(II)  
 
Reaction of Ly, Lz or LA’ with CuSO4.5H2O in a mixed solvent system (methanol 
/water/acetonitrile) followed by slow diffusion of diethyl ether gave crystals 
suitable for X-ray structural determination. Each of the complexes formed from 
the three ligands is essentially the same; the Cu(II) ions have alternating L- and 
D- configurations leading to the meso-helicate. Each metal centre has a 
distorted octahedral coordination geometry with binding to two bidentate 
pyridylimine strands of different ligands and one sulfate ion, resulting in a 
neutral hexanuclear complex with six anions associated with the molecule. The 
Ly LA'Lz
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anions have been shown to play a major role within the formation of these 
assemblies as substitution of the anion for alternatives (e.g. ClO4- or NO3-) 
yields a non-cyclic structure under otherwise identical reaction conditions. The 
hexanuclear meso-helicates produced are the first examples of neutral circular 
meso-helicates. As well as hydrogen bonding and π–π stacking interactions, 
the assembly is controlled by association with the sulfate anions which provide 
a double stranded rather than a triple-stranded structure around the metal ions. 
The variation of linkers within the ligands surprisingly showed little influence 
over the resulting complexes.  
 
The examples given demonstrate a whole host of inspiring architectures. This 
research has expanded upon the principles determined for the successful 
assembly of linear helicates and applied them to the higher nuclearity species 
known as circular helicates, showing that complex architectures may result due 
to complementarity of the chemical information stored within the covalent frame 
work of the ligands and the intrinsic properties of the metal centres. Other 
components, such as anions and solvents, may also play important roles within 
these assemblies. 
 
1.8 Allosteric interactions  
 
For self-assembly and self-organisation to occur components containing two or 
more interaction sites are required; this introduces the possibility of allosteric 
interactions which can play a significant role within self-processes. Allostery 
results when occupation at one site influences the binding features of another. 
This may mean the binding at the second site is favoured or disfavoured, giving 
positive co-operativity and negative co-operativity respectively.1 Allosteric 
interactions are important within biological systems, for example hemoglobin is 
an extremely important protein present in red blood cells. This respiratory 
protein is responsible for the transport of oxygen into tissues and the removal of 
carbon dioxide. The binding of oxygen atoms by this protein is cooperative; the 
binding of one oxygen atom leads to favourable binding of additional oxygen 
atoms. Enzymes are another example of biological systems capable of 
54 
 
displaying allosteric effects. Enzymes are seen as biological catalysts, they are 
responsible for a number of biologically important processes and functions 
within nature. A simple enzyme may contain an active site which is specific for 
a particular substrate; in addition to the active site another, allosteric, site may 
be present. The allosteric site could potentially bind to a species which 
activates the enzyme to bind the substrate or an inhibitor may be present at the 
allosteric site which can turn off the enzyme’s activity. This simplified 
explanation of allosteric effects within enzymes provides the basic ideas of 
what takes place in order to regulate enzyme activity. These features of 
enzyme activity are a target for application within synthetic systems.113 
 
The initial application of allosteric effects to synthetic systems was proposed by 
Rebek et al.113 Identification of the minimum requirements for an allosteric 
effect, i.e. an active site, a remote site (also known as an allosteric site) and a 
conformational mechanism which connects the two, provided a starting point for 
developing supramolecular systems capable of mimicking this type of 
behaviour.  A macrocyclic polyether incorporating a β,β’-bipyridyl and crown 
ether site within the same structure (LB’) gave a system containing two binding 
sites required for allosteric behaviour (figure 1.41).114 The polyethers are known 
to bind alkali metal ions and the β,β’-bipyridyl unit to chelate transition metals. 
Although the two sites are separated from one another they are not expected to 
behave independently. The binding at one site forces conformational 
restrictions on the other site thereby altering its receptivity to binding. 
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Figure 1.41 Representation of binding-induced conformational changes within a 
synthetic system114 
 
In this example the allosteric effect was determined by ion transport 
experiments. Transport of ions, Li+, Na+, and K+, across a chloroform liquid 
membrane with LB’ containing tungsten (W) was examined within a U-tube. The 
free macrocyclic crown was shown to preferentially transport K+, while the 
complex of LB’ showed preferential transport of the smaller ions. This difference 
was attributed to the availability of the oxygen atom within the crown. The 
chelation of metal ions at the β,β’-bipyridyl unit forces the aromatic groups 
towards co-planarity and consequently the oxygen atoms of the ether are 
directed away from one another. This means the oxygen atoms are no longer 
able to function as part of the ether cavity. Rebek and co-workers have 
provided numerous examples which beautifully demonstrate allosteric effects 
with increased selectivity with a goal to produce synthetic systems that better 
resemble those seen in nature. From this initial research supramolecular 
systems displaying allosteric effects have been investigated to advance these 
synthetic systems.  
LB'
= transition metal ion
= alkali metal ion
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1.8.1 Ditopic ligands 
 
The investigation of allosteric effects within supramolecular systems has 
allowed further diversification of the known architectures. Ligands are able to 
partition into distinct binding domains which influence the formation of the 
metallosupramolecular assembly. The ligands are thus designed and 
synthesised to contain different binding domains which give, upon reaction with 
metal ions, a desired supramolecular entity. The covalent information within the 
ligands can thus be selected to direct the system to a given architecture. The 
information is permanently contained within the covalent framework of the 
ligand once it has been synthesised, which can be thought of as a ‘pre-
programmed’ component. A number of ditopic ligands have been reported, 
however, which allow the binding modes of the ligands to be altered or 
‘reprogrammed’. This is related to the allosteric effect demonstrated by Rebek 
et al. seen in the previous section.  
 
A ditopic ligand reported by Rice et al.115 elegantly demonstrates the 
reprogramming of a dinuclear double helicate. The ligand, LC’, contains a 
potentially tetradentate pyridyl-thiazole chain and an additional crown ether 
binding site connecting the two halves of the ligand chain. Reaction of an 
equimolar amount of LC’ and Hg(ClO4)2·3H2O in acetonitrile resulted in the self-
assembly of a dinuclear double helicate [Hg2(LC’)2]4+. Addition of excess 
NaClO4 to the complex give [Hg2(LC’)2Na2]6+. The Hg(II) centres have a 
distorted tetrahedral geometry from coordination of the two thiazole-pyridyl 
units, one from each ligand. The ligands are twisted around the bond between 
the central pyridyl rings. Both crown ethers partially coordinate sodium ions; the 
sodium ions are unable to coordinate all the oxygen atoms of the crown ether 
which is to be expected as the crown used is known to be too large to optimally 
coordinate sodium cations. In comparison, on reaction of the dimercury 
complex with excess Ba(ClO4)2 a mononuclear complex [Hg(LC’)Ba]+ is 
produced. The ligand is near planar with a slight twist due to steric interactions 
between the methylene substituents on the central bipyridyl core. In this 
structure the Hg(II) centres display a distorted octahedral geometry from the 
nitrogen atoms of the two thiazole–pyridyl units of the ligand and two 
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perchlorate anions. The Ba(II) cation is ten-coordinate and bonded by all six 
oxygen atoms of the crown ether, with additional coordination to perchlorate 
anions. The Ba(II) ion is coordinated by all the oxygen atoms of the crown ether 
moiety demonstrating the better size match between this cation and crown 
(figure 1.42). This control over the self-assembly may be attributed to one of 
two factors; an electrostatic effect as coordination of barium to the helicate 
would produce a higher charged 8+ ion, consequently the disassembly of the 
double helicate to the mononuclear species lowers electrostatic repulsion and 
increases the entropy; alternatively, this change in structure may be due to an 
allosteric effect. Either way this demonstrates how ligand-binding domains may 
be altered or ‘reprogrammed’. 
 
Figure 1.42 Ligand LC’ and the two complex cations [Hg2(LC’)2Na2]6+ and 
[Hg(LC’)Ba]4+115 
LC'
Hg(II), ex Na(I)Hg(II), ex Ba(II)
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These types of interactions are useful in the development of sensors, as the 
coordination of a guest is signalled at the secondary connected site. Sensors 
often consist of a selective coordination site, connected by a communication 
bridge to a secondary site which is capable of a physical response. A number 
of artificial allosteric receptors and catalysts are now known.116, 117 
1.9 Ligand design 
 
Self-organisation and self-assembly, i.e. self-processes, are now a major theme 
of supramolecular chemistry. The incorporation of metal ions provides access 
to new and varied architectures, this subdivision becoming known as 
metallosupramolecular chemistry. Well-researched examples are the helicates; 
as seen previously an enormous quantity of research has been directed 
towards their synthesis and understanding of their formation. Self-organisation 
of a system occurs when the components converge to produce a larger, and 
generally more complicated, assembly.  
 
Taking helicates as an example, the components within these assemblies are 
the metal ions and helicands (ligands which form helicates). The metal ions are 
selected as they possess, to some degree, known coordination geometries. 
Certain metals are known to form octahedral coordination compounds for 
example Zn(II) and Co(II), others form tetrahedral geometries such as Ag(I) and 
Cu(I). These two examples are the most commonly utilised geometries, 
however, the incorporation of lanthanides, which possess higher coordination 
numbers, is increasingly being employed118, 119. The important aspect with 
regards to helicate formation is that the metal ion selected must be 
complementary to the binding domains within the ligand. Ligands are the 
organic component of the system; they must contain sufficient donor atoms to 
interact with the metal centres. Specifically, for a helicate the ligand must 
contain at least two binding sites which are positioned such that both sites 
within the ligand are unable to coordinate the same metal ion. The ligand 
employed can have a significant influence on the resulting architecture and 
potentially gives the supramolecular chemist some control over the assembly. 
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1.9.1 Ligand programming  
 
Chemical systems with molecular building blocks which contain all the 
necessary information (size, shape, electronic properties) to selectively produce 
the desired architecture represent pre-programmed systems. Through self-
processes; self-organisation and self-assembly, the molecular instructions 
contained within the components lead to the generation of a well-defined 
supramolecular entity. This concept of molecular information is seen as one of 
the basic principles within supramolecular chemistry.  
 
Self-assembly may be directed towards a particular architecture based on the 
design of the ligand and coordination geometries of the metal ions. The 
processing of the same ligand information by different interaction algorithms, 
metal ions, allows the self-organization of different architectures, resulting in 
multiple expressions of the molecular information. An elegant example by Lehn 
et al. demonstrates how the molecular instructions within a ligand may generate 
different structures upon exposure to different metal ions. From previous 
research it was established that LD’, when treated with octahedral metal ions, 
provides a square [2x2] grid assembly,53 and LE’ gives dinuclear double 
helicate complexes with tetrahedral metal ions.72 By combining the binding 
domains of LD’ and LE’ a new ligand, LF’,120 was produced (figure 1.43). By 
designing this ligand it was hoped that, as the ligand contains both bidentate 
and tridentate binding sites, the assembly may be directed towards a different 
architecture by careful selection of metal centre, in contrast to previous 
investigations in which only one metal ion could be complexed by the ligand 
strand.121 A suspension of LF’ in acetonitrile was treated with one equivalent of 
[Cu(CH3CN)4]ClO4 and two equivalents of Cu(ClO4)2.6H2O. Addition to an 
aqueous solution of ammonium hexafluorophosphate produced a precipitate. 
Upon diffusion of benzene into a solution of the complex single crystals were 
obtained. X-ray structural determination revealed a large complex ion 
[Cu12(LF’)4]20+ for the compound. The Cu(I) centres display a distorted 
tetrahedral coordination geometry while the Cu(II) centres have a severely 
distorted trigonal bipyramidal  geometry. The ligands are wrapped around each 
other linking four double helical sections with 12 crossing points (figure 1.44). 
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The structure contains two types of duplexes of opposite helicity which are 
connected in an alternating fashion resulting in the formation of an achiral, or 
meso, form. 
 
 
Figure 1.43 Ligands, LD’ and LE’, from previous research. Combination of these 
ligands produced a more complex ligand, LF’ 
 
Reactions of LF’ with Cu(I) and M(II) (M= Fe, Co, Ni, Cu) ClO4- salts in 
acetonitrile in a 1:2:1 ratio (LF’:Cu(I):M(II)) gave [M4Cu8(LF’)4](ClO4)16 
complexes. All the spectrometric results obtained for these structures point 
towards the formation of a complex with the structure shown in figure 1.44 
which may be seen to combine the [2x2] grid (of LD’) in the centre and four 
helicate units (of LE’) at the corner of the central grid. This demonstrates the 
controlled generation of two different supramolecular architectures from the 
same ligand, LF’, by processing of molecular information by different 
coordination algorithms, in this case different sets of metal ions.  
  
a X=H
b X=Br
a X=R= H
b X=Me, R=H
c X=R= Me
LF '
LE 'LD '
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Figure 1.44 Self-assembly modes of ligand, LF’, and metal ions of different 
coordination geometries120 
Constable and co-workers also produced a number of metallosupramolecular 
assemblies with sexipyridine showing that different metal ions can produce 
remarkably different structures depending on the stereochemical requirements 
of the metal centres.122 Rice et al. reported the synthesis of a new group of 
thiazole-containing polydentate ligands for the self-assembly of helicates with 
Cu(II) (figure 1.45).123 In this instance the same metal ion is used and different 
ligands employed to produce different architectures. These ligands are of 
interest as the ligands naturally partition into distinct binding domains as 
adjacent thiazolyl units are unable to coordinate the same metal ion. Reaction 
of LG’ and two equivalents of Cu(PF6)2 in acetone under an atmosphere of ethyl 
acetate produced crystals. X-ray structural determination showed two Cu(II) 
ions coordinated to three LG’ ligands in a triple helical assembly with each metal 
ion in a pseudo-octahedral coordination geometry formed from three thiazole-
LF '
8 + 4 + 8 4 
= pentacoordinated ion: Cu(II) 
= hexacoordinated ion: Fe(II), Co(II), Ni(II) or Cu(II) 
= tetracoordinated ion: Cu(I) 
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pyridyl unit from each of the ligand strands. In contrast reaction of LH’ with 
Cu(ClO4)2 in acetonitrile gives double helicates, with the metal centres in a 
pseudo-octahedral arrangement by coordination of two thiazolyl-phenanthroline 
tridentate domains from each ligand. The thiazole ligand examples shown here 
are only a few of the ligands which have been produced which contain this 
natural partition for the self-assembly of helicates.124, 125 
 
Figure 1.45 Thiazole-containing ligands which self-assemble into different 
helicates, LG’ triple helicate and LH’ double helicate, upon coordination to Cu(II) 
 
As well as the examples shown here there are numerous others of 
programmed assemblies which display higher levels of control over the final 
architecture dependent on the design of the ligand and metal centres 
employed. As seen previously it is possible to produce circular helicates and 
the chirality of a helicate may also be controlled, in both linear and circular 
helicates, by incorporating chiral ligands.  
 
LH'
LG'
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1.9.2 Ligand recognition  
The self-assembly of inorganic helicates is clearly an area of significant interest 
within supramolecular chemistry. This self-assembly has been linked to 
processes within biological systems in particular, in this case, the formation of 
the DNA double helix. The self-assembly of synthetic helical systems has thus 
received rigorous investigation. The basic features for their formation, in 
addition to the requirements of complementary molecular components, occur 
with positive cooperativity126 and self-recognition.127 
 
Krämer et al. elegantly demonstrated this feature of self-recognition within 
helicate assembly. From a mixture of 6,6'- connected oligo(β,β’-bipyridine) 
ligands strands which contained a varying number of β,β’-bipyridine subunits 
(between two and five) it was shown that coordination with copper(I) ions 
resulted in the formation of homostranded double helicates (figure 1.46) without 
significant crossover. All combinations of ligands tried gave the corresponding 
double helicates, indicating that helicate self-assembly occurs with self-
recognition. This introduces the idea that ligands are able to discriminate 
between self and non-self; thus species with like ligands are strongly preferred 
over species with unlike ligands.127 
  
LL'
LJ '
LI '
LK'
a  X= H
b X= CONEt2
c X= COOEt
CL'
CJ '
CI '
CK'
 
Figure 1.46 Self-recognition in the self-assembly of double helicates from a 
mixture of oligobipyridine ligand strands
In addition to the recognition of similar ligands a mixture of two tris-bipyridine 
ligands LJ’ and Ls (containing different bridging units) react with copper(I) and 
nickel(II) ions to form only the double helicate and the triple helicate (figure 
1.47).127 The previously reported 5,5'-disubstituted ligand strand (Ls) was 
shown to form a triple helicate with octahedrally-coordinated Ni(II) ions.128 This 
architecture results from the steric programming of the ligand and the 
stereochemical information provided by the metal ion. This also applies to the 
double helicate produced from LJ’ and tetrahedral metal ions. Side-by-side 
operation of two programmed molecular systems led to the self-assembly of 
two discrete helical complexes from a mixture. As only discrete helicates 
resulted these systems are sufficiently instructed to produce programmed 
structures even with alteration of the parameters for self-assembly.  
 
 
Figure 1.47 Self-recognition in the self-assembly of a double helicate and triple 
helicate from a mixture of oligobipyridine ligand strands (Ls, LJ’) with Cu(I) and 
Ni(II) 
 
Described in this work is the synthesis and coordination chemistry of 17 novel 
ligands. These ligands were designed in such a way as to direct the self-
LSLJ '
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assembly of the resulting supramolecular architecture. Chapter two exhibits an 
example of a pentanuclear circular helicate, similar to circular helicates 
mentioned previously. Chapter three illustrates how the interplay between 
ligand strand and metal ion size can control the formation of helicates and 
meso-helicate assemblies. Finally chapter four demonstrates how lanthanide 
metal ions can be incorporated within supramolecular systems; in this case 
providing dinuclear double stranded helicates. 
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2. Diastereoselective assembly of pentanuclear circular helicates 
 
Described in this chapter is the synthesis and coordination chemistry of mixed 
N-donor and O-donor ligands which assemble into circular helicates upon 
exposure to zinc metal centres. These ligands contain two tridentate donor 
domains separated by a 1,3-phenylene spacer unit. The first ligand, L1, is a 
symmetrical ligand which can potentially act as a hexadentate donor; however, 
the 1,3-phenylene unit effectively partitions the ligand into two tridentate donor 
domains. The other ligands are essentially the same as L1 with the difference 
being the terminal functional groups. For L2 – L4 variation of the terminal group 
led to the incorporation of amino acid esters and the potential to control the 
stereoselectivity of the resulting chiral supramolecular architectures (figure 2.1). 
 
Figure 2.1 New class of helicands L1 – L4  
(L1)
(L4)
(L2)
(L3)
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2.1 Ligand synthesis  
 
The ligands, L1 – L4, were synthesised in an analogous fashion via a multi-step 
synthetic process (Scheme 2.1). 
2.1.1 Synthesis of L1 
 
The synthesis of the ligand, L1, was achieved by activation of picolinic acid with 
oxalyl chloride followed by reaction with diethylamine to give, after liquid-liquid 
extraction, a crude product. By dissolving in ether and using decolourising 
charcoal the pure amide was obtained as a yellow oil (1a). Reaction of the 
amide with mCPBA in DCM was monitored by TLC, until all the amide was 
consumed. Purification by column chromatography gave the corresponding N-
oxide as a white solid (2a). The 1H NMR spectrum for the N-oxide should 
contain the same signals as those seen for 1a (figure 2.2, 1a) as the 
compounds contain the same protons, however, the presence of the oxygen 
atom dramatically alters the aromatic region of the 1H NMR spectrum for 2a 
(figure 2.2, 2a). Methylation of the N-oxide was achieved by dissolving the solid 
in dimethyl sulfate and heating for 24 hours. After a wash with ether the 
resulting oil was dissolved in deionised water and neutralised with NaHCO3. 
Addition of sodium cyanide and stirring at room temperature for five minutes 
gave a yellow oil; extraction into DCM gave the 6-cyanopicolinamide species, 
3a. Formation of the product was confirmed using 1H NMR by the 
disappearance of one aromatic signal corresponding to the loss of a proton 
from the pyridine ring (figure 2.2, 3a). The corresponding thioamide, 4a, was 
produced upon exposure of the cyanopicolinamide to hydrogen sulfide which 
was isolated upon filtration of the resulting yellow precipitate. Confirmation of 
the thioamide was obtained from the 1H NMR spectrum which shows two new 
broad singlet peaks (9.31 and 7.67 ppm) corresponding to the -NH2 protons 
(figure 2.2, 4a). A solution of the thioamide (4a) and 1,3-di(α-
bromoacetyl)benzene (6) was refluxed for 3 hours in the final step of the 
synthesis. The resulting precipitate was isolated via filtration giving the ligand 
L1 (figure 2.2) as a white solid which was subsequently characterized by 1H 
NMR, ESI-MS and HR ESI-MS. The 1H NMR spectrum showed a total of 7 
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aromatic signals as well as 4 aliphatic signals corresponding to the 8 ethyl and 
12 methyl protons (figure 2.2, L1). ESI-MS showed an ion at m/z 619 which is 
consistent with [L1+Na]+. 
 
 
Scheme 2.1 Synthesis of L1 – L4. 
Reagents and conditions: a) C2O2Cl2, Et3N, DCM 0˚C; b) RR’NH, Et3N, DCM, 
RT; c) mCPBA, DCM, RT; d) (MeO)2SO2, 60˚C; e) NaHCO3, NaCN, H2O RT; f) 
H2S, Et3N, EtOH, RT; g) 1,3-di(α-bromoacetyl)benzene (6), EtOH, reflux. 
  
a, b
1a R = R' = -CH2CH3
1b R = H, R' = -CH2CO2Me
1c R = H, R' = (S)-CH(CH(CH3)2)CO2Me
1d R = H, R' = (S)-CH(CH2Ph)CO2Me
L1 R = R' = -CH2CH3
L2 R = H, R' = -CH2CO2Me
L3 R = H, R' = (S)-CH(CH(CH3)2)CO2Me
L4 R = H, R' = (S)-CH(CH2Ph)CO2Me
4a R = R' = -CH2CH3
4b R = H, R' = -CH2CO2Me
4c R = H, R' = (S)-CH(CH(CH3)2)CO2Me
4d R = H, R' = (S)-CH(CH2Ph)CO2Me
2a R = R' = -CH2CH3
2b R = H, R' = -CH2CO2Me
2c R = H, R' = (S)-CH(CH(CH3)2)CO2Me
2d R = H, R' = (S)-CH(CH2Ph)CO2Me
3a R = R' = -CH2CH3
3b R = H, R' = -CH2CO2Me
3c R = H, R' = (S)-CH(CH(CH3)2)CO2Me
3d R = H, R' = (S)-CH(CH2Ph)CO2Me
c
fd, e
g
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6.87.07.27.47.67.88.08.28.48.68.89.09.29.4 ppm
Scale: 0.1376 ppm/cm, 55.06 Hz/cm
6.87.07.27.47.67.88.08.28.48.68.89.09.29.4 ppm
6.87.07.27.47.67.88.08.28.48.68.89.09.29.4 ppm
6.87.07.27.47.67.88.08.28.48.68.89.09.29.4 ppm
6.87.07.27.47.67.88.08.28.48.68.89.09.29.4 ppm
1a
2a
3a
4a
L1
Figure 2.2 Aromatic regions in the 1H NMR (400 MHz, CDCl3) spectra of (1a) 
picolinamide derivative, (2a) picolinamide-N-oxide, (3a) 6-cyanopicolinamide, 
(4a) picolinamide-6-thioamide and Ligand 1(L1) 
2.1.2 Synthesis of L2 – L4 
 
For the synthesis of L2 – L4 methods analogous to that described for L1 were 
employed. However, for L2, glycine methyl ester was used in place of 
diethylamine in step b of the synthesis (Scheme 2.1). For the two remaining 
ligands chiral methyl esters were used, for L3 S-valine methyl ester and L4 S-
phenylalanine methyl ester substituted the diethylamine used for L1. This 
resulted in variation of the terminal functionality of the four ligands. For each 
subsequent ligand the structures were confirmed by 1H NMR, ESI-MS and HR 
ESI-MS. 
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2.2 Coordination chemistry 
2.2.1 Complexes of L1 with zinc(II)  
 
Reaction of L1 with an equimolar amount of Zn(CF3SO3)2 in acetonitrile gave a 
colourless solution. Analysis by ESI-MS gave an ion at m/z 2251 corresponding 
to the pentanuclear helicate complex {[Zn5(L1)5](CF3SO3)8}2+ with some 
additional peaks observed likely due to fragmentation of the parent 
pentanuclear species. The 1H NMR spectrum shows 9 signals, with seven 
aromatic signals consistent with the helical wrapping of a helicate, as the 
signals have shifted with respect to the free ligand. Slow diffusion of ethyl 
acetate into the acetonitrile complex solution resulted in the formation of X-ray 
quality colourless crystals. The single crystal X-ray structure confirmed the 
formation of the pentanuclear species [Zn5(L1)5]10+ which crystallised in triclinic 
space group P-1(figure 2.3).i  
 
Figure 2.3 Solid state structure of the complex cation [Zn5(L1)5]10+ 
                                            
i
 X-ray data recorded by Professor Craig Rice with additional structure refinements contributed 
by Dr. Thomas Riis-Johannessen 
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The crystal structure confirms that in the solid state the ligand, L1, and Zn(II) 
ions self-assemble to form a pentanuclear circular helicate in which the ligand 
strand partitions into two tridentate donor domains, separated by the 1,3-
phenylene spacer unit (figure 2.3). The two tridentate donor domains of each 
ligand coordinate two different metal ions. Each of the five Zn(II) ions is six-
coordinate arising from the coordination of two tridentate N,N,O-domains (Zn–N 
distances: 2.029(7) – 2.261(7) Å ; Zn–O distances: 2.105(6) – 2.202(6) Å). The 
1,3-phenylene spacers bridge the tridentate domains in an “over-and-under” 
conformation, giving rise to a helical cyclic oligomer in contrast to a “face-to-
face” arrangement associated with grid-like arrays. Selected bond lengths and 
angles for the complex are shown in tables 2.1 and 2.2. 
 
Bond Bond Length (Å) Bond Bond Length (Å) 
Zn(1)-N(130) 2.061(7) Zn(3)-O(297) 2.160(8) 
Zn(1)-(N150) 2.071(7) Zn(3)-N(310) 2.214(7) 
Zn(1)-O(137) 2.138(6) Zn(3)-N(260) 2.223(8) 
Zn(1)-O(157) 2.138(6) Zn(4)-N(10) 2.062(6) 
Zn(1)-N(124) 2.192(7) Zn(4)-N(80) 2.071(6) 
Zn(1)-(N174) 2.204(7) Zn(4)-O(87) 2.143(6) 
Zn(2)-N(200) 2.032(7) Zn(4)-O(17) 2.175(5) 
Zn(2)-N(220) 2.062(8) Zn(4) N(30) 2.209(6) 
Zn(2)-O(227) 2.105(6) Zn(4)-N(104) 2.261(7) 
Zn(2)-O(207) 2.202(6) Zn(5)-N(60) 2.029(7) 
Zn(2)-N(240) 2.221(7) Zn(5)-N(340) 2.065(7) 
Zn(2)-N(194) 2.236(8) Zn(5)-O(347) 2.146(6) 
Zn(3)-N(270) 2.044(8) Zn(5)-O(67) 2.171(5) 
Zn(3)-N(290) 2.049(8) Zn(5)-N(50) 2.204(6) 
Zn(3)-O(277) 2.153(7) Zn(5)-N(330) 2.222(6) 
 
Table 2.1 Selected bond lengths (Å) for the complex cation [Zn5(L1)5]10+ 
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Bond Angle (˚) Bond Angle (˚) 
N(130)-Zn(1)-N(150) 162.7(3) O(277)-Zn(3)-N(310) 99.6(3) 
N(130)-Zn(1)-O(137) 75.2(3) O(297)-Zn(3)-N(310) 150.9(3) 
N(150)-Zn(1)-O(137) 91.4(3) N(270)-Zn(3)-N(260) 76.6(3) 
N(130)-Zn(1)-O(157) 94.6(3) N(290)-Zn(3)-N(260) 114.6(3) 
N(150)-Zn(1)O(157) 74.6(3) O(277)-Zn(3)-N(260) 150.6(3) 
O(137)-Zn(1)-O(157) 91.5(3) O(297)-Zn(3)-N(260) 99.9(3) 
N(130)-Zn(1)-N(124) 76.0(3) N(310)-Zn(3)-N(260) 83.7(3) 
N(150)-Zn(1)-N(124) 118.6(3) N(10)-Zn(4)-N(80) 169.7(3) 
O(137)-Zn(1)-N(124) 149.8(3) N(10)-Zn(4)-O(87) 100.2(2) 
O(157)-Zn(1)-N(124) 99.8(3) N(80)-Zn(4)-O(87) 75.7(2) 
N(130)-Zn(1)-N(174) 116.2(3) N(10)-Zn(4)-O(17) 76.0(2) 
N(150)-Zn(1)-N(174) 76.4(3) N(80)-Zn(4)-O(17 ) 94.1(2) 
O(137)-Zn(1)-N(174) 99.8(3) O(87)-Zn(4)-O(17) 85.4(2) 
O(157)-Zn(1)-N(174) 149.0(3) N(10)-Zn(4)-N(30) 76.1(3) 
N(124)-Zn(1)-N(174) 84.8(3) N(80)-Zn(4)-N(30) 113.9(2) 
N(200)-Zn(2)-N(220) 170.1(3) O(87)-Zn(4)-N(30) 102.2(2) 
N(200)-Zn(2)-O(227) 98.6(3) O(17)-Zn(4)-N(30) 152.0(2) 
N(220)-Zn(2)-O(227) 75.6(3) N(10)-Zn(4)-N(104) 109.8(2) 
N(200)-Zn(2)-O(207) 75.2(3) N(80)-Zn(4)-N(104) 75.1(2) 
N(220)-Zn(2)-O(207) 96.3(2) O(87)-Zn(4)-N(104) 1-49.9(2) 
O(227)-Zn(2)-O(207) 87.9(3) O(17)-Zn(4)-N(104) 103.7(2) 
N(200)-Zn(2)-N(240) 111.2(3) N(30)-Zn(4)-N(104) 83.4(2) 
N(220)-Zn(2)-N(240) 75.4(3) N(60)-Zn(5)-N(340) 167.9(3) 
O(227)-Zn(2)-N(240) 150.1(3) N(60)-Zn(5)-O(347) 96.7(3) 
O(207)-Zn(2)-N(240) 102.6(2) N(340)-Zn(5)-O(347) 75.3(2) 
N(200)-Zn(2)-N(194) 77.7(3) N(60)-Zn(5)-O(67) 75.1(3) 
N(220)-Zn(2)-N(194) 111.1(3) N(340)-Zn(5)-O(67) 95.3(2) 
O(227)-Zn(2)-N(194) 100.5(3) O(347)-Zn(5)-O(67) 88.2(3) 
O(207)-Zn(2)-N(194) 152.6(3) N(60)-Zn(5)-N(50) 76.4(3) 
N(240)-Zn(2)-N(194) 83.1(2) N(340)-Zn(5)-N(50) 113.6(2) 
N(270)-Zn(3)-N(290) 166.5(4) O(347)-Zn(5)-N(50) 100.8(2) 
N(270)-Zn(3)-O(277) 75.2(3) O967)-Zn(5)-N(50) 151.0(3) 
N(290)-Zn(3)-O(277) 94.5(3) N(60)-Zn(5)-N(330) 113.7(3) 
N(270)-Zn(3)-O(297) 96.1(3) N(340)-Zn(5)-N(330) 75.3(3) 
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Bond Angle (˚) Bond Angle (˚) 
N(290)-Zn(3)-O(297) 75.1(3) O(347)-Zn(5)-N(330) 149.3(3) 
O(277)-Zn(3)-O(297) 91.3(3) O(67)-Zn(5)-N(330) 103.2(2) 
N(270)-Zn(3)-N(310) 112.7(3) N(50)-Zn(5)-N(330) 83.0(2) 
N(290)-Zn(3)-N(310) 77.2(3)   
 
Table 2.2 Selected bond angles (˚) for the complex cation [Zn5(L1)5]10+ 
 
The ligand, L1, contains two tridentate N-N-O donor domains separated by a 
phenylene spacer unit (figure 2.4). The incorporation of a 1,3-phenylene spacer 
unit has been shown to be a robust method for the successful synthesis of 
circular helicates.107, 108 The inter-ligand steric and/or electrostatic interactions 
between the protons present on the central phenylene units are an important 
factor which directs the assembly towards the formation of the more complex 
circular helicate instead of the thermodynamically more stable linear dinuclear 
helicate. The proximity of the phenylene protons is in turn controlled by the 
metal ion radii.  
 
 
Figure 2.4 Structure of L1 (i) diagram showing the two tridentate domains 
separated by the a 1,3-phenylene space unit and (ii) the partitioning seen within 
the crystal structure for L1. 
(L1)
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As can be seen in the space-filling diagram (figure 2.5) of the pentanuclear 
helicate for L1 there is a cavity within the complex cation; this is occupied by 
triflate anions. From previous research the anions have been shown to play 
major roles in the self-assembly and can influence the structure of the final 
complex. Recent research by Rice et al., however, has shown there was no 
change to the 1H NMR spectrum of a similar complex containing Lu (figure 
1.36) upon addition of other anions, even when an excess of anion was added.  
 
 
Figure 2.5 Space-filling picture of L1 showing atoms with their van der Waal’s 
radii  
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2.3 Solution studies  
2.3.1 Solution state characterisation of [Zn5(L1)5]10+ 
 
The one-dimensional 1H NMR spectrum of a CD3NO2 solution of [Zn5(L1)5]10+ 
shows the expected 9 resonances for a complex of D5 symmetry (figure 2.6). 
Four of the seven aromatic signals, corresponding to the pyridyl and thiazole 
protons, are present between 7.0 and 8.4 ppm. The three protons of the 
bridging phenylene unit, however, resonate at much lower frequency (5.8–
7.0ppm). This has been observed previously in related circular helicates and 
has been ascribed to the close proximity of the central phenylene rings to the 
pyridyl-thiazole domains (average centroid---centroid distance of γ.87 A˚). The 
protons of the phenylene spacer in the complex, [Zn5(L1)5]10+, are exposed to 
the shielding ring currents produced by the aromatic heterocycles of adjacent 
ligand strands, which explains the unusually low chemical shifts. This 
phenomenon is thus a useful diagnostic tool for the confirmation of helical 
wrapping in linear and circular helicates.  
 
 
Figure 2.6 Aromatic region in the 1H NMR (400 MHz, CD3NO2) spectrum of L1 
with Zn(II).   
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As stated briefly the ESI-mass spectrum of the L1 complex with Zn(II) is also 
consistent with the formation of the pentanuclear species in the solution/gas 
phase showing ions at m/z 2251 corresponding to {[Zn5(L1)5](CF3SO3)8}2+, as 
well as other ions at m/z 2732 and 1771 corresponding to 
{[Zn3(L1)3](CF3SO3)5}+ and {[Zn4(L1)4](CF3SO3)6}2+ respectively (figure 2.7). 
Other peaks observed corresponding to smaller di- or mononuclear species 
were also present; however, these species are likely due to fragmentation of 
the parent species.108 
 
Figure 2.7 ESI-MS spectrum of [Zn5(L1)5](CF3SO3)10 
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2.3.2 Solution state characterisation of L2–L4 
 
As the structure of the L1 complex with Zn(II) has been successfully established 
as a system which assembles to give circular helicates the terminal groups of 
the ligand were varied to incorporate amino acid esters. This was in an attempt 
to control the enantio-selective assembly of the circular helicate. The same 
method employed for the crystallisation of L1 was used to try and obtain solid 
state structures for L2–L4, however, all attempts were unsuccessful in forming 
good quality crystals. The use of glycine methyl ester in the second step (step 
b) of the synthesis resulted in the production of a glycine-containing ligand, L2. 
Reaction of L2 with Zn(CF3SO3)2 in CD3NO2 gave a colourless solution for 
which the 1H NMR and ESI-MS were recorded. The ESI-MS showed a signal at 
m/z 2330 corresponding to {[Zn5(L2)5](CF3SO3)8}2+. The 1H NMR showed a total 
of ten signals, seven aromatic signals, a signal corresponding to the amide –
NH and two aliphatic signals (figure 2.8, b). Observed here are signals between 
6.0–7.0 ppm, which are due to the protons present on the central phenylene 
spacer. This has been identified previously to be a characteristic of the protons 
of the phenylene spacer unit within similar helical structures. As can be seen 
this spectrum is very similar to that for the complex of L1 ([Zn5(L1)5](CF3SO3)10) 
(figure 2.8 a). From these results it is suggested that the glycine-containing 
derivative, L2, forms an analogous pentanuclear species ([Zn5(L2)5](CF3SO3)10) 
as that observed for L1. 
 
In addition to the glycine-containing derivative ligands L3, valine methyl ester 
ligand, and L4, phenylalanine methyl ester ligand, were produced to give two 
new ligands functionalised with enantiopure terminal amide groups. Reaction 
with Zn(CF3SO3)2 in CD3NO2, for both ligands, once again gave a colourless 
solution for which ESI-MS showed the expected peaks corresponding to a 
pentanuclear complex cation (m/z 2541 for {[Zn5(L3)5](CF3SO3)8}2+ and m/z 
2781 for{[Zn5(L4)5](CF3SO3)8}2+). The 1H NMR spectra of the resulting solutions 
are again consistent with the formation of a helical structure (figure 2.8 c, d) as 
the phenylene protons are observed at a significantly lower frequency than the 
other aromatic signals. For ligands L3 and L4, however, additional subsets of 
low intensity peaks are observed in the NMR spectra. These peaks are unlikely 
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to correspond to different nuclearity species, e.g. [M6L6]12+ or [M4L4]8+, as 
generally for these species the signals appear at significantly different chemical 
shifts (Δδ >0.2 ppm). Thus these additional peaks can be attributed to the 
possible minor diastereoisomer with some confidence.129 To establish the 
diastereoisomer excess (d.e) the ratio of the integrated sets of peaks for 
[Zn5(L3)5]10+ gave a 9:1 ratio for the two diastereoisomers present. This 
demonstrates that the optically pure valine unit controls the self-assembly of the 
helicate and one isomer thus results giving an approximate 80% d.e. As for the 
phenylalanine-containing ligand the process appears to be less selective thus 
the self-assembly leads to a lower d.e. of ~ 70%.  
 
Figure 2.8 Aromatic region of the 1H NMR spectra of (a) [Zn5(L1)5]10+(CD3NO2), 
(b) [Zn5(L2)5]10+(CD3NO2), (c) [Zn5(L3)5]10+(CD3NO2) and (d) 
[Zn5(L4)5]10+(CD3NO2): 
= selected peaks corresponding to the minor diastereoisomer. 
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Circular dichroism (CD) is the difference in the absorption of left-handed and 
right-handed circularly polarised light (CPL) which occurs when a molecule 
contains one or more chiral chromophores. CD spectroscopy is a technique 
where the CD of molecules is measured over a range of wavelengths. CD 
spectroscopy is used to study chiral molecules; its most important application is 
the study of the secondary structure of proteins. These structures are sensitive 
to changes in environment and as such CD spectroscopy can be used to 
observe how the structure changes as a result of alteration to environmental 
conditions or interaction with other molecules. For molecules that contain chiral 
components one circularly polarised light state will be absorbed to a greater 
extent than the other and the CD signal over the corresponding wavelength will 
be non-zero. The signal may be positive or negative depending on the 
difference in absorption between left-handed and right-handed circularly 
polarised light.  
Figure 2.9 L5, (R,R)- enantiomer of ligand L3 
To conduct this type of analysis another ligand was required thus L5, (R,R)-
enantiomer), was prepared. This was produced in an identical manner to the 
(S,S)-enantiomer, L3, apart from D-valine was used in the synthesis in place of 
L-valine. To all intents and purposes the NMR, ESI-MS data and yields of L5 
were identical to that obtained for L3. The CD spectra of ligands L3 and L5 
(figure 2.9 a), opposite isomers, show a very weak equal and opposite bi-
signate Cotton effect relating to the higher energy π–π* transitions. These 
probably arise from a degree of exciton coupling between the two halves of the 
ligand. Addition of Zn(II) into the solution results in a considerable change to 
the observed CD spectrum of the free ligand (figure 2.9, b). As can be seen the 
signal around 355 nm has grown, although the intensity of the signals does not 
(L5)
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dramatically increase, as had been anticipated. In addition to this the UV/vis 
absorption spectrum also shows a change in the large absorption at 264 nm 
which reduces in intensity and broadens. This is indicative of a strong exciton 
coupling assuming the complex adopts a similar configuration to that of L1 in 
the solid state structure of [Zn5(L1)5]10+. 
 
From this information it should be possible, in principle, to assign an overall 
sense of handedness to the dominant isomer by implementing exciton 
theoretical analysis.130, 131 The 330 nm absorption is assumed to relate to the 
π–π* transitions of the pyridyl-thiazole group. The complex derived from L3 
demonstrates a negative signal at the lowest energy transitions in the CD 
spectrum in this region. Assuming a similar structure is adopted to that of ligand 
L1, with a dihedral angle between the two chromophores of 70.8˚, and the two 
chromophores at an angle of 59.8˚ relative to the perpendicular between them, 
then the resulting dominant complex can tentatively be assigned as having a D 
metal-centred configuration, and an overall M helicity. Extreme caution should 
be placed on this assignment given that the metal-centred exciton couplings will 
invariably be cancelled out by additional couplings in the structure as previously 
reported by Telfer and co-workers.132  In this particular case, it is observed in 
the structural analysis of [Zn5L15]10+ that inter-ligand phenyl-thiazole contacts 
possess the opposite sense of handedness with a separation of only 4.0 to 5.0 
Å, whilst the metal-centred chromophores are longer (4.5–5.5 Å). Given that the 
strength of the observed exciton coupling is related by an inverse r3 relationship 
these interactions cannot be ignored,130, 131 with the possibility that these 
conflicting bi-signate interactions could account for the surprisingly low 
observed Cotton effect, and could even lead to the mis-assignment of the 
overall helicity. 
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Figure 2.10 The CD spectra of (a) ligand L3 (red) and L5 (blue) and (b) the 
resulting complexes upon the addition of one equivalent of Zn (II) in acetonitrile 
(298 K, concentration of 2.5 x 10-5 mol dm-3) 
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2.4 Conclusion 
 
In conclusion five ligands, L1-L5, containing both N-donor and O-donor domains 
and a 1,3-phenylene spacer unit have been produced. L1 has been shown to 
self-assemble into pentanuclear circular helicates upon reaction with Zn(II) ions 
and this structure persists in both the solid and solution state. This high 
nuclearity species forms as a result of unfavourable steric interactions between 
the phenyl units which destabilize the similar linear helicate, which in turn is 
governed by the size of the metal ion employed. Variation of the ligand allowed 
incorporation of enantiopure units within the strand leading to 
diastereoselective self-assembly giving up to 80% d.e.  
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3 Steric control over the formation of dinuclear double helicate and 
dinuclear meso-helicate assemblies  
 
The term meso-helicate (mesocate or side-by-side helicate98) has been 
introduced previously. These supramolecular complexes are closely related to 
helicates, but they differ in the manner by which the ligand strands are 
arranged. Taking an octahedral dinuclear double-stranded helicate, M2L2 as an 
example, each metal centre can either be left handed (Λ) or right handed (Δ) 
there are four possible configurations that may result: ΛΛ, ΔΔ, ΔΛ and ΛΔ. The 
first two configurations represent the possible homochiral complexes, giving 
rise to left-handed (M-) and right-handed (P-) helicates, respectively, as the 
ligand strands would wrap helically around the metal centres. Alternatively, 
since the two heterochiral (ΔΛ or ΛΔ)  complex has two opposite chiral centres 
the strands would need to be in a side-by-side conformation generating a mirror 
plane within the structure thus giving an achiral structure known as a meso-
helicate (figure 3.1). These systems can become more complicated as the 
number of metal ions and/or ligands employed within the assembly increases 
(e.g. M2L3, figure 3.1). 
 
Figure 3.1 A schematic representation of the enantiomeric forms of a dinuclear 
triple helicate (left: ΔΔ, centre: ΛΛ) and the meso-helicate (right: ΛΔ)(99) 
 
The assembly of dinuclear helicates is achieved with selection of appropriate 
ligand strands which can partition into two separate donor domains, allowing 
coordination to separate metal ions. This criterion is essentially the same as 
M
M
M
M
M
M
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that required for the formation of the meso-helicate assembly. Even though the 
field of helicates has expanded rapidly over the years, controlling the formation 
of helicate versus mesocate is still not fully understood. 
 
The first mesocate was reported by Albrecht in 1995,133 using the dicatechol 
ligand, LM’ (n=3), (figure 3.2). Exposure to Ti(II) metal ions resulted in the 
assembly of a triple stranded mesocate. To determine the factors which direct 
the formation of the mesocate the group produced a number of dicatechol 
ligands with varying spacer length. It was determined that an odd number of 
methylene units produced the mesocate which was shown to exist in the solid 
state as well as in solution, while the compounds possessing even spacer 
length adopt a helicate structure. In the helicate the ligands show an “S”-type 
configuration while the ligands of the mesocate adopt a “C”-type 
configuration.100, 133-135 
 
Figure 3.2 Dicatechol ligand, LM’, employed to investigate the 
diastereoselectivity of helicates versus mesocate (100) 
 
Besides the dicatechol ligands, the odd-even rule was shown to be applicable 
to some other ligands with alkyl linkers. For instance, the bis(bipyridine) ligand, 
LN’, led to a mesocate upon coordination with Fe(II) (figure 3.3).135 
LM'
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Figure 3.3 Bis(β,β’-bypyridine) ligand, LN’ (135) 
 
Raymond et al. report the synthesis and inversion mechanism of dinuclear 
biscatechol triple helicates.136 To understand the racemisation of homochiral 
helicates the kinetics of inversion were investigated using NMR as a probe. 
This showed the inversion of the dinuclear complexes employed occurs via an 
intramolecular mechanism from the individual twisting of both metal centres. 
Thus the inversion of the ΛΛ- and ΔΔ- helicates was not achieved by the 
simultaneous inversion of both metal centres but via a stepwise inversion 
involving the heterochiral mesocate as an intermediate, with the intermediate 
being short-lived. Even though the mesocate intermediate was short-lived this 
study suggests the helicate and mesocate may interconvert under certain 
conditions.  
 
This was elegantly demonstrated by Raymond et al. with the interconversion 
between helicate and mesocate driven by the formation of a host-guest 
complex.137 Helical and meso complexes were formed from the same ligand 
strand, LO’ (figure 3.4). Single crystal structural analysis confirms that in the 
solid state the [Al2(LO’)3] complex is a helicate, while the [Ga2(LO’)3] complex is 
a mesocate, with the helicate encapsulating a water molecule, with this host-
guest complex being the most favourable thermodynamic product. NMR studies 
revealed for [Ga2(LO’)3] and [Al2(LO’)3] complexes in DMSO-d6 both the helicate 
and mesocate are present, with the mesocate being enthalpically favoured. It 
was subsequently shown that the ratio of meso to helical complex is 
temperature dependent, with the stabilisation of helicate also being dependent 
on guest concentration. 
  
LN'
87 
 
 
 
Figure 3.4 Chemical structure of ligand, LO’ (137) 
 
The formation of helicate versus mesocate has been an area of some interest. 
Different groups have reported different reasons as to why the mesocate forms 
in preference to the helicate. As proposed by Albrecht et al. the spacer length 
was one method to predict which assembly will result,100, 133-135 Wu and co-
workers demonstrated that the self-assembly could be controlled based on 
anion size.138 Hooley et al. have recently demonstrated similar stereochemical 
control over these self-assemblies using functionalised v-shaped ligands and 
Fe(II).139 
 
Hooley produced six pre-ligands, LP’, these ligands being used to form the final 
complexes (figure 3.5). Combination of the pre-ligands with 2-formylpyridine 
and Fe(ClO4)2 in degassed acetonitrile resulted in the formation of iminopyridine 
complexes. The complexes, (LP’(1-5))3Fe(ClO4)4, were isolated as purple solids 
by precipitation with ether. The larger pre-ligand 6(adamantanamide) was 
incapable of forming the desired assembly and mostly formed insoluble 
coordination polymers. The complexes produced were mostly stable, but 
sensitive to air and moisture, meaning no X-ray quality crystals could be 
obtained. Therefore, assemblies were characterised by 1H NMR, 2D NMR, 
diffusion NMR and ESI-MS.  
 
LO'
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LP '
1: X = Y = H
2: X = H, Y = NH2
3: X = NO2, Y = NH2
4: X = H, Y = OBn
5: X = NO2, Y = O-4-(tBu)Bn
6: X = H, Y = NHCOAd
LQ '
 
Figure 3.5 Chemical structure of pre-ligands, LP’ (139) 
 
An additional ligand, LQ’, was also analysed alongside these complexes as a 
control (figure 3.6). LQ’ is known to form the homotopic isomer, and the 
mesocate (heterotopic isomer) is not observed in solution. Comparison of the 
LO’ complex 1H NMR with that of (LP’(1-3))3Fe(ClO4)4 showed two sets of 
resonances, attributed to the homotopic and heterotopic species. This showed 
the longer more flexible ligands did not generate significant strain within the 
assembly, in comparison with LO’, thus the additional freedom of the ligand 
allowed heterotopic species to form. 
 
 
Figure 3.6 Chemical structure of ligand, LQ’ (139) 
 
(LP’(4-5))3Fe(ClO4)4 were shown to form only one isomer (homotopic matched 
isomer) which was due to the bulky groups limiting the flexibility of the ligand 
and preventing the formation of the meso-isomer. 
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Described in this chapter is the synthesis and coordination chemistry of a 
number of N-donor ligands (L6-L14) which assemble into dinuclear 
supramolecular arrays upon coordination to transition metal ions. These ligands 
contain two tridentate donor domains (pyridyl-pyridyl-thiazole) separated by 
different spacer units. The first ligand, L6, consists of two tridentate donor 
domains separated by a biphenyl spacer group. The spacer units of the 
remaining ligands each consist of three aromatic rings, with variation of the 
central ring of the spacer unit, in an effort to influence the final supramolecular 
architecture (figure 3.7). 
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Figure 3.7 New class of ligands L6 – L14 
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3.1 Ligand synthesis  
 
The ligands, L6 – L14, were synthesised via a multi-step synthetic process which 
differed in the initial stages of the synthesis and in the reagents employed. 
Further details regarding the synthesis of these ligands can be found within 
chapter 6 (section 6.2) 
3.1.1 Synthesis of L6 
 
The synthesis of the ligand, L6, was achieved by a Suzuki cross-coupling 
reaction between 3-bromoacetophenone and 1,3-aceteylphenyl boronic acid 
(11) following a procedure reported previously in the literature (scheme 3.1).140 
3,3'-Diacetylbiphenyl (7) upon exposure to bromine in acetic acid gave the di-α-
bromoacetyl (8) after separation and purification via column chromatography. 
The aromatic region of the 1H NMR spectrum of the product is not significantly 
altered from that of the starting material, however the appearance of a singlet, 
corresponding to methylene protons, is observed at 4.52 ppm; along with the 
disappearance of the original methyl peak which was seen at 2.69 ppm for 3,3'-
diacetylbiphenyl (7). Reaction between the α-bromoacetyl (8) and β,β’-
bipyridine-6-thioamide (9) in ethanol was refluxed for several hours. The 
resulting precipitate was isolated via filtration giving the ligand, L6, as an off-
white solid which was subsequently characterized by 1H NMR, ESI-MS and HR 
ESI-MS. The 1H NMR spectrum showed the expected 11 aromatic signals, with 
two signals overlapping. ESI-MS showed an ion at m/z 416 which is consistent 
with [L6+H]+. 
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Scheme 3.1 Synthesis of L6  
Reagents and conditions: a) [Pd(PPh3)2Cl2], NaHCO3, nBu4NBr, H2O, 70 ˚C 
(71%); b) Br2, CH3COOH, 80 ˚C (37%); c) β,β’-bipyridine-6-thioamide (9), 
EtOH, reflux (70%) 
 
  
b
c
a
(L6)
(8)
(7)(11)
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3.1.2 Synthesis of L7– L14 
 
The synthesis of these ligands is outlined in schemes 3.2 and 3.3 and was 
carried out in a similar manner to that of L6.  
3.1.2.1 Synthesis of L7 
 
The synthesis of the ligand, L7, was achieved by a Suzuki cross-coupling 
reaction between 1,3-dibromobenzene (10) and 1,3-aceteylphenyl boronic acid 
(11) following the same procedure employed for the synthesis of 3,3'-
diacetylbiphenyl (7).140 After purification via column chromatography the 
diacetyl (12) was obtained, the 1H NMR spectrum confirms the formation of the 
desired compound (54 % yield). Exposure of the diacetyl to bromine in acetic 
acid gave the di-α-bromoacetyl (13) after column chromatography (63 % yield). 
Again the aromatic region of the 1H NMR spectrum of the product is not 
significantly altered from that of the starting material; however the appearance 
of a singlet, corresponding to methylene protons, is observed at 4.53 ppm; 
along with the disappearance of the original methyl peak which was seen at 
2.69 ppm for the starting material. Reaction between the α-bromoacetyl (13) 
and β,β’-bipyridine-6-thioamide (9) in ethanol was refluxed for several hours. 
The resulting precipitate was isolated via filtration giving the ligand, L7, as a 
light brown powder which was subsequently characterized by 1H NMR, ESI-MS 
and HR ESI-MS (71 % yield). The 1H NMR spectrum showed the expected 15 
aromatic signals, with two signals overlapping. ESI-MS showed an ion at m/z 
705 which is consistent with [L7+H]+. 
3.1.2.2 Synthesis of L8 
 
L8 also consists of a spacer unit containing three aromatic rings similar to L7, 
except the central ring of the space group contains a heteroatom, nitrogen. 
Thus this spacer unit has a central pyridyl ring and two phenyl rings. This ligand 
was produced by following a synthesis scheme identical to that employed for L7 
(scheme 3.2, b) with 2,6-dibromopyridine (14) employed in the first step of the 
synthesis for L8 . 
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3.1.2.3 Synthesis of L9 
 
L9 was also produced in an analogous fashion to L7, with the difference being a 
variation of the central aromatic ring of the spacer unit (scheme 3.2, c). L9 is a 
ligand possessing two tridentate donor domains separated by a spacer unit 
which consists of two phenyl groups and a methoxytoluene-type aromatic ring 
as the central component of the spacer. This was achieved using 1,3-dibromo-
2-methoxy-5-methylbenzene (17) for the Suzuki cross-coupling reaction in the 
first step of ligand synthesis.  
3.1.2.4 Synthesis of L10 
 
L10 may be seen as an extension of L9, as the ligands are similar except a 
glycol ether chain is present on the central aromatic ring for L10. Once again the 
synthesis for this ligand follows the same multistep scheme employed for the 
other ligands described here (scheme 3.2, d). 
3.1.2.5 Synthesis of L11  
 
The synthesis for L11 is outlined in scheme 3.2, e. As with previous ligands the 
synthesis of this ligand was carried out in a similar manner to that of L7 with the 
incorporation of different starting materials for the Suzuki cross-coupling 
reaction further variation of the spacer unit was achieved. The central aromatic 
ring of the spacer group for L11 is a p-toluidine (aminotoluene) functionality.  
 
3.1.2.6 Synthesis of L12 and L13  
The synthesis schemes for L12 and L13 are outlined in scheme 3.2, f and g 
respectively. As with previous ligands the synthesis for this ligand was carried 
out in a similar manner to that of L7. The central aromatic ring of the spacer unit 
for L12 is essentially acetyl amino toluene. L13 is similar to that of L12, except the 
central aromatic group possesses a benzoyl pendant group from the amino 
toluene central aromatic ring, giving a larger pendant group. 
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3.1.2.7 Synthesis of L14 
 
The initial synthesis for this ligand follows the same procedure as employed for 
the other ligands seen herein, with the difference in starting material allowing 
variation of the triphenyl spacer (scheme 3.3). However, in this case an 
additional synthesis step was required to produce a ligand containing a benzyl 
pendant group on the central aromatic ring.  
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Scheme 3.2 Synthesis of L7- L13  
Reagents and conditions: a) [Pd(PPh3)2Cl2],NaHCO3, nBu4NBr, EtOH, H2O, 70 
˚C; b) Br2, CH3COOH; c) β,β’-bipyridine-6-thioamide (9), EtOH, reflux 
  
a) X = C, R1 = R2 =H (10)
b) X = N, R1 = N/A, R2 = H (14)
c) X = C, R1 =OCH3, R2 = CH3 (18)
d) X = C, R1 = O(CH2CH2)O(CH2CH2)OCH3, R2 = CH3 (24)
e) X = C, R1 = NH2, R2 = CH3 (27)
f) X = C, R1 = NH(COCH3), R2 = CH3 (30)
g) X = C, R1 = NH(COPh), R2 = CH3 (33)
a) X = C, R1 = R2 =H (13)
b) X = N, R1 = N/A, R2 = H (16)
c) X = C, R1 =OCH3, R2 = CH3 (20)
d) X = C, R1 = O(CH2CH2)O(CH2CH2)OCH3, R2 = CH3 (26)
e) X = C, R1 = NH2, R2 = CH3 (29)
f) X = C, R1 = NH(COCH3), R2 = CH3 (32)
g) X = C, R1 = NH(COPh), R2 = CH3 (35)
a) X = C, R1 = R2 =H (12)
b) X = N, R1 = N/A, R2 = H (15)
c) X = C, R1 =OCH3, R2 = CH3 (19)
d) X = C, R1 = O(CH2CH2)O(CH2CH2)OCH3, R2 = CH3 (25)
e) X = C, R1 = NH2, R2 = CH3 (28)
f) X = C, R1 = NH(COCH3), R2 = CH3 (31)
g) X = C, R1 = NH(COPh), R2 = CH3 (34)
a) X = C, R1 = R2 =H (L7)
b) X = N, R1 = N/A, R2 = H (L8)
c) X = C, R1 =OCH3, R2 = CH3 (L9)
d) X = C, R1 = O(CH2CH2)O(CH2CH2)OCH3, R2 = CH3 (L10)
e) X = C, R1 = NH2, R2 = CH3 (L11)
f) X = C, R1 = NH(COCH3), R2 = CH3 (L12)
g) X = C, R1 = NH(COPh), R2 = CH3 (L13)
a
b
c
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b
c
d
(11)
(37)
(17) (36)
(38)
(L14)
 
 
Scheme 3.3 Synthesis of L14  
Reagents and conditions: a) [Pd(PPh3)2Cl2],NaHCO3, nBu4NBr, EtOH, H2O, 70 
˚C (65%); b) Br2, CH3COOH (89%); c) β,β’-bipyridine-6-thioamide (9), EtOH, 
reflux (79%); d) NaH, DMF, N2 (g), benzyl bromide, 80 ˚C (56%) 
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3.2 Coordination chemistry  
3.2.1 Complexes of L6 with copper(II)  
 
Reaction of L6 with an equimolar quantity of Cu(ClO4)2 in acetonitrile gave a 
light green solution, which upon analysis by ESI-MS showed ions at m/z 1683 
and 792 corresponding to {[Cu2(L6)2](ClO4)3}+ and {[Cu2(L6)2](ClO4)2}2+. Slow 
diffusion of ether into the acetonitrile complex solution resulted in the formation 
of X-ray quality green crystals. Single crystal X-ray structure determination 
showed crystallisation in the triclinic space group P-1 and confirmed the 
formation of the dinuclear species [Cu2(L6)2]4+ (figure 3.8). 
 
Figure 3.8 Two views for the solid state structure of the complex cation 
[Cu2(L6)2]4+ii 
The crystal structure confirms that in the solid state the ligand, L6, and Cu(II) 
ions self-assemble to form a dinuclear double helicate, in which the ligand 
strand partitions into two tridentate donor domains, separated by the bi-
phenylene spacer unit (figure 3.8). The bi-phenyl spacer bridges the tridentate 
domains in an “over-and-under” conformation giving a helical structure. Each 
                                            
ii
 All X-ray crystallography data for this chapter was recorded by Professor Craig Rice. 
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ligand twists and adopts an S-type arrangement resulting in the two metal ions 
having the same chirality which leads to a “true” helicate. The two tridentate 
donor domains of each ligand coordinate both of the metal ions. The two Cu(II) 
ions (Cu–Cu distance: 7.955(1) Å) are six-coordinate arising from coordination 
with two tridentate N,N,N-domains (Cu–N distances: 1.954(3) – 2.358(3) Å). 
Selected bond lengths and angles for the complex are shown in tables 3.1 and 
3.2. 
Bond Bond Length (Å) Bond Bond Length (Å) 
Cu(1)-N(8) 1.968(3) Cu(2)-N(5) 1.954(3) 
Cu(1)-N(2) 1.968(3) Cu(2)-N(11) 1.964(3) 
Cu(1)-N(7) 2.138(3) Cu(2)-N(6) 2.109(3) 
Cu(1)-N(1) 2.141(3) Cu(2)-N(12 ) 2.167(3) 
Cu(1)-N(9) 2.304(3) Cu(2)-N(4) 2.290(3) 
Cu(1)-N(3) 2.358(3) Cu(2)-N(10) 2.356(3) 
 
Table 3.1 Selected bond lengths (Å) for the complex cation [Cu2(L6)2]4+ 
 
Bond Angle (˚) Bond Angle (˚) 
N(8)-Cu(1)-N(2) 176.53(12) N(5)-Cu(2)-N(11) 178.49(13) 
N(8)-Cu(1)-N(7) 78.76(12) N(5)-Cu(2)-N(6) 79.07(13) 
N(2)-Cu(1)-N(7) 101.76(11) N(11)-Cu(2)-N(6) 102.33(13) 
N(8)-Cu(1)-N(1) 104.20(12) N(5)-Cu(2)-N(12) 101.77(13) 
N(2)-Cu(1)-N(1) 78.83(13) N(11)-Cu(2)-N(12) 78.31(13) 
N(7)-Cu(1)-N(1) 112.27(12) N(6)-Cu(2)-N(12) 110.06(13) 
N(8)-Cu(1)-N(9) 76.34(12) N(5)-Cu(2)-N(4) 77.30(12) 
N(2)-Cu(1)-N(9) 102.75(12) N(11)-Cu(2)-N(4) 101.25(12) 
N(7)-Cu(1)-N(9) 154.43(11) N(6)-Cu(2)-N(4) 155.81(13) 
N(1)-Cu(1)-N(9) 79.74(11) N(12)-Cu(2)-N(4) 79.96(12) 
N(8)-Cu(1)-N(3) 100.89(12) N(5)-Cu(2)-N(10) 103.58(12) 
N(2)-Cu(1)-N(3) 75.90(12) N(11)-Cu(2)-N(10) 76.14(12) 
N(7)-Cu(1)-N(3) 79.67(11) N(6)-Cu(2)-N(10) 82.70(12) 
N(1)-Cu(1)-N(3) 153.86(12) N(12)-Cu(2)-N(10) 153.41(12) 
N(9)-Cu(1)-N(3) 99.35(11) N(4)-Cu(2)-N(10) 97.87(11) 
 
Table 3.2 Selected bond angles (˚) for the complex cation [Cu2(L6)2]4+ 
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3.2.2 Complexes of L7 with iron(II) 
Reaction of L7 with an equimolar amount of Fe(ClO4)2 in nitromethane gave a 
deep purple solution. Analysis by ESI-MS showed an ion at m/z 1819 
corresponding to {[Fe2(L7)2](ClO4)3}+ indicating a dinuclear species has formed. 
Slow diffusion of ether into the nitromethane complex solution resulted in the 
formation of X-ray quality purple crystals. Single crystal X-ray structure 
determination showed crystallisation in the orthorhombic space group Cmca 
and confirmed the formation of the dinuclear species [Fe2(L7)2]4+ (figure 3.9). 
 
Figure 3.9 Two views for the solid state structure of the complex cation 
[Fe2(L7)2]4+ 
 
The crystal structure confirms in the solid state the ligand, L7, and Fe(II) ions 
self-assemble to form a dinuclear double helicate, in a similar manner seen for 
the previous ligand, L6. This ligand strand partitions into two tridentate donor 
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domains due to the central phenylene spacer group; the two tridentate donor 
domains of each ligand coordinate both of the metal ions. The Fe(II) ions (Fe–
Fe distance: 8.8746(7) Å) are six coordinate arising from coordination with two 
tridentate N,N,N-domains (Fe–N distances: 2.142(3) – 2.270(3) Å). Selected 
bond lengths and angles for the complex are shown in tables 3.3 and 3.4. 
 
Figure 3. 10 ESI-MS of [Fe2(L7)2](ClO4)4 with the found (top) and predicted 
(bottom) isotopic distribution pattern of {[Fe2(L7)2](ClO4)3}+ (inset) 
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Bond Bond Length (Å) 
Fe(1)-N(5) 2.142(3) 
Fe(1)-N(2) 2.148(3) 
Fe(1)-N(4) 2.215(3) 
Fe(1)-N(1) 2.216(3) 
Fe(1)-N(3) 2.221(3) 
Fe(1)-N(6) 2.270(3) 
 
Table 3.3 Selected bond lengths (Å) for the complex cation [Fe2(L7)2]4+ 
 
Bond Angle (˚) 
N(5)-Fe(1)-N(2) 165.65(11) 
N(5)-Fe(1)-N(4) 73.59(11) 
N(2)-Fe(1)-N(4) 103.18(11) 
N(5)-Fe(1)-N(1) 93.90(10) 
N(2)-Fe(1)-N(1) 73.06(11) 
N(4)-Fe(1)-N(1) 103.73(10) 
N(5)-Fe(1)-N(3) 118.99(11) 
N(2)-Fe(1)-N(3) 73.70(11) 
N(4)-Fe(1)-N(3) 82.71(10) 
N(1)-Fe(1)-N(3) 146.74(11) 
N(5)-Fe(1)-N(6) 73.78(11) 
N(2)-Fe(1)-N(6) 109.48(11) 
N(4)-Fe(1)-N(6) 147.10(10) 
N(1)-Fe(1)-N(6) 82.51(10) 
N(3)-Fe(1)-N(6) 109.89(10) 
 
Table 3.4 Selected bond angles (˚) for the complex cation [Fe2(L7)2]4+ 
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3.2.3 Complexes of L8 with mercury(II) 
 
Reaction of L8 with an equimolar amount of Hg(ClO4)2 in nitromethane gave a 
pale yellow solution, which upon analysis by ESI-MS showed an ion at m/z 
2111 corresponding to {[Hg2(L8)2](ClO4)3}+. Slow diffusion of diisopropyl ether 
into the nitromethane complex solution resulted in the formation of X-ray quality 
colourless crystals. X-ray crystal structure determination showed crystallisation 
in the monoclinic space group P2(1)/c and confirmed the formation of the 
dinuclear species [Hg2(L8)2]4+ (figure 3.10). 
 
Figure 3.11 Solid state structure of the complex cation [Hg2(L8)2]4+ 
 
The crystal structure confirms in the solid state this ligand, L8, and Hg(II) ions 
self-assemble to form a dinuclear double helicate. The Hg(II) ions (Hg–Hg 
distance: 8.1526(3) Å) are six coordinate arising from coordination with two 
tridentate N,N,N-domains from two different ligands (Hg–N distances: 
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2.273(3)– 2.578(3)Å).  Selected bond lengths and angles for the complex are 
shown in tables 3.5 and 3.6. 
 
Bond Bond Length (Å) Bond Bond Length (Å) 
Hg(1)-N(9) 2.333(3) Hg(2)-N(5) 2.273(3) 
Hg(1)-N(11) 2.333(3) Hg(2)-N(2) 2.311(3) 
Hg(1)-N(7) 2.383(3) Hg(2)-N(4) 2.364(3) 
Hg(1)-N(10) 2.411(3) Hg(2)-N(1) 2.388(3) 
Hg(1)-N(8) 2.454(3) Hg(2)-N(3) 2.438(3) 
Hg(1)-N(12) 2.490(3) Hg(2)-N(6) 2.578(3) 
 
Table 3.5 Selected bond lengths (Å) for the complex cation [Hg2(L8)2]4+ 
 
Bond Angle (˚) Bond Angle (˚) 
N(9)-Hg(1)-N(11) 162.96(10) N(5)-Hg(2)-N(2) 160.68(10) 
N(9)-Hg(1)-N(7) 126.06(10) N(5)-Hg(2)-N(4) 71.42(10) 
N(11)-Hg(1)-N(7) 70.67(10) N(2)-Hg(2)-N(4) 126.43(10) 
N(9)-Hg(1)-N(10) 68.89(10) N(5)-Hg(2)-N(1) 122.16(9) 
N(11)-Hg(1)-N(10) 120.71(10) N(2)-Hg(2)-N(1) 70.60(10) 
N(7)-Hg(1)-N(10) 83.49(10) N(4)-Hg(2)-N(1) 86.59(10) 
N(9)-Hg(1)-N(8) 69.88(9) N(5)-Hg(2)-N(3) 96.38(10) 
N(11)-Hg(1)-N(8) 102.14(9) N(2)-Hg(2)-N(3) 69.19(10) 
N(7)-Hg(1)-N(8) 112.38(9) N(4)-Hg(2)-N(3) 119.28(10) 
N(10)-Hg(1)-N(8) 137.14(10) N(1)-Hg(2)-N(3) 139.74(10) 
N(9)-Hg(1)-N(12) 95.17(10) N(5)-Hg(2)-N(6) 68.49(10) 
N(11)-Hg(1)-N(12) 68.20(10) N(2)-Hg(2)-N(6) 95.19(10) 
N(7)-Hg(1)-N(12) 138.77(10) N(4)-Hg(2)-N(6) 137.93(9) 
N(10)-Hg(1)-N(12) 115.51(10) N(1)-Hg(2)-N(6) 104.13(9) 
N(8)-Hg(1)-N(12) 79.29(9) N(3)-Hg(2)-N(6) 77.85(9) 
 
Table 3.6 Selected bond angles (˚) for the complex cation [Hg2(L8)2]4+ 
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3.2.4 Complexes of L9  
3.2.4.1 Complex of L9 cobalt(II)  
 
Reaction of L9 with an equimolar amount of Co(BF4)2 in nitromethane gave an 
orange solution which gave an ion in the ESI-MS at m/z 1876 corresponding to 
{[Co2(L9)2](BF4)3}+ indicating the formation of a dinuclear assembly. Slow 
diffusion of chloroform into the nitromethane complex solution resulted in the 
formation of X-ray quality orange crystals. The X-ray structure determination 
showed crystallisation in the triclinic space group P-1 and confirmed the 
formation of the dinuclear species [Co2(L9)2]4+ (figure 3.11). 
 
Figure 3.12 Two views for the solid state structure of the complex cation 
[Co2(L9)2]4+ 
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Figure 3.11 shows the solid state structure which results upon complex 
formation between cobalt and L9. This self-assembly results in the formation of 
a dinuclear double meso-helicate, in which the two tridentate domains of each 
ligand coordinate two different metal ions in a ‘side by side’ conformation. Each 
of the ligands coordinates via a C-type arrangement giving rise to metal centres 
of opposite chirality which leads to a dinuclear double meso-helicate, as 
opposed to a “true” helicate where the ligand twists and adopts an S-type 
arrangement resulting in the two metal ions having the same chirality. The 
cobalt metal ions (Co–Co distance: 14.0996(3) Å) display an octahedral 
geometry from coordination with six nitrogen atoms from two coordination sites 
(Co–N distances: 2.059(3) – 2.213(2) Å). Selected bond lengths and angles for 
the complex are shown in tables 3.7 and 3.8. 
 
Bond Bond Length (Å) 
Co(1)-N(1) 2.191(3) 
Co(1)-N(2) 2.059(3) 
Co(1)-N(3) 2.213(2) 
Co(1)-N(4) 2.157(3) 
Co(1)-N(5) 2.069(3) 
Co(1)-N(6) 2.153(3) 
 
Table 3.7 Selected bond lengths (Å) for the complex cation [Co2(L9)2]4+ 
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Bond Angle 
N(2)-Co(1)-N(5) 167.44(10) 
N(2)-Co(1)-N(6) 111.90(11) 
N(5)-Co(1)-N(6) 76.57(10) 
N(2)-Co(1)-N(4) 97.52(11) 
N(5)-Co(1)-N(4) 75.39(10) 
N(6)-Co(1)-N(4) 150.07(10) 
N(2)-Co(1)-N(1) 75.53(10) 
N(5)-Co(1)-N(1) 94.54(10) 
N(6)-Co(1)-N(1) 97.47(10) 
N(4)-Co(1)-N(1) 94.98(10) 
N(2)-Co(1)-N(3) 76.26(10) 
N(5)-Co(1)-N(3) 114.33(10) 
N(6)-Co(1)-N(3) 86.62(9) 
N(4)-Co(1)-N(3) 95.49(10) 
N(1)-Co(1)-N(3) 150.94(10) 
 
Table 3.8 Selected bond angles (˚) for the complex cation [Co2(L9)2]4+ 
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3.2.4.1 Complex of L9 cadmium(II) 
 
Reaction of L9 with an equimolar amount of Cd(ClO4)2 in acetonitrile gave a pale 
yellow solution and analysis by ESI-MS showed ions corresponding to 
{[Cd(L9)]ClO4}+ and {[Cd2(L9)2](ClO4)3}+ (m/z 961 and 2022 respectively). 
Layering of the acetonitrile complex solution with diethyl ether resulted in the 
formation of X-ray quality crystals. The X-ray crystal structure showed 
crystallisation in the triclinic space group P-1 and confirmed the formation of the 
dinuclear species [Cd2(L9)2]4+. 
 
 
Figure 3.13 Two views for the solid state structure of the complex cation 
[Cd2(L9)2]4+ 
 
Figure 3.12 shows the solid state structure which results upon complex 
formation between cadmium(II) and L9. This self-assembly allows the formation 
of a dinuclear double helicate, in contrast with the previous complex observed 
for this ligand with cobalt(II). Each metal ion (Cd–Cd distance: 11.0466(6) Å) 
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displays an octahedral geometry from coordination with six nitrogen atoms from 
two coordination sites (Cd–N distances: 2.295(3) – 2.422(3) Å). The “over-and-
under” conformation of the ligand giving a helical structure may be seen more 
clearly in figure 3.13 in which only one of the ligands of the dinuclear species is 
shown. Selected bond lengths and angles for the complex are shown in tables 
3.9 and 3.10. 
 
 
 
Figure 3.14 (i) Structure of L9, (ii) ligand coordination within the complex cation 
[Cd2(L9)2]4+ 
  
(L9)
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Bond Bond Length (Å) Bond Bond Length (Å) 
Cd(1)-N(11) 2.295(3) Cd(2)-N(2) 2.313(3) 
Cd(1)-N(5) 2.312(3) Cd(2)-N(8) 2.326(4) 
Cd(1)-N(4) 2.336(3) Cd(2)-N(1) 2.352(4) 
Cd(1)-N(12) 2.383(4) Cd(2)-N(9) 2.352(4) 
Cd(1)-N(6) 2.385(3) Cd(2)-N(7) 2.386(4) 
Cd(1)-N(10) 2.422(3) Cd(2)-N(3) 2.395(3) 
 
 Table 3.9 Selected bond lengths (Å) for the complex cation [Cd2(L9)2]4+ 
Bond Angle (˚) Bond Angle (˚) 
N(11)-Cd(1)-N(5) 161.90(12) N(2)-Cd(2)-N(8) 160.80(14) 
N(11)-Cd(1)-N(4) 127.66(11) N(2)-Cd(2)-N(1) 69.47(12) 
N(5)-Cd(1)-N(4) 70.38(11) N(8)-Cd(2)-N(1) 102.86(13) 
N(11)-Cd(1)-N(12) 69.57(13) N(2)-Cd(2)-N(9) 125.32(13) 
N(5)-Cd(1)-N(12) 113.65(12) N(8)-Cd(2)-N(9) 71.08(16) 
N(4)-Cd(1)-N(12) 88.54(12) N(1)-Cd(2)-N(9) 91.31(12) 
N(11)-Cd(1)-N(6) 92.80(12) N(2)-Cd(2)-N(7) 94.31(13) 
N(5)-Cd(1)-N(6) 69.19(12) N(8)-Cd(2)-N(7) 68.74(15) 
N(4)-Cd(1)-N(6) 138.38(12) N(1)-Cd(2)-N(7) 97.63(12) 
N(12)-Cd(1)-N(6) 98.69(12) N(9)-Cd(2)-N(7) 139.82(14) 
N(11)-Cd(1)-N(10) 70.82(12) N(2)-Cd(2)-N(3) 70.30(12) 
N(5)-Cd(1)-N(10) 108.54(11) N(8)-Cd(2)-N(3) 116.76(12) 
N(4)-Cd(1)-N(10) 104.55(11) N(1)-Cd(2)-N(3) 139.53(12) 
N(12)-Cd(1)-N(10) 137.79(12) N(9)-Cd(2)-N(3) 108.43(11) 
N(6)-Cd(1)-N(10) 97.20(11) N(7)-Cd(2)-N(3) 89.57(12) 
 
Table 3.10 Selected bond angles (˚) for the complex cation [Cd2(L9)2]4+ 
 
For this ligand, L9, two different self-assembled structures have been shown to 
form. This demonstrates well how subtle changes within such a reaction, i.e. 
different metal ion, can influence the resulting supramolecular architecture. In 
contrast with the previous ligand, L7, the inclusion of a more bulky pendant 
group on the central aromatic ring sufficiently prevents the formation of the 
more compact double helicate, when first row transition metals are employed, 
resulting in  a meso-helicate structure. 
111 
 
3.2.5 Complexes of L10 with iron(II) 
 
Reaction of L10 with an equimolar amount of Fe(ClO4)2 in acetonitrile gave a 
deep purple solution which upon analysis by ESI-MS showed ions at m/z 2084 
and 992 corresponding to {[Fe2(L10)2](ClO4)3}+ and {[Fe2(L10)2](ClO4)2}2+ 
respectively, indicating the formation of a dinuclear species. Slow diffusion of 
chloroform into the acetonitrile complex solution resulted in the formation of X-
ray quality purple crystals. The X-ray crystal structure showed crystallisation in 
the triclinic space group P-1 and confirmed the formation of the dinuclear 
species [Fe2(L10)2]4+ (figure 3.14). 
Figure 3.15 Two views for the solid state structure of the complex cation 
[Fe2(L10)2]4+ 
 
The solid sate structure of the complex cation [Fe2(L10)2]4+ (figure 3.14) 
confirms the formation of a dinuclear species, as is expected for a ligand 
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possessing tridentate domains, separated by a spacer unit preventing 
coordination to a single metal ion. In the structure the two Fe(II) ions (Fe–Fe 
distance: 13.0506(9) Å) are six-coordinate from coordination by two thiazole-
pyridyl-pyridyl donor domains from each ligand (Fe–N distances: 1.897(3) – 
2.040(3) Å). However in this case the spacers bridge the tridentate domains in 
a “side-by-side” conformation not an “over-and-under” conformation as seen for 
helicates, for this structure a mesocate is produced (figure 3.15). Selected bond 
lengths and angles for the complex are shown in tables 3.11 and 3.12. 
 
Figure 3.16 solid state structure of the complex cation [Fe2(L10)2]4+. One ligand 
shown in yellow to better illustrate the “side-by-side” conformation of the ligand 
strands 
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Figure 3. 17 ESI-MS of [Fe2(L10)2](ClO4)4 with the found (top) and predicted 
(bottom) isotopic distribution pattern of {[Fe2(L10)2](ClO4)3}+ (inset) 
 
Bond Bond Length (Å) 
Fe(1)-N(5) 1.897(3) 
Fe(1)-N(2) 1.904(3) 
Fe(1)-N(4) 1.966(3) 
Fe(1)-N(1) 1.983(3) 
Fe(1)-N(6) 2.038(3) 
Fe(1)-N(3) 2.040(3) 
 
Table 3.11 Selected bond lengths (Å) for the complex cation [Fe2(L10)2]4+ 
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Bond Angle (˚) 
N(5)-Fe(1)-N(2) 172.35(12) 
N(5)-Fe(1)-N(4) 80.50(12) 
N(2)-Fe(1)-N(4) 95.46(12) 
N(5)-Fe(1)-N(1) 93.30(12) 
N(2)-Fe(1)-N(1) 80.12(12) 
N(4)-Fe(1)-N(1) 89.65(12) 
N(5)-Fe(1)-N(6) 79.70(12) 
N(2)-Fe(1)-N(6) 104.95(12) 
N(4)-Fe(1)-N(6) 159.12(12) 
N(1)-Fe(1)-N(6) 98.03(12) 
N(5)-Fe(1)-N(3) 106.64(12) 
N(2)-Fe(1)-N(3) 80.03(12) 
N(4)-Fe(1)-N(3) 94.28(12) 
N(1)-Fe(1)-N(3) 160.04(12) 
N(6)-Fe(1)-N(3) 85.12(11) 
 
Table 3.12 Selected bond angles (˚) for the complex cation [Fe2(L10)2]4+ 
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3.2.6 Complexes of L11 with cadmium(II)  
 
Reaction of L11 with an equimolar amount of Cd(ClO4)2 in nitromethane gave a 
colourless solution, which upon analysis by ESI-MS showed ions at m/z 1990 
and 946 corresponding to {[Cd2(L11)2](ClO4)3}+ and {[Cd2(L11)2](ClO4)2}2+ 
indicating a dinuclear species. Camphorsulfonic acid (1 equivalent per ligand 
for protonation of the amine groups) was added to the solution and upon slow 
diffusion of dichloromethane into the nitromethane complex solution X-ray 
quality colourless crystals were obtained. The structural determination showed 
crystallisation in the triclinic space group P-1 and confirmed the formation of the 
dinuclear species [Cd2(L11)(L11-H)]5+ (figure 3.16). 
 
Figure 3.18 Solid state structure of the complex cation [Cd2(L11)(L11-H)]5+ 
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The solid state structure of the complex cation [Cd2(L11)(L11-H)]5+ confirms the 
formation of a dinuclear species. In the structure Cd(II) metal ions (Cd–Cd 
distance: 14.3905(6) Å) coordinate two thiazole-pyridyl-pyridyl donor domains 
giving a six-coordinate geometry (Cd–N distances: 2.301(3) – 2.396(3) Å). 
Selected bond lengths and angles for the complex are shown in tables 3.13 
and 3.14. Again in this case the spacers bridge the tridentate domains in a 
“side-by-side” conformation giving a meso-helicate (figure 3.16). As can be 
seen from the formula for this complex cation there are five perchlorate counter 
anions ([Cd2(L11)(L11-H)](ClO4)5) and as the crystals were grown in the 
presence of camphorsulfonic acid it is assumed that one of the amine nitrogen 
atoms has been protonated. In the central cavity a water molecule is present 
and this is able to act as a hydrogen bond acceptor to the protonated amine 
(2.850(6) Å) and a donor to the other, unprotonated, amine (3.254(6) Å) (figure 
3.17). Selected bond lengths and angles for the complex are shown in tables 
3.13 and 3.14. 
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Figure 3.19 Two views of the complex cation [Cd2(L11)(L11-H)]5+ (i) Solid state 
structure including the water molecule within the cavity; (ii) Solid state structure 
showing hydrogen bonding. 
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Bond Bond Length (Å) Bond Bond Length (Å) 
Cd(1)-N(6) 2.301(3) Cd(2)-N(9) 2.308(3) 
Cd(1)-N(13) 2.309(3) Cd(2)-N(2) 2.313(3) 
Cd(1)-N(12) 2.335(3) Cd(2)-N(8) 2.352(3) 
Cd(1)-N(7) 2.339(3) Cd(2)-N(3) 2.373(3) 
Cd(1)-N(5) 2.342(3) Cd(2)-N(1) 2.378(3) 
Cd(1)-N(14) 2.351(4) Cd(2)-N(10) 2.396(3) 
 
Table 3.13 Selected bond lengths (Å) for the complex cation [Cd2(L11)(L11-H)]5+ 
 
Bond Angle (˚) Bond Angle (˚) 
N(6)-Cd(1)-N(13) 169.09(11) N(9)-Cd(2)-N(2) 173.25(11) 
N(6)-Cd(1)-N(12) 117.50(11) N(9)-Cd(2)-N(8) 69.25(11) 
N(13)-Cd(1)-N(12) 70.95(11) N(2)-Cd(2)-N(8) 107.30(11) 
N(6)-Cd(1)-N(7) 69.58(12) N(9)-Cd(2)-N(3) 115.10(11) 
N(13)-Cd(1)-N(7) 102.84(12) N(2)-Cd(2)-N(3) 71.17(11) 
N(12)-Cd(1)-N(7) 100.84(11) N(8)-Cd(2)-N(3) 105.05(11) 
N(6)-Cd(1)-N(5) 71.45(11) N(9)-Cd(2)-N(1) 105.06(11) 
N(13)-Cd(1)-N(5) 117.04(11) N(2)-Cd(2)-N(1) 69.00(11) 
N(12)-Cd(1)-N(5) 88.73(11) N(8)-Cd(2)-N(1) 93.69(12) 
N(7)-Cd(1)-N(5) 139.89(11) N(3)-Cd(2)-N(1) 139.46(11) 
N(6)-Cd(1)-N(14) 102.47(11) N(9)-Cd(2)-N(10) 70.54(11) 
N(13)-Cd(1)-N(14) 69.68(11) N(2)-Cd(2)-N(10) 113.56(11) 
N(12)-Cd(1)-N(14) 139.98(11) N(8)-Cd(2)-N(10) 138.89(11) 
N(7)-Cd(1)-N(14) 94.55(12) N(3)-Cd(2)-N(10) 84.47(11) 
N(5)-Cd(1)-N(14) 102.78(12) N(1)-Cd(2)-N(10) 104.62(11) 
 
Table 3.14 Selected bond angles (˚) for the complex cation [Cd2(L11)(L11-H)]5+ 
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3.2.7 Complexes of L12 with zinc(II) 
 
Reaction of L12 with an equimolar quantity of Zn(ClO4)2 in nitromethane gave a 
colourless solution which gave ions in the ESI-MS at m/z 1981 and 940 
corresponding to {[Cd2(L12)2](ClO4)3}+ and {[Cd2(L12)2](ClO4)2}2+ indicating the 
formation of a dinuclear assembly. Slow diffusion of dichloromethane into the 
nitromethane complex solution resulted in the formation of X-ray quality 
colourless crystals. The X-ray crystal structure determination showed 
crystallisation in the triclinic space group P-1 and confirmed the formation of the 
dinuclear species [Zn2(L12)2]4+ (figure 3.18). 
 
Figure 3.20 Solid state structure of the complex cation [Zn2(L12)2]4+ 
 
The solid state structure of the complex cation [Zn2(L12)2]4+ shows the formation 
of a dinuclear species. In the structure Zn(II) metal ions are coordinated by two 
thiazole-pyridyl-pyridyl donor domains giving a six-coordinate geometry; again 
in this case the spacers bridge the tridentate domains in a “side-by-side” 
conformation giving a meso-helicate. The data obtained for this particular 
structure, however, was not of the highest quality due to the loss of solvent. As 
a result the data should be interpreted with caution; however, the structure 
does provide enough information about the gross molecular connectivity within 
the self-assembly.  
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3.2.8 Complexes of L13 with zinc(II) 
 
Reaction of L13 with an equimolar amount of Zn(ClO4)2 in nitromethane gave a 
colourless solution, which upon analysis by ESI-MS showed ions at m/z  2105 
and 1002 corresponding to {[Zn2(L13)2](ClO4)3}+ and {[Zn2(L13)2](ClO4)2}2+ 
respectively, indicating a dinuclear species has formed. Slow diffusion of 
dichloromethane into the nitromethane complex solution resulted in the 
formation of X-ray quality colourless crystals. The X-ray crystal structure 
determination showed crystallisation in the triclinic space group P-1 and 
confirmed the formation of the dinuclear species [Zn2(L13)2]4+ (figure 3.19). 
 
Figure 3.21 Two views for the solid state structure of the complex cation 
[Zn2(L13)2]4+, solvent molecule omitted for clarity. 
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The crystal structure confirms that in the solid state the ligand, L13, and Zn(II) 
ions self-assemble to form a dinuclear double meso-helicate, in which the 
ligand strand partitions into two tridentate donor domains, separated by the tri-
phenylene spacer unit (figure 3.19). The two tridentate donor domains of each 
ligand coordinate both of the metal ions; the two Zn(II) ions (Zn–Zn distance: 
14.1821(5) Å) are six coordinate arising from coordination with two tridentate 
N,N,N-domains (Zn–N distances: 2.073(3) – 2.214(4) Å).  
 
Figure 3.22 Two views of the complex cation [Zn2(L13)2]4+ (i) Solid state 
structure; (ii) a space-filling picture showing all atoms and their van der Waal’s 
radii  
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Within the cavity of the meso-helicate there is a water molecule present, this fits 
well between the two ligands (figure 3.20). This is held in place through 
hydrogen bonding, where the water is able to act as a hydrogen bond acceptor 
(2.1288(1) – 2.5589(1) Å) as well as a donor (1.8811(1) Å). Selected bond 
lengths and angles for the complex are shown in tables 3.15 and 3.16. 
 
Bond Bond Length (Å) Bond Bond Length (Å) 
Zn(1)-N(1) 2.195(3) Zn(2)-N(4) 2.196(3) 
Zn(1)-N(2) 2.073(3) Zn(2)-N(5) 2.076(3) 
Zn(1)-N(3) 2.198(3) Zn(2)-N(6) 2.214(4) 
Zn(1)-N(8) 2.198(4) Zn(2)-N(11) 2.197(3) 
Zn(1)-N(9) 2.078(3) Zn(2)-N(12) 2.090(4) 
Zn(1)-N(10) 2.195(3) Zn(2)-N(13) 2.171(4) 
 
Table 3.15 Selected bond lengths (Å) for the complex cation [Zn2(L13)2]4+ 
 
Bond Angle (˚) Bond Angle (˚) 
N(2)-Zn(1)-N(1) 75.35(13) N(5)-Zn(2)-N(4) 77.03(13) 
N(3)-Zn(1)-N(1) 149.42(13) N(6)-Zn(2)-N(4) 150.83(13) 
N(3)-Zn(1)-N(2) 76.44(13) N(6)-Zn(2)-N(5) 74.94(14) 
N(8)-Zn(1)-N(1) 93.17(13) N(11)-Zn(2)-N(4) 87.59(13) 
N(8)-Zn(1)-N(2) 94.88(13) N(11)-Zn(2)-N(5) 114.89(14) 
N(8)-Zn(1)-N(3) 100.75(13) N(11)-Zn(2)-N(6) 96.93(13) 
N(9)-Zn(1)-N(1) 94.08(13) N(12)-Zn(2)-N(4) 115.69(14) 
N(9)-Zn(1)-N(2) 165.14(13) N(12)-Zn(2)-N(5) 164.67(14) 
N(9)-Zn(1)-N(3) 115.71(13) N(12)-Zn(2)-N(6) 93.27(14) 
N(9)-Zn(1)-N(8) 75.01(13) N(12)-Zn(2)-N(11) 75.69(14) 
N(10)-Zn(1)-N(1) 93.47(13) N(13)-Zn(2)-N(4) 96.44(13) 
N(10)-Zn(1)-N(2) 114.13(13) N(13)-Zn(2)-N(5) 95.53(14) 
N(10)-Zn(1)-N(3) 87.43(13) N(13)-Zn(2)-N(6) 94.11(14) 
N(10)-Zn(1)-N(8) 150.98(13) N(13)-Zn(2)-N(11) 149.39(13) 
N(10)-Zn(1)-N(9) 76.36(13) N(13)-Zn(2)-N(12) 75.25(14) 
 
Table 3.16 Selected bond angles (˚) for the complex cation [Zn2(L13)2]4+ 
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3.2.9 Complexes of L14 with cadmium(II) 
 
Reaction of L14 with an equimolar amount of Cd(ClO4)2 in acetonitrile gave a 
colourless solution, which upon analysis by ESI-MS showed ions at m/z 1037 
and 2173 corresponding to {[Cd(L14)]ClO4}+ and {[Cd2(L14)2](ClO4)3}+. Slow 
diffusion of dichloromethane into the acetonitrile complex solution resulted in 
the formation of X-ray quality colourless crystals. The X-ray crystal structure 
showed crystallisation in the monoclinic space group P 1 21/c and confirmed 
the formation of the dinuclear species [Cd2(L14)2]4+ (figure 3.21). 
 
Figure 3.23 Two views for the solid state structure of the complex cation 
[Cd2(L14)2]4+ 
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The crystal structure confirms that in the solid state the ligand, L14, and Cd(II) 
ions self-assemble to form a dinuclear double meso-helicate, in which the 
ligand strand partitions into two tridentate donor domains, separated by the tri-
phenylene spacer unit (figure 3.21). The space-filling structure is shown in 
figure 3.22. The two tridentate donor domains of each ligand coordinate each of 
the two metal ions; the two Cd(II) ions (Cd–Cd distance: 14.1958(6) Å) are six-
coordinate arising from coordination by two tridentate N,N,N-domains (Cd–N 
distances: 2.301(4) – 2.379(4) Å). Selected bond lengths and angles for the 
complex are shown in tables 3.16 and 3.17. 
 
 
Figure 3.24 Space-filling picture of the complex cation [Cd2(L14)2]4+ showing all 
atoms and their van der Waal’s radii 
 
Bond Bond Length (Å) 
Cd(1)-N(2) 2.301(4) 
Cd(1)-N(5) 2.314(4) 
Cd(1)-N(6) 2.333(3) 
Cd(1)-N(1) 2.355(3) 
Cd(1)-N(3) 2.374(3) 
Cd(1)-N(4) 2.379(4) 
 
Table 3.17 Selected bond lengths (Å) for the complex cation [Cd2(L14)2]4+ 
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Bond Angle (˚) 
N(2)-Cd(1)-N(5) 165.97(12) 
N(2)-Cd(1)-N(6) 119.33(13) 
N(5)-Cd(1)-N(6) 71.27(13) 
N(2)-Cd(1)-N(1) 70.13(12) 
N(5)-Cd(1)-N(1) 98.70(13) 
N(6)-Cd(1)-N(1) 106.65(13) 
N(2)-Cd(1)-N(3) 71.05(12) 
N(5)-Cd(1)-N(3) 120.36(12) 
N(6)-Cd(1)-N(3) 88.47(12) 
N(1)-Cd(1)-N(3) 140.92(13) 
N(2)-Cd(1)-N(4) 101.82(14) 
N(5)-Cd(1)-N(4) 68.57(14) 
N(6)-Cd(1)-N(4) 138.79(13) 
N(1)-Cd(1)-N(4) 88.32(13) 
N(3)-Cd(1)-N(4) 103.86(13) 
 
Table 3.18 Selected bond angles (˚) for the complex cation [Cd2(L14)2]4+ 
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 3.3 Solution studies 
3.3.1 Solution state characterisation of complexes of L9 
 
The zinc containing species, [Zn2(L9)2]4+, is iso-structural to the cobalt complex 
seen previously (figure 3.8); mesocates are formed in both cases. This gives a 
better species for direct comparison with the cadmium complex, i.e. both have 
d10 electronic configuration. 
 
3.3.1.1 Solution state characterisation of [Zn2(L9)2]4+ 
 
The 1H NMR spectrum of a CD3NO2 solution of [Zn2(L9)2](CF3SO3)4 is an 
interesting spectrum. Some of the signals are coincident; even with this it is 
clear there are two species present (figure 3.23, a). It has been shown 
previously with such complexes that typically the less symmetrical mismatched 
species are disfavoured in solution, in this case the mesocate, which is seen as 
the lower percentage of the equilibrium mixture.141 Here the minor set of signals 
observed correspond to the mesocate while the major set corresponds to the 
helicate.  
 
3.3.1.2 Solution state characterisation of [Cd2(L9)2]4+ 
 
The one-dimensional 1H NMR spectrum of [Cd2(L9)2](ClO4)4 in CD3NO2 shows 
the 13 aromatic signals expected for such an assembly, in this case showing 
only one species is present (figure 3.23, b). Seen in the spectrum are a number 
of broad peaks, cooling of the NMR sample only resulted in further broadening 
of the peaks, thus the broad peaks have been attributed to restricted rotation of 
the ligand framework. 
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Figure 3.25 Aromatic region of the 1H NMR spectra (CD3NO2) of a) [Zn2(L9)2]4+ 
(● = mesocate), b) [Cd2(L9)2]4+, c) [Zn2(L14)2]4+ and d) [Cd2(L14)2]4+ 
 
3.3.2 Solution state characterisation of complexes of L14 
 
The one-dimensional 1H NMR spectrum of [Cd2(L14)2](ClO4)4 in CD3NO2 shows 
the expected 16 aromatic signals, in this case showing one species is present 
(figure 3.23, d), which is consistent with formation of the mesocate assembly. In 
addition the [Zn2(L14)2](CF3SO3)4 complex in CD3NO2 shows only one set of 
signals, which it is reasonable to assume is the mesocate species (figure 3.23, 
c). The 1H-1H COSY NMR spectrum shows the coupling between protons 
allowing identification of which signals correspond to which proton (figure 3.24). 
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Figure 3.26 Aromatic region of the 1H-1H COSY spectrum of [Zn2(L14)2]4+ in 
CD3NO2 
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From the 1H-1H COSY spectrum of [Zn2(L14)2]4+ it is possible to identify which 
signals correspond to the benzyl group (Bn), this functional group essentially 
being the structural difference between L14 and L9. Therefore, if the signals for 
this group (Bn) are not taken into consideration, the remaining signals 
represent what would be expected for L9 if only the mesocate species was 
present in solution. Comparison of the 1H NMR spectrum of [Zn2(L14)2]4+ with 
[Zn2(L9)2]4+ reveals several of the minor peaks seen in [Zn2(L9)2]4+ directly 
correspond to those present in the complex solution of L14 which is known to be 
the mesocate. This demonstrates it is reasonable to assume that the minor 
peaks seen in the 1H NMR spectrum of [Zn2(L9)2]4+ are indeed due to the 
mesocate assembly.  
 
3.4 Discussion 
 
The ligands L6, L7 and L8 have been shown to form dinuclear double helicates 
in the solid state upon complexation with selected transition metals; in addition 
L9 gives a similar assembly with cadmium(ll). In the self-assembly of the 
helicate (cadmium(II) and L9) the oxygen atoms of each ligand are brought into 
close proximity (γ.644 Å) and examination of the van der Waal’s radii shows 
minimal space between the inward facing atoms. Cobalt(II) is smaller than 
cadmium(II), giving smaller metal to ligand bond lengths. It is likely that steric 
and/or electrostatic repulsion between the ligands would be significantly 
amplified in an isostructural dicobalt(II) helicate. Thus an alternative species 
forms, where the two methoxy groups are not within such close proximity, 
giving the meso-helicate. The zinc containing assembly ([Zn2(L9)2]4+) for L9 is 
isostructural with that observed for the cobalt(II) assembly i.e. a double meso-
helicate. 
 
This shows how an assembly can be destabilized due to subtle changes in 
metal-ligand bond distances, which in turn influences inter-ligand interactions 
and contributes significantly to the resulting self-assembly. This steric control is 
further supported by L14, this ligand consisting of the same basic ligand chain 
as L9 but containing the more sterically demanding benzyl unit in place of the 
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methyl group. L14 provides the expected dinuclear species upon reaction with 
cadmium(II), in this case the mesocate, demonstrating how increasing the 
steric bulk of the central unit is significant in directing the self-assembly. 
 
Inspection of the space-filling structures shows that in the helicate there is 
extensive π–stacking from the aromatic groups (figure 3.25). Comparison of the 
complexes of L7 and L9 illustrate this well. To define a close interaction 
between aromatic units as ≤5Å and essentially co-planar (≤γ0˚ interannular 
angle) then in the helicate (figure 3.25, a) there are 23 close interactions 
whereas only 14 in the meso-species (figure 3.25, b). These interactions arise 
in the helicate structure as the tridentate pyridyl-pyridyl-thiazole domains are 
closely aligned to the central triphenylene spacer. This type of interaction is not 
observed in the mesocate ([Co2(L2)2]4+ or ([Zn2(L2)2]4+) and it is the π-
interaction that must favour the formation of the helicate species.  
 
Figure 3.27 Space-filling view of the crystal structures of a) [Fe2(L7)2]4+, b) 
[Co2(L9)2]4+    
a) 
b) 
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Reaction between L10, which possesses an ethylene glycol chain on the central 
phenyl spacer, and Fe(II) gives a meso-helicate complex ([Fe2(L10)2]4+). This 
structure is observed as the ligands coordinate the metal ions via a C-type 
arrangement giving metal ions of opposite chirality which leads to a dinuclear 
double meso-helicate. This is observed due to the ethylene glycol chain within 
the ligand strand which would be bought into close proximity preventing the 
formation of a “true” helicate, where the ligand twists and adopts an S-type 
arrangement and giving metal ions of the same chirality.  Reaction of L11 with 
Cd(II) again gives a dinuclear meso-helicate with the ligand partitioning into two 
tridentate donor units, each of which coordinates a different metal ion. In the 
solid-state each of the helicate assemblies has five perchlorate counter anions 
associated with it ([Cd2(L11)2](ClO4)5), as the crystals were grown in the 
presence of camphorsulfonic acid it is assumed that one of the amine nitrogen 
atoms has been protonated giving [Cd2(L11)(L11-H)]5+. In the central cavity a 
water molecule is present and this acts as a hydrogen bond acceptor to the 
protonated amine and a donor to the other unprotonated amine. It is unclear 
why only one of the amine groups is protonated even though enough acid was 
used to protonate both. It is possible that the ability of the mono-protonated 
complex to act as both a hydrogen bond acceptor and donor offers some 
stability compared to the di-protonated species. 
 
Reaction of L10, L11, Cd(ClO4)2.6(H2O) and camphorsulfonic acid in 
nitromethane (in the ratio 1:1:2:1) gave a colourless solution. Slow diffusion of 
dichloromethane into the nitromethane complex solution resulted in the 
formation of large colourless crystals. Analysis by X-ray crystallographyiii 
showed that in the solid state both the dinuclear meso-helicate containing Cd(II) 
and L10 and L11 were present (figure 3.28). The complex with L10 (e.g. 
[Cd2(L10)2]4+, figure 3.26) is very similar to the iron-containing structure 
([Fe2(L10)2]4+, figure 3.14) the ligand coordinates different metal ions via its 
tridentate, thiazole-pyridyl-pyridyl, donor units separated by the triphenylene 
unit bearing an ethylene glycol group on the central phenyl spacer. The metal-
nitrogen bond lengths are similar to those observed for the Fe(II) complex, 
                                            
iii
 Some structural refinements for the complex cation [Cd2(L10)2][Cd2(L12-H)2]10+ were provided 
by Dr. Michaele Hardie. 
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[Fe2(L10)2]4+, one major difference observed between the two structures is that 
in [Cd2(L10)2]4+ complex the two glycol arms do not curl around the complex but 
extend away from the assembly with the two outer oxygen atoms pointing away 
from the complex. This cannot be an effect of the different metal ions, Cd(II) vs. 
Fe(II), as the metal ions are remote to the glycol arms.  
 
Figure 3.28 The [Cd2(L10)2]4+ section of the one-dimensional 
([[Cd2(L10)2][Cd2(L11-H)2]]10+)n heteroleptic chain assembly.  
 
A similar meso-helicate species for L11 and Cd(II) is also observed and again 
this is almost identical to the complex isolated by the reaction of L11 with Cd(II). 
However, due to the number of perchlorate counter ions present it is assumed 
that in this case both the amine groups are protonated giving the complex  
[Cd2(L11-H)2]6+. In the central cavity there are two water molecules which act as 
hydrogen bond acceptors from the protonated amine (N–O 2.763(1) Å) (figure 
3.27). The Cd2+ metal ions adopt a six-coordinate pseudo-octahedral geometry 
arising from coordination of a thiazole-pyridyl-pyridyl domain from each ligand. 
The metal-nitrogen bond lengths range from 2.309(8) to 2.356(8) Å similar to 
those observed for the complex of just L11 with Cd(II), [Cd2(L11)(L11-H)]5+. 
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Figure 3.29 The [Cd2(L11-H)2]6+ section of the one-dimensional chain 
([[Cd2(L10)2][Cd2(L11-H)2]]10+)n assembly containing the two hydrogen-bond 
acceptor water molecules 
 
Thus upon reaction of Cd(II) with both L10 and L11, in the presence of acid, an 
infinite one-dimensional chain containing units of [Cd2(L10)2]4+ and [Cd2(L11-
H)2]6+ is observed. In the solid state each of the meso-helicate assemblies 
interact with one another via the protonated amine of L11 and the glycol chains 
from L10 such that the two oxygen atoms at the end of the glycol chain 
hydrogen bond to the –NH3+ unit (average O-N distance 2.947 Å, figure 3.28). 
This results in a structure which contains both of these meso-helicate structures 
in an extended one-dimensional system (([Cd2(L10)2][Cd2(L12-H)2])(ClO4)10)n. 
 
Even though identical stoichiometry of acid was used in the crystallisation of L11 
and Cd2+, when just this ligand and cadmium were crystallised only one of the 
ligands in the helicate system is protonated but for the mixed ligand system 
((([Cd2(L10)2][Cd2(L11-H)2])(ClO4)10)n) each ligand in the meso-helicate assembly 
is protonated. As mentioned previously mono-protonation (e.g. [Cd2(L11)(L11-
H)]5+) may be stabilised due to a water molecule within the mesocate cavity as 
this can act as a hydrogen-bond acceptor/donor. In the case of the mixed 
ligand system ([Cd2(L11-H)2]6+) it is conceivable that diprotonation is stabilised, 
in the solid state, by interaction with the ethylene glycol chain on the 
neighbouring helicate assemblies.  
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Figure 3.30 The X-ray crystal structure of the mesocate-containing one-
dimensional chain ([[Cd2(L10)2][Cd2(L11-H)2]]10+)n showing the hydrogen-bonding 
interaction 
 
This is the first example where meso-helicate assemblies form a one-
dimensional chain via interaction between an ammonium and glycol chain unit 
resulting in a heteroleptic system. One-dimensional helicate-containing chains 
have been reported previously, such as the example by Ward et al. where 
infinite chains are produced due to Ag∙∙∙Ag interactions, giving a triple helical 
braid.142 Hannon et al. also report a hydroxyl substituted helicate which forms a 
chain via hydrogen bonding either with itself or chloride anions.143 However, in 
both these cases only one type of helicate is present in the chains i.e. a 
homoleptic system. 
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3.5 Conclusion 
 
In conclusion, nine novel ligands L6-L14, consisting of two tridentate N-donor 
domains separated by various phenyl spacer units were successfully 
synthesised. It has been demonstrated here that if possible the ligands prefer to 
form the helicate assembly; this preferential formation of the helicate has been 
attributed to increased π-stacking interactions. However, inclusion of sterically 
demanding groups leading to unfavourable inter-ligand interactions (which in 
turn is governed by ion size) can destabilise this assembly resulting in a meso-
helicate.  
 
Additionally a mixture of two ligands, L10 and L11, react with cadmium(II) ions to 
form two discrete meso-helicate complexes. This architecture results due to the 
steric programming of the ligand and the stereochemical information provided 
by the metal ion. Further to this, favourable interactions of the ethylene glycol 
chain (L10) with the ammonium functionality (L11) direct the assembly towards a 
one-dimensional chain of the two meso-helicates. This is the first example 
where meso-helicate assemblies form a one-dimensional chain via interaction 
between an ammonium and glycol chain unit resulting in a heteroleptic system.  
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4. Emissive lanthanide-containing dinuclear double stranded 
helicates  
 
As previously stated a metallo-helicate is a supramolecular complex composed 
of one or more covalent organic strands coordinated to at least two metal ions 
defining the helical axis.72 So far most examples discussed have focused on 
the use of transition metal ions; however it is possible to employ lanthanide 
metal ions to play the same role within the supramolecular assembly. The use 
of these metal ions has expanded rapidly since the first lanthanide-containing 
helicate reported by Piguet et al. in 1992.144  
 
The chemistry of the lanthanides is different from the transition metals; these 
ions are larger and prefer higher coordination numbers, normally observed as 
8- or 9- coordinate, with the favoured oxidation state being 3+. The bonding 
between metal and ligand is mostly electrostatic bonding (ionic), thus 
directionality of the bonding is not as easily predicted as with the transition 
metals (generally tetrahedral or octahedral). They are known to interact strongly 
with ligands containing oxygen atoms i.e. they are oxophilic.145 However, a 
weakness of the lanthanides is that the f - f transitions are Laporte forbidden, 
thus direct luminescent excitation is difficult to achieve. This problem may be 
overcome via the indirect luminescent excitation of the lanthanide ion by an 
‘antenna’, this is a sensitising chromophore which could be an organic system 
(containing aromatic chromophores or conjugated components) or may be an 
inorganic coordination complex (containing other metal ions to sensitize the 
lanthanide ions). 
 
So what has made the lanthanide ions desirable for use in supramolecular 
coordination chemistry? The main interest stems from their potential 
applications due to their unique photophysical and magnetic properties, leading 
to the production of sensors146, 147, switches and molecular probes148 to name a 
few. The interest of incorporating lanthanide ions within helicates is thus to 
provide functional applications for such assemblies. However, due to the 
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chemistry of the lanthanide orbitals, as stated the bonding is significantly less 
covalent than the transition metals, as such the lanthanides exhibit no 
pronounced stereochemical preferences. Consequently the lanthanide 
assemblies rely almost exclusively on the programming of the ligand strands 
and as such there are fewer examples of such assemblies. 
 
Despite these drawbacks there are now numerous examples of supramolecular 
assemblies containing lanthanide metal centres from various research groups, 
including those of Piguet,149, 150 Albrecht151, 152 and Gunnlaugsson.153 The 
pioneering studies by Piguet and Bünzli focusing on helicate assembly have led 
to some fascinating architectures. By developing ligand systems based on LR’ 
(figure 4.1) and related derivatives Piguet et al. have created numerous helicate 
assemblies possessing lanthanide metal centres.  
 
 
Figure 4.1 Basic ligand, LR’, employed to investigate lanthanide-containing 
helicates154-158 
 
Incorporation of this basic motif, LR’, within several ditopic ligands resulted in 
the self-assembly of helicates containing lanthanide and/or transition metals to 
give 4f-4f, 4f-4f’ or 3d-4f bimetallic complexes.155-158 Two segmental ligands 
were produced, LS’, which possesses a bidentate 2-(benzimidazolyl)pyridine 
unit and a tridentate 2,6-bis-(benzimidalyl)pyridine unit coded for coordination 
with octahedral transition metal ions and nine-coordinate lanthanide metal ions 
LR'
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respectively,  and LT’ which possesses similar functionality except for a terminal 
carboxamide group within the tridentate unit (figure 4.2).159, 160 For ligand LS’ 
the heterodinuclear d-f complexes were investigated in solution (f = La and d = 
Zn). Spectroscopic titrations of the ligand gave a mixture with the 
heterodimetallic species being the predominant product when the ligand and 
metal ions (La(ClO4)3.7H2O and Zn(ClO4)2.6H2O) were mixed in a 
stoichiometric ratio (3:1:1). It was rationalised that the tridentate domains 
considerable affinity for the transition metals limited the selectivity of domains 
and thus for the formation of the heterodimetallic helicate.159  
 
 
Figure 4.2 Ligands, LS’ and LT’, employed for the self-assembly of 
heterodinuclear d-f helicates(160) 
 
For the second ligand, LT’, the incorporation of a carboxamide terminal group 
was shown to improve the selectivity of the assembly process.  The 1H NMR 
spectrum of [EuZn(LT’)3]5+ showed one species in solution consistent with three 
equivalent head-to-head ligands wrapped about the Eu-Zn axis.160 Due to 
unsuitable crystals the assembly with LS’ could not be structurally characterised 
by X-ray diffraction. For LT’ slow diffusion of diethyl ether into a concentrated 
acetonitrile solution of the ligand and metal ions allowed isolation of a 
polycrystalline aggregate. Colourless single crystals suitable for X-ray 
diffraction were subsequently obtained upon diffusion of diisopropyl ether into 
LS' LT'
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an acetonitrile solution of the isolated polycrystalline material containing 30 
equivalents of NBu4CF3SO3. The Eu(III) is coordinated by the tridentate 
domains of three ligands giving a slightly distorted tricapped trigonal prism with  
three nitrogen atoms of the benzimidazole units and the three oxygen atoms 
occupying the vertices of the prism. Coordination of the bidentate site of the 
three ligands gives an octahedral Zn(II) centre which is severely distorted. This 
results in the Zn-N bond lengths for the pyridine nitrogen being longer than 
what is generally observed for such interactions. 
 
Subsequent analysis of the complexes showed the heterodinuclear complex 
[EuZn(LT’)3]5+ possesses a lifetime which is indicative of an ion which is well 
protected  from quenching processes. Quantum yield data of the two 
complexes ([EuZn(LS’)3]5+ and [EuZn(LT’)3]5+) in acetonitrile show that the 
heterodinuclear complex of  LT’  is more luminescent than the corresponding LS’ 
complex, this increase in luminescence being attributed to a more efficient 
antenna effect associated with LT’. Further to this LT’ has been employed within 
a number of triple-stranded helicates using different combinations of transition 
metals and lanthanide ions. For a given transition metal (Fe, Co or Zn) a triple-
stranded helicate was obtained for all lanthanides with the structure being 
confirmed by NMR analysis, with these types of systems displaying potential as 
luminescent probes.89 
 
Piguet and co-workers have also skilfully produced a ligand which is capable of 
selectively forming a heterodimetallic helicate consisting of different lanthanide 
metal ions, assuming there is sufficient size difference between the metals 
selected.161 Other groups have reported similar heterometallic helicate 
assemblies.151, 162 Not only have lanthanide helicates been produced there are 
now other assemblies incorporating lanthanide metals; for example, circular 
helicates149,163 and cage complexes164 have recently been reported.   
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Described in this chapter is the synthesis and coordination chemistry of three 
mixed N-donor and O-donor ligands, L15-L17, which possesses the same 
central p-cresol unit. Reaction of these ligands with selected lanthanide metal 
ions results in the formation of dinuclear double helicates. All three ligands are 
symmetrical, L15 contains thiazole-hydroxyquinoline, L16 possesses thiazole-
pyridine-pyridine binding domains and L17 consists of thiazole-pyridine-pyridine-
N-oxide binding domains (Figure 4.3). 
 
 
Figure 4.3 A new group of multidentate ligands L15 – L17 
  
(L17)
(L16)
(L15)
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4.1 Ligand synthesis  
 
The ligands, L15 – L17, were synthesised via multi-step synthetic processes 
(Schemes 4.1 and 4.2); for further details regarding the synthesis of L15 – L17 
see chapter 6 section 6.3. 
4.1.1 Synthesis of L15  
 
The synthesis of the ligand, L15, was achieved following a three step synthesis 
route (Scheme 4.1). Starting with 8-hydroxyquinoline-2-carbonitrile (39) and 
triethylamine in ethanol, H2S was slowly bubbled through the solution which 
turned the solution yellow after a few minutes, on standing for 48 hours a 
precipitate was produced. Filtration gave 8-hydroxyquinoline-2-carbothioamide 
(40) as a yellow powder. The 1H NMR spectrum confirms the formation of the 
desired compound with the presence of two broad singlets (9.21 and 7.76 ppm) 
corresponding to the –NH2 protons. Reaction of diacetyl cresol165 (41) with 
bromine in acetic acid gave the desired dibrominated species (42) after 
separation and purification via column chromatography. 1H NMR analysis of the 
product shows the appearance of a singlet at 4.60 ppm corresponding to 
methylene protons, along with the disappearance of the original methyl peak 
seen for the starting material. Reaction of the 8-hydroxyquinoline-2-
carbothioamide (40) with the dibromocresol (42) in ethanol at reflux afforded 
L15 as a pale yellow solid. Confirmation of the successful formation of the ligand 
was obtained by 1H NMR analysis which showed 9 aromatic signals, with 
overlapping multiplets corresponding to the protons of the terminal phenol ring. 
Furthermore an ion in the ESI-MS was observed at m/z 583 which is consistent 
with [L15+Na]+. 
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(L15)
(41)
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c
b
 
 
Scheme 4.1 Synthesis of L15 
Reagents and conditions: a) H2S, Et3N, EtOH, RT (91 %); b) Br2, CH3COOH, 
60˚C (41 %); c) EtOH, reflux (78 %).  
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4.1.2 Synthesis of L16 and L17  
 
The synthesis of ligands L16 and L17 was achieved following a multi-step 
synthesis route (Scheme 4.2). These two ligands have the same central ring as 
L15, however, the thioamides employed are different to the one used for L15. 
The synthesis of β,β’-bipyridine-6-thioamide was achieved following methods 
already reported in the literature.166, 167 Reaction of β,β’-bipyridine-6-thioamide 
(9) with the α-dibromoacetyl (42) in DMF gave L16 after deprotonation. 
Confirmation of the successful formation of the ligand was obtained by 1H NMR 
analysis which showed 10 aromatic signals, two signals overlapping, including 
two signals expected for the hydroxyl and methyl groups. Furthermore an ion in 
the ESI-MS was observed at m/z 605 which is consistent with [L16+Na]+. The 
synthesis of L17 is essentially the same procedure used for L16 except N-oxide-
β,β’-bipyridine-6’-thioamide was used in place of 2,β’-bipyridine-6-thioamide. 
For L16, 6-cyano-β,β’-bipyridine (43) was reacted with mCPBA in DCM to give 
6’-cyano-β,β’-bipyridine-N-oxide (44).  The corresponding thioamide (45) was 
produced upon exposure of the N-oxide to hydrogen sulphide which was 
isolated upon filtration of the resulting yellow precipitate. Reaction of β,β’-
bipyridine-6-thioamide-N’-oxide (45) with the α-dibromoacetyl (42) in DMF gave 
L17 after deprotonation. Confirmation of the formation of the ligand was not 
obtained by 1H NMR spectrometry due to poor solubility in organic solvents. 
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Scheme 4. 2 Syntheses of L16 and L17 
Reagents and conditions: a) H2S, Et3N, EtOH, RT; b) DMF, 80˚c (84 %). I) 
mCPBA, DCM, RT (78 %); II) H2S, Et3N, EtOH, RT (88 %); III) DMF, 80˚C (62 
%). 
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4.2 Coordination chemistry 
4.2.1 Complex of L15 with europium(III) 
 
Reaction of L15 with an equimolar quantity of Eu(CF3SO3)3 in nitromethane gave 
a yellow solution. Analysis by ESI-MS showed an ion at m/z 1869 which 
corresponds to {[(L15)2Eu2](CF3SO3)3}+ indicating that a dinuclear species had 
formed and the ligand was acting as a monoanionic species. Slow diffusion of 
chloroform into the nitromethane complex solution resulted in the formation of 
X-ray quality yellow crystals. . The X-ray crystal structure showed crystallisation 
in the monoclinic space group C2/c and confirmed the formation of the 
dinuclear species [(L15)2Eu2]4+ (figure 4.4)iv.  
 
 
Figure 4.4 Two views for the solid state structure of the complex cation 
[(L15)2Eu2(H2O)2]4+ 
 
The crystal structure confirms that in the solid state the ligand, L15, and Eu(III) 
ions self-assemble to form a dinuclear double helicate. The binding domains of 
the ligand strand partition into two tridentate donor domains due to the p-cresol 
                                            
iv
 All X-ray crystallography data for this chapter was recorded by Professor Craig Rice. 
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central bridging unit. However in this case, as the bridging group possesses an 
O-donor, this p-cresol unit also coordinates both metal ions (figure 4.4). The 
two Eu(III) ions (Eu–Eu distance: 3.9275(1) Å) are nine coordinate arising from 
coordination of two tridentate N,N,O-domains, the O-donor from the central p-
cresol unit of both ligands and one water molecule (Eu–N distances: 2.591(3) – 
2.605(3) Å, Eu–O distances: 2.3332(18) – 2.521(3) Å).  Selected bond lengths 
and angles are shown in tables 4.1 and 4.2. 
 
Figure 4. 5 ESI-MS of [(L15)2Eu2](CF3SO3)4 with the found (top) and predicted 
(bottom) isotopic distribution pattern of {[(L15)2Eu2](CF3SO3)3}+ (inset) 
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Bond Bond Length (Å) Bond Bond Length (Å) 
Eu(1)-O(4) 2.513(3) Eu(1)-N(3) 2.604(3) 
Eu(1)-N(1) 2.604(3) Eu(1)-O(2) 2.3369(18) 
Eu(1)-O(3) 2.3332(18) Eu(1)-N(2) 2.591(3) 
Eu(1)-O(11) 2.471(3) Eu(1)-N(4) 2.605(3) 
Eu(1)-O(1) 2.521(3)   
 
Table 4.1 Selected bond lengths (Å) for the complex cation [(L15)2Eu2(H2O)2]4+ 
 
Bond Angle (˚) Bond Angle (˚) 
N(1)-Eu(1)-O(4) 109.34(9) O(2)-Eu(1)-O(11) 146.89(10) 
O(3)-Eu(1)-O(4) 80.72(9) O(2)-Eu(1)-O(1) 80.21(10) 
O(3)-Eu(1)-N(1) 114.15(8) O(2)-Eu(1)-N(3) 112.43(8) 
O(11)-Eu(1)-O(4) 66.87(9) N(2)-Eu(1)-O(4) 66.61(9) 
O(11)-Eu(1)-N(1) 78.50(11) N(2)-Eu(1)-N(1) 62.55(10) 
O(11)-Eu(1)-O(3) 147.59(10) N(2)-Eu(1)-O(3) 64.04(7) 
O(1)-Eu(1)-O(4) 133.58(9) N(2)-Eu(1)-O(11) 101.20(10) 
O(1)-Eu(1)-N(1) 62.02(10) N(2)-Eu(1)-O(1) 124.56(9) 
O(1)-Eu(1)-O(3) 145.66(10) N(2)-Eu(1)-N(3) 122.04(10) 
O(1)-Eu(1)-O(11) 66.73(10) N(2)-Eu(1)-O(2) 95.82(8) 
N(3)-Eu(1)-O(4) 61.94(10) N(4)-Eu(1)-O(4) 124.08(10) 
N(3)-Eu(1)-N(1) 160.45(10) N(4)-Eu(1)-N(1) 122.32(11) 
N(3)-Eu(1)-O(3) 82.76(8) N(4)-Eu(1)-O(3) 95.51(8) 
N(3)-Eu(1)-O(11) 81.95(11) N(4)-Eu(1)-O(11) 102.29(10) 
N(3)-Eu(1)-O(1) 109.92(10) N(4)-Eu(1)-O(1) 65.82(10) 
O(2)-Eu(1)-O(4) 146.20(9) N(4)-Eu(1)-N(3) 62.24(11) 
O(2)-Eu(1)-N(1) 84.63(8) N(4)-Eu(1)-O(2) 63.60(8) 
O(2)-Eu(1)-O(3) 65.51(10) N(4)-Eu(1)-N(2) 156.50(10) 
 
Table 4.2 Selected bond angles (˚) for the complex cation [(L15)2Eu2(H2O)2]4+ 
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4.2.2 Complex of L16 with lanthanum(III)  
 
Reaction of L16 with an equimolar amount of La(CF3SO3)3 in nitromethane gave 
a  light yellow solution. ESI-MS analysis gave an ion at m/z 1887 corresponding 
to {[(L16)2La2](CF3SO3)3}+ again with the ligand acting as a monoanionic 
species. Slow diffusion of diisopropyl ether into the nitromethane complex 
solution resulted in the formation of X-ray quality crystals. The X-ray crystal 
structure showed crystallisation in the triclinic space group P-1 and confirmed 
the formation of the dinuclear double helicate [(L16)2La2(H2O)2(CF3SO3)2]2+ 
(figure 4.5).  
 
Figure 4.6 Two views for the solid state structure of the complex cation 
[(L16)2La2(H2O)2(CF3SO3)2]2+ 
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The crystal structure confirms that in the solid state the ligand, L16, and La(III) 
ions form a dinuclear double helicate. The coordination of this ligand is similar 
to that seen for the previous ligand, L15. The phenolic central unit deprotonates 
and bridges the two lanthanide ions contributing to the coordination sphere of 
the metal ions (figure 4.7). The two La(III) ions (La–La distance: 4.2111(4) Å) 
are ten-coordinate arising from coordination of two tridentate N,N,N-domains, 
the O-donor of the p-cresol central units, one water molecule and a triflate 
anion (La–N distances: 2.698(5) – 2.846(6) Å, La–O distances: 2.462(4) – 
2.689(5) Å). Selected bond lengths and angles are shown in tables 4.3 and 4.4.  
 
 
Figure 4. 7 ESI-MS of [(L16)2La2](CF3SO3)4 with the found (top) and predicted 
(bottom) isotopic distribution pattern of {[(L16)2La2](CF3SO3)3}+ (inset)  
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Bond Bond Length (Å) Bond Bond Length (Å) 
La(1)-O(2) 2.482(4) La(2)-O(2) 2.462(4) 
La(1)-O(1) 2.488(4) La(2)-O(1) 2.484(4) 
La(1)-O(3) 2.575(4) La(2)-O(5) 2.588(4) 
La(1)-O(8) 2.684(4) La(2)-O(4) 2.689(5) 
La(1)-N(3) 2.698(5) La(2)-N(10) 2.748(5) 
La(1)-N(9) 2.726(5) La(2)-N(12) 2.761(5) 
La(1)-N(1) 2.740(5) La(2)-N(4) 2.763(5) 
La(1)-N(7) 2.773(5) La(2)-N(6) 2.802(5) 
La(1)-N(2) 2.801(5) La(2)-N(5) 2.822(5) 
La(1)-N(8) 2.818(5) La(2)-N(11) 2.846(6) 
 
Table 4.3 Selected bond lengths (Å) for the complex cation 
[(L16)2La2(H2O)2(CF3SO3)2]2+ 
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Bond Angle (˚) Bond Angle (˚) 
O(2)-La(1)-O(1) 63.28(13) O(2)-La(1)-N(2) 103.84(14) 
O(2)-La(1)-O(3) 139.96(15) O(1)-La(1)-N(2) 78.66(14) 
O(1)-La(1)-O(3) 130.57(16) O(3)-La(1)-N(2) 115.38(16) 
O(2)-La(1)-O(8) 135.31(13) O(8)-La(1)-N(2) 60.37(14) 
O(1)-La(1)-O(8) 137.11(13) N(3)-La(1)-N(2) 59.87(16) 
O(3)-La(1)-O(8) 65.52(15) N(9)-La(1)-N(2) 127.34(16) 
O(2)-La(1)-N(3) 60.30(14) N(1)-La(1)-N(2) 59.06(16) 
O(1)-La(1)-N(3) 93.97(14) N(7)-La(1)-N(2) 114.64(16) 
O(3)-La(1)-N(3) 134.86(17) O(2)-La(1)-N(8) 77.09(14) 
O(8)-La(1)-N(3) 76.98(14) O(1)-La(1)-N(8) 107.98(14) 
O(2)-La(1)-N(9) 88.96(14) O(3)-La(1)-N(8) 62.98(15) 
O(1)-La(1)-N(9) 61.97(15) O(8)-La(1)-N(8) 113.76(14) 
O(3)-La(1)-N(9) 74.05(17) N(3)-La(1)-N(8) 115.59(15) 
O(8)-La(1)-N(9) 134.86(14) N(9)-La(1)-N(8) 59.76(16) 
N(3)-La(1)-N(9) 148.07(15) N(1)-La(1)-N(8) 124.75(15) 
O(2)-La(1)-N(1) 139.92(15) N(7)-La(1)-N(8) 58.06(15) 
O(1)-La(1)-N(1) 77.31(14) N(2)-La(1)-N(8) 172.65(16) 
O(3)-La(1)-N(1) 72.55(16) O(2)-La(1)-La(2) 31.45(10) 
O(8)-La(1)-N(1) 71.34(14) O(1)-La(1)-La(2) 32.10(9) 
N(3)-La(1)-N(1) 118.85(16) O(3)-La(1)-La(2) 149.34(13) 
N(9)-La(1)-N(1) 78.29(15) O(8)-La(1)-La(2) 144.90(9) 
O(2)-La(1)-N(7) 83.54(14) N(3)-La(1)-La(2) 72.77(11) 
O(1)-La(1)-N(7) 146.66(14) N(9)-La(1)-La(2) 76.24(11) 
O(3)-La(1)-N(7) 73.43(16) N(1)-La(1)-La(2) 108.57(11) 
O(8)-La(1)-N(7) 69.62(14) N(7)-La(1)-La(2) 114.95(10) 
N(3)-La(1)-N(7) 70.50(15) N(2)-La(1)-La(2) 88.77(11) 
N(9)-La(1)-N(7) 117.48(16) N(8)-La(1)-La(2) 95.34(10) 
N(1)-La(1)-N(7) 136.01(15)   
 
Table 4.4 Selected bond angles (˚) for the complex cation 
[(L16)2La2(H2O)2(CF3SO3)2]2+ 
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4.2.3 Complex of L17 with terbium(III) 
 
Reaction of L17 with an equimolar amount of Tb(CF3SO3)3 in nitromethane gave 
a yellow solution. Again the formation of a dinuclear species was demonstrated 
by ESI-MS with an ion at m/z 1991 corresponding to {[(L17)2Tb2](CF3SO3)3}+. 
Slow diffusion of diethyl ether into the nitromethane complex solution resulted 
in the formation of X-ray quality crystals. The X-ray crystal structure showed 
crystallisation in the monoclinic space group P2(1)/n and confirmed the 
formation of the dinuclear species [(L17)2Tb2]4+ (figure 4.6)  
 
 
 
Figure 4.8 Two views for the solid state structure of the complex cation 
[(L17)2Tb2]4+ 
 
The crystal structure confirms this ligand and Tb(III) ions form a dinuclear 
double helicate. The binding of this ligand, L17, is similar to that seen for the 
previous ligand, L15. The central p-cresol again acts as a bridging bidentate 
donor coordinating both terbium cations (figure 4.6). The two Tb(III) ions (Tb–
Tb distance: 3.8501(2) Å) are eight-coordinate arising from coordination of two 
tridentate N,N,O-domains and the O-donor from the p-cresol central units (Tb–
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N distances: 2.543(4) – 2.642(5) Å, Tb–O distances: 2.278(4) – 2.314(4) Å). 
Selected bond lengths and angles are shown in tables 4.5 and 4.6. 
 
Bond Bond Length (Å) Bond Bond Length (Å) 
Tb(1)-O(4) 2.279(4) Tb(2)-O(6) 2.278(4) 
Tb(1)-O(1) 2.295(4) Tb(2)-O(2) 2.290(4) 
Tb(1)-O(2) 2.304(4) Tb(2)-O(5) 2.296(4) 
Tb(1)-O(5) 2.314(4) Tb(2)-O(3) 2.300(4) 
Tb(1)-N(9) 2.543(4) Tb(2)-N(10) 2.573(5) 
Tb(1)-N(3) 2.557(4) Tb(2)-N(4) 2.581(5) 
Tb(1)-N(8) 2.590(5) Tb(2)-N(11) 2.634(5) 
Tb(1)-N(2) 2.601(5) Tb(2)-N(5) 2.642(5) 
 
Table 4.5 Selected bond lengths (Å) for the complex cation [(L17)2Tb2]4+. 
 
Bond Angle (˚) Bond Angle (˚) 
O(4)-Tb(1)-O(1) 72.76(10) O(6)-Tb(2)-O(2) 173.47(10) 
O(4)-Tb(1)-O(2) 174.37(10) O(6)-Tb(2)-O(5) 108.92(10) 
O(1)-Tb(1)-O(2) 111.06(10) O(2)-Tb(2)-O(5) 66.70(10) 
O(4)-Tb(1)-O(5) 110.53(10) O(6)-Tb(2)-O(3) 77.02(11) 
O(1)-Tb(1)-O(5) 173.24(10) O(2)-Tb(2)-O(3) 107.75(10) 
O(2)-Tb(1)-O(5) 66.14(10) O(5)-Tb(2)-O(3) 172.67(11) 
O(4)-Tb(1)-N(9) 120.74(10) O(6)-Tb(2)-N(10) 122.04(11) 
O(1)-Tb(1)-N(9) 76.16(10) O(2)-Tb(2)-N(10) 64.05(11) 
O(2)-Tb(1)-N(9) 64.71(10) O(5)-Tb(2)-N(10) 96.77(11) 
O(5)-Tb(1)-N(9) 97.16(10) O(3)-Tb(2)-N(10) 76.19(12) 
O(4)-Tb(1)-N(3) 76.92(10) O(6)-Tb(2)-N(4) 76.23(11) 
O(1)-Tb(1)-N(3) 122.09(11) O(2)-Tb(2)-N(4) 97.32(10) 
O(2)-Tb(1)-N(3) 97.46(10) O(5)-Tb(2)-N(4) 64.23(10) 
O(5)-Tb(1)-N(3) 64.66(10) O(3)-Tb(2)-N(4) 122.25(11) 
N(9)-Tb(1)-N(3) 159.35(11) N(10)-Tb(2)-N(4) 158.36(12) 
O(4)-Tb(1)-N(8) 67.75(10) O(6)-Tb(2)-N(11) 67.53(11) 
O(1)-Tb(1)-N(8) 92.60(10) O(2)-Tb(2)-N(11) 115.89(11) 
O(2)-Tb(1)-N(8) 115.50(10) O(5)-Tb(2)-N(11) 84.82(11) 
O(5)-Tb(1)-N(8) 83.48(10) O(3)-Tb(2)-N(11) 93.79(12) 
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Bond Angle (˚) Bond Angle (˚) 
N(9)-Tb(1)-N(8) 64.69(10) N(10)-Tb(2)-N(11) 64.16(12) 
N(3)-Tb(1)-N(8) 119.36(11) N(4)-Tb(2)-N(11) 120.59(11) 
O(4)-Tb(1)-N(2) 91.75(11) O(6)-Tb(2)-N(5) 92.95(11) 
O(1)-Tb(1)-N(2) 68.40(11) O(2)-Tb(2)-N(5) 84.97(10) 
O(2)-Tb(1)-N(2) 86.03(11) O(5)-Tb(2)-N(5) 115.46(10) 
O(5)-Tb(1)-N(2) 116.77(11) O(3)-Tb(2)-N(5) 67.66(11) 
N(9)-Tb(1)-N(2) 121.13(11) N(10)-Tb(2)-N(5) 121.57(11) 
N(3)-Tb(1)-N(2) 64.50(11) N(4)-Tb(2)-N(5) 63.77(11) 
N(8)-Tb(1)-N(2) 155.92(12) N(11)-Tb(2)-N(5) 156.21(12) 
O(4)-Tb(1)-Tb(2) 143.61(7) O(6)-Tb(2)-Tb(1) 142.07(8) 
O(1)-Tb(1)-Tb(2) 143.56(7) O(2)-Tb(2)-Tb(1) 33.26(7) 
O(2)-Tb(1)-Tb(2) 32.96(7) O(5)-Tb(2)-Tb(1) 33.45(7) 
O(5)-Tb(1)-Tb(2) 33.19(7) O(3)-Tb(2)-Tb(1) 140.90(8) 
N(9)-Tb(1)-Tb(2) 78.99(8) N(10)-Tb(2)-Tb(1) 79.48(8) 
N(3)-Tb(1)-Tb(2) 80.37(8) N(4)-Tb(2)-Tb(1) 78.89(8) 
N(8)-Tb(1)-Tb(2) 100.40(8) N(11)-Tb(2)-Tb(1) 102.58(9) 
N(2)-Tb(1)-Tb(2) 103.66(8) N(5)-Tb(2)-Tb(1) 101.20(8) 
 
Table 4.6 Selected bond angles (˚) for the complex cation [(L17)2Tb2]4+. 
 
4.3 Photophysical measurements 
 
Since both the metal ion coordination and second sphere proximity of solvent 
molecules (particularly protic solvents and water) are known to quench the 
excited states of lanthanide ions, complexes based upon L17 were selected for 
further study; through the crystallographic structural studies, it was deduced 
that these species revealed the most effective encapsulation of the coordinated 
lanthanide ion. Additionally analysis by ESI-MS demonstrated that L17 has 
analogous reactivity with all the lanthanide ions, for example reaction with 
Nd(CF3SO3)3  gave an ion at m/z 1963 corresponding to 
{[(L17)2Nd2](CF3SO3)3}+. The ESI-MS of [(L17)2Gd2](CF3SO3)4 shows ions at m/z 
= 1989, 1384 and 920 corresponding to {[(L17)2Gd2](CF3SO3)3}+, {[(L17)2Gd]}+ 
and {[(L17)2Gd2](CF3SO3)2}2+ respectively (figure 4.7).   
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Figure 4.9 ESI-MS of [(L17)2Gd2](CF3SO3)4 with the found (top) and predicted 
(bottom) isotopic distribution pattern of {[(L17)2Gd2](CF3SO3)3}+ (inset) 
 
Firstly, the dimetallic Gd(III) complex was assessed in aerated solution 
(acetonitrile) revealing that the ligand itself was fluorescent at 440 nm (ex = 
380 nm). Since the 6P7/2 excited state of Gd(III) lies at approximately 32000 cm-
1
 an ethanolic glass of [(L17)2Gd2]4+ was formed at 77K and the resultant 
emission spectrum obtained, revealing that the corresponding excited triplet 
level, obtained from the onset of the peak, of the coordinated ligand was at ca. 
19300 cm-1. This energy level is insufficient for populating the accepting excited 
state of Tb(III) (5D4 at ca. 20430 cm-1). Preliminary measurements on 
[(L17)2Eu2]4+ using ex = 340 nm, revealed significant ligand-based fluorescence 
at 426 nm (cf. free ligand at 440 nm), but negligible Eu(III)-based peaks, 
suggesting that energy transfer to Eu(III) is relatively inefficient, where the 5D1 
and 5D0 accepting states lie at ca. 19020 and 17250 cm-1 respectively. 
However, using a shorter excitation wavelength (ex = 290 nm), which would be 
sufficient to excite the bridging phenolate chromophoric unit, did subsequently 
reveal both ligand-based and characteristic Eu(III)-centred emission lines 
between 580-730 nm (figure 4.8), the latter corresponding to 5D0 – 7FJ. 
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Figure 4.10 Total emission spectrum of [(L17)2Eu2]2+ recorded in acetonitrile (ex 
= 290 nm). 
 
The relatively low-lying triplet state of L17 was advantageously utilised by 
incorporating the near-IR-emitting Ln(III) ions, Nd(III), Er(III) and Yb(III), since 
these possess lower energy excited 4f states. Firstly, emission lifetime 
measurements were obtained on room temperature acetonitrile solutions of the 
near-IR-emitting complexes utilising pulsed 355 nm excitation. Each of the 
dimetallic species (Ln(III) = Nd, Er and Yb) revealed mono-exponential decay 
profiles (figure 4.9), consistent with the existence of a single Ln(III) coordination 
environment within the complex in solution. The magnitude of the life time for 
[(L17)2Eu2]4+ ( = 21.0 s) was particularly notable, suggesting that both Yb(III) 
ions are not only well shielded from quenching solvent and typical of an 
anhydrous environment, but that the ligand structure and conformation induces 
a rigid architecture that limits the non-radiative deactivation pathways available 
through vibrational modes. The measured lifetime for the Yb(III) dimer 
compares very favourably with those reported for hetero-bimetallic complexes 
based upon benzoxazole-substituted 8-hydroxyquinolines,168 albeit in 
dichloromethane solution. However, such enhancements in lifetime were not as 
pronounced for the Nd(III) ( = 0.362 s) and Er(III) ( = 1.45 s) analogues.  
 
The corresponding steady state spectra were also obtained for these 
complexes; for [(L17)2Nd2]4+ (ex = 370 nm) this revealed the characteristic 4F3/2 
– 4I9/2, 4F3/2 – 4I11/2 and 4F3/2 – 4I13/2 transitions between 880-1350 nm (figure 4.9, 
a). For [(L17)2Yb2]4+ the spectrum displayed a very sharp transition at 971 nm 
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(2F5/2 – 2F7/2) with minor features to low energy of this peak, often attributed to 
ligand-field-induced splitting of the 2F7/2 manifold. 
 
Figure 4.11 a) Steady state emission spectrum of [(L17)2Yb2]2+ and [(L17)2Nd2]2+ 
recorded in acetonitrile (ex = 370 nm); b) fitted decay profile for [(L17)2Yb2]2+ 
(ex = 355 nm) 
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4.4 Discussion 
 
All three structures are very similar; each ligand partitions into two tetradentate 
domains (comprising of four nitrogen or three nitrogen and one oxygen donor 
atoms) and these units coordinate different metal ions. The central phenolic unit 
deprotonates and bridges the two lanthanide metal ions (figure 4.10).  
 
 
Figure 4.12 Structure of the complex cation [[(L15)2Eu2(H2O)2]4+ showing the 
{Eu(µ-O2)Eu} core 
 
The only major difference is the supplementation of the coordination sphere by 
either solvents or anions i.e. the metal centre in [(L15)2Eu2]4+ is coordinated by a 
molecule of water and [(L16)2La2]4+ is coordinated by both a molecule of water 
and a triflate anion. However, in the N-oxide containing complex [(L17)2Tb2]4+ 
there are no additional species which coordinate the metal ion; this behaviour is 
attributed to the shape of the ligand strands. With both L15 and L16 the linear 
nature of the ligand strands leaves some of the metal exposed (figure 3.11), 
allowing coordination of solvent molecules. However, due to the shape of the 
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N-oxide-containing ligand L17 the lanthanide ion is totally encompassed by the 
ligand strand, minimising solvent access (fig. 4.11). 
 
 
Figure 4.13 End-on view of the space-filled X-ray structures of complexes a) 
[(L15)2Eu2]4+, b) [(L16)2La2]4+ and c) [(L17)2Tb2]4+(c). Coordinated anions/water 
molecules omitted for clarity 
 
4.5 Conclusion 
 
In conclusion, three novel ligands L15-L17, consisting of two tetradentate 
domains (comprising nitrogen and oxygen donor atoms) were successfully 
synthesised. It has been demonstrated here that if the ligand does not 
effectively encapsulate the lanthanide ion supplementation of the coordination 
sphere will result. As L17 successfully encompasses the lanthanide ion non-
radiative deactivation pathways available through vibrational modes are limited. 
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5. Conclusion 
 
In conclusion 17 novel ligands, L1-L17, have been successfully synthesised and 
where possible the coordination chemistry of these ligands has been 
investigated in the solid state and in solution. L17 has recently been reported, 
however this research was focused on the influence of N-oxide within self-
assembly rather than lanthanide ions and luminescence.169 
 
The potentially hexadentate ligands, L1-L5, contain both N-donor and O-donor 
domains separated by a 1,3-phenylene spacer unit, the incorporation of this 
space group with careful selection of the metal ion has been shown to be a 
robust method for the successful formation of circular helicates.107, 108 These 
higher nuclearity species form due to destabilization of the similar linear 
helicate. Reaction of L1 with Zn(II) results in the self-assembly of a 
pentanuclear circular helicate which persists in both the solution and solid state. 
Variation of the terminal functional group of the ligand allowed incorporation of 
enantiopure units which were shown to selectively direct the self-assembly. 
These ligands, L2-L5, led to the diastereoselective control of the resulting 
supramolecular architecture upon coordination with selected metal ions giving 
up to 80% diastereomeric excess. 
 
The potentially hexadentate symmetrical ligands, L6-L14, partition into two 
tridentate pyridyl-pyridyl-thiazolyl domains due to separation by various 
aromatic space-units allowing coordination with two different metal ions. 
Reaction of L9 with Cd(II) results in the formation of a dinuclear double helicate 
[Cd2(L9)2]4+, the two tridentate donor domains of each ligand coordinate both of 
the metal ions with the triphenyl space group bridging the tridentate domains in 
an “over-and-under” conformation giving a helical structure. However, reaction 
of this same ligand with Co(II) results in the formation of a dinuclear double 
mesocate [Co2(L9)2]4+, where the two metal ions again adopt an octahedral 
coordination geometry arising from the coordination of the two tridentate 
domains from two different ligand strands, in this case the triphenyl space 
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group bridges the tridentate domains in a “side by side’” conformation in the 
solid state. This difference in structure is attributed to unfavourable steric and/or 
electrostatic repulsion which prevent the ligands forming the dicobalt(II) helicate 
with these unfavourable interactions not present within the complex employing 
the larger  Cd(II) ion. Further to this L14, which consists of the same basic 
ligand chain as L9, contains the more sterically demanding benzyl functionality, 
results in the self-assembly of the mesocate species even upon coordination 
with the larger second row transition metal ions.  
 
The final class of symmetrical ligands described here, L15-L17, possess 
tridentate donor domains separated by a central phenol unit. The tridentate 
domains of these ligands consist of either a thiazole-hydroxyquinoline, thiazole-
pyridine-pyridine or thiazole-pyridine-pyridine-N-oxide units. All three of these 
ligands form dinuclear double helicates with trivalent lanthanide metal ions, with 
the central phenol unit deprotonating and bridging the two lanthanide cations. 
Depending on how effective the ligand is at surrounding the metal ion, the 
complex may also coordinate anions and/or solvent molecules. L17, which 
possesses the pyridine-N-oxide as the terminal group, effectively encompasses 
the cations minimising access for the coordination of any anions or solvent 
molecules. Photophysical measurements show that this ligand forms emissive 
complexes with a number of lanthanide ions, with the magnitude of the lifetime 
for [(L17)2Yb2]4+ ( = β1.0 μs) suggesting both the Yb(III) ions are well shielded 
from quenching solvent and typical of an anhydrous environment. In addition 
the ligand structure and conformation induces a rigid architecture which limits 
the non-radiative deactivation pathways available through vibrational modes.  
 
It has been shown in this thesis that judicious programming and matching of the 
components (i.e. the metal ions and ligands) provides control over the self-
assembly process. For example the diastereoselectivity of circular helicates can 
be governed by the incorporation of chiral units within the ligand strand. Also 
shown here is the preferential assembly of meso-helicates; controlled by the 
inclusion of sterically demanding substituents within the ligand strand. A 
mixture of two ligands  and metal ions resulted in the self-assembly of discrete 
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meso-helicates, due to the correct matching of the components, which led to 
the assembly of a heteroleptic one-dimensional chain thorough hydrogen bond 
donor and acceptor groups. Finally it has been shown that dimetallic 
lanthanide-containing double helicates can be formed and by employing the 
correct donor units within the ligand gives emissive self-assembled species.  
 
Supplementary to the work presented herein it may be interesting to investigate 
some of these ligands further. For example L1 possesses terminal N,N'-
diethylcarboxamido functionalities which have been shown previously to 
coordinate well with trivalent lanthanide metal ions. Additionally new ligands 
could be synthesised with variation in coordination domains of the ligand 
strands to see the influence on the assemblies. For example incorporation of 
alternative domains (e.g. thiazole-pyridine-pyridine-N-oxide) within the ligands 
presented in chapter three, e.g. L9, may provide new ligands which behave 
differently upon coordination and within the resulting assemblies. As the ligands 
throughtout this work have been symmetrical, i.e. homotopic, it would be 
interesting to investigate some systems which are heterotopic. One possibility 
could be the alteration of L17 to incorporate a thiazole-pyridine-pyridine domain 
(as seen within ligand L16) while keeping the same central p-cresol unit and a 
thiazole-pyridine-pyridine-N-oxide domain. 
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6. Experimental 
 
Chemicals were purchased and used without further purification. 1H NMR 
spectra were recorded on a 400MHz Bruker Avance DP X400 or on a 500MHz 
Bruker Avance 500. Mass spectra were obtained on a Bruker MicroTOF-q LC 
mass spectrometer. 
 
The following compounds were prepared using literature methods:  
 
3,3'-Diacetylbiphenyl (7)140 
Bipythioamide (9)166, 167 
Acetyl cresol (39)165 
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6.1 Preparation of diastereoselective ligands (L1-L4) 
6.1.1 Synthesis of picolinamide derivative 1a 170 
 
To a two necked round bottom flask charged with picolinic acid (1) (1.5 g, 0.012 
mol), anhydrous DCM was added and the reaction stirred under an atmosphere 
of dinitrogen at 0˚C. To this was then added oxalyl chloride (βM, 8.5 ml, 0.017 
mol) and the solution left to stir for 10 minutes. After this time triethylamine (2.4 
g, 0.024 mol) was slowly added and the reaction was left at room temperature 
for 3 h. The solvent was removed by rotary evaporation giving a black solid. 
This was redissolved in anhydrous DCM, stirred at 0˚C and triethylamine (1.9 g, 
0.019 mol) and diethylamine (0.73 g, 0.010 mol) were added and the reaction 
stirred at room temperature for 2 h. The solution was poured into NaHCO3 (aq) 
(30ml) and extracted into DCM (3 x 50 ml), then the combined organic layers 
were dried (MgSO4) and concentrated. The crude product was dissolved in 
ether (100 ml) and decolourising charcoal (0.1 g) added; filtration followed by 
removal of solvent gave the pure product as a light brown oil (1a) (0.6 g, 60% 
yield). 
 
1H NMR [400 MHz, CDCl3]: δH =8.59 (ddd, J = 4.8, 1.6, 1.0, 1H, Py), 7.78 (dt, J 
= 7.7, 1.7, 1H, Py), 7.58 ( dt, J = 7.8, 1.0, 1H, Py), 7.33 (ddd, J = 7.6, 4.9, 1.2, 
1H, Py), 3.58 (q, J = 7.2, 2H, -CH2CH3), 3.39 (q, J = 7.1, 2H, -CH2CH3), 1.28 (t, 
J = 7.1, 3H, -CH2CH3), 1.16 (t, J = 7.1 Hz, 3H, -CH2CH3).  
 
ESI-MS m/z 201.1 ([M+Na]+), HR ESI-MS found 201.1002 C10H14N2NaO 
requires 201.0998 (error 2.03 ppm). 
  
1. C2O2Cl2, Et3N
2. Et2NH 
(1) (1a)
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6.1.2 Synthesis of picolinamide derivative 1b 
 
 
This compound was prepared in an identical manner to 1a, except glycine 
methyl ester was used in place of diethylamine and the resulting compound 
was purified via column chromatography (Al2O3, 5% MeOH in DCM) giving 1b 
as a brown oil (42%  yield). 
 
1H NMR [400 MHz, CDCl3]: δH = 8.60 (ddd, J = 4.8, 1.6, 0.9, 1H, Py), 8.49 (br s, 
1H, -CONH), 8.19 (dt, J = 7.8, 1.0, 1H, Py), 7.86 ( dt, J = 7.8, 1.7, 1H, Py), 7.46 
(ddd, J = 7.6, 4.8, 1.2, 1H, Py), 4.29 (d, J = 5.7 Hz, 2H, -NHCH2CO2), 3.80 (s, 
3H, -CO2CH3).  
 
ESI-MS m/z 217 ([M+Na]+), HR ESI-MS found 217.0590 C9H10N2NaO3 requires 
217.0584 (error 3.11 ppm). 
 
6.1.3 Synthesis of picolinamide derivative 1c 
 
 
This compound was prepared in an identical manner to 1a, except S-valine 
1. C2O2Cl2, Et3N
2. NH2CH2CO2CH3
(1) (1b)
1. C2O2Cl2, Et3N
2. (CH3)2CHCH(NH2)CO2CH3
(1) (1c)
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methyl ester was used in place of diethylamine giving 1c as a yellow oil (37% 
yield). 
 
1H NMR [400 MHz, CDCl3]: δH = 8.61 (ddd, J= 4.8, 1.6, 0.9, 1H, Py), 8.53 (br d, 
J = 8.9, 1H, -CONH), 8.19 (dt, J = 7.8, 1.0, 1H, Py), 7.86 ( dt, J = 7.7, 1.7, 1H, 
Py), 7.45 (ddd, J = 7.6, 4.8, 1.2, 1H, Py), 4.75 (dd, J = 9.3, 5.2, 1H, -NHCH), 
3.78 (s, 3H, -CO2CH3), 2.33 (m, 1H, -CH(CH3)2), 1.03 (d, J = 6.9, 3H, -
CH(CH3)2), 1.02 (d, J = 6.9 Hz, 3H, -CH(CH3)2). 
 
ESI-MS m/z 259 ([M+Na]+), HR ESI-MS found 259.1051 C12H16N2NaO3 
requires 259.1053 (error 0.98 ppm) 
 
6.1.4 Synthesis of picolinamide derivative 1d  
 
 
This compound was prepared in an identical manner to 1a, except S-
phenylalanine methyl ester was used in place of diethylamine giving 1d as a 
brown oil (54 % yield). 
 
1H NMR [400 MHz, CDCl3]: δH = 8.56 (ddd, J = 4.8, 1.6, 0.9, 1H, Py), 8.50 (br d, 
J = 8.2, 1H, -CONH), 8.17 (dt, J = 7.8, 1.0, 1H, Py), 7.85 (dt, J = 7.7, 1.7, 1H, 
Py), 7.44 (ddd, J = 7.6, 4.8, 1.2, 1H, Py), 7.31-7.20 (m, overlap, 5H, Ph), 5.08 
(dt, J = 8.4, 6.1, 1H,-CHCH2Ph), 3.74 (s, 3H, -CO2CH3), 3.28 (dd, J = 13.8, 6.0, 
1H, -CH2Ph), 3.23 (dd, J = 13.8, 6.2 Hz, 1H, -CH2Ph). 
 
1. C2O2Cl2, Et3N
2. C6H5CH2CH(NH2)CO2CH3
(1) (1d)
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ESI-MS m/z 307 ([M+Na]+), HR ESI-MS found 307.1047 C16H16N2NaO3 
requires 307.1053 (error 1.95 ppm). 
 
6.1.5 Synthesis of picolinamide-N-oxide derivative 2a 
 
 
To a solution of 1a (0.3 g, 1.7 mmol) in DCM (25 ml) mCPBA (70%, 0.89 g, 3.7 
mmol) was slowly added over 30 minutes, while the solution stirred at room 
temperature. The reaction was monitored via TLC and upon completion (~ 8 h) 
the reaction was carefully evaporated (Caution: N-oxides are potentially 
explosive). Purification by column chromatography (Al2O3, 2% MeOH in DCM) 
gave the N-oxide 2a as a white solid (0.3 g, 91% yield). 
 
1H NMR [400 MHz, CDCl3]: δH = 8.32 (d, J = 6.2, 1H, Py), 7.35- 7.28 (m, 
overlap, 3H, Py), 3.65 (m, 1H, -CH2CH3), 3.54 (m, 1H, -CH2CH3), 3.20 (m, 2H, -
CH2CH3), 1.29 (t, J = 7.2, 3H, -CH2CH3), 1.13 (t, J = 7.2 Hz, 3H, -CH2CH3).  
 
ESI-MS m/z 217 ([M+Na]+),HR ESI-MS found 217.0958 C10H14N2NaO2 requires 
217.0947 (error 4.91 ppm). 
  
1. mCPBA, DCM
(1a) (2a)
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6.1.6 Synthesis of picolinamide-N-oxide derivative 2b 
 
 
This compound was prepared in an identical manner to 2a, except 1b was used 
instead of 1a. Purification via column chromatography (Al2O3, 1 % MeOH in 
DCM) gave the N-oxide 2b as a fine white powder (85 % yield). 
 
1H NMR [400 MHz, CDCl3]: δH = 11.72 (br s, 1H, -CONH), 8.43 (dd, J = 7.8, 
2.3, 1H, Py), 8.29 (dd, J = 6.4, 1.2, 1H, Py), 7.47 (dt, J = 7.7, 1.3, 1H, Py), 7.42 
(dt, J = 6.4, 2.3, 1H, Py), 4.29 (d, J = 5.6 Hz, 2H, -NHCH2CO2), 3.80 (s, 3H, -
CO2CH3). 
 
ESI-MS m/z 233 ([M+Na]+), HR ESI-MS found 233.0538 C9H10N2NaO4 requires 
233.0533 (error 2.25 ppm). 
 
6.1.7 Synthesis of picolinamide-N-oxide derivative 2c 
 
 
This compound was prepared in an identical manner to 2a, except 1c was used 
instead of 1a. Purification via column chromatography (Al2O3, 2 % MeOH in 
1. mCPBA, DCM
(2b)(1b)
1. mCPBA, DCM
(1c) (2c)
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DCM) gave the N-oxide 2c as a white solid (88 % yield). 
 
1H NMR [400 MHz, CDCl3]: δH = 11.82 (br d, J= 7.9, 1H, -CONH), 8.42 (dd, J = 
7.9, 2.2, 1H, Py), 8.28 (dd, J = 6.3, 0.9, 1H, Py), 7.47 (dt, J = 7.8, 1.0, 1H, Py), 
7.42 (dt, J = 6.4, 2.3 , 1H, Py), 4.70 (dd, J = 8.0, 4.9, 1H, -NHCH), 3.77 (s, 3H, -
CO2CH3), 2.36 (m, 1H, -CH(CH3)2), 1.05 (d, J = 6.8, 3H, -CH(CH3)2), 1.04 (d, J 
= 6.9 Hz, 3H, -CH(CH3)2).  
 
ESI-MS m/z 275 ([M+Na]+), HR ESI-MS found 275.1008 C12H16N2NaO4 
requires 275.1002 (error 2.24 ppm). 
 
6.1.8 Synthesis of picolinamide-N-oxide derivative 2d 
 
 
This compound was prepared in an identical manner to 2a, except 1d was used 
instead of 1a. Purification via column chromatography (Al2O3, 2 % MeOH in 
DCM) gave the N-oxide 2d (80 % yield).  
 
1H NMR [400 MHz, CDCl3]: δH = 11.75 (br d, J= 5.5, 1H, -CONH), 8.38 (dd, J = 
7.9, 2.3, 1H, Py), 8.25 (dd, J = 6.3, 1.2 1H, Py), 7.44 ( dt, J = 7.6, 1.4, 1H, Py), 
7.39 (dt, J = 6.3, 2.4, 1H, Py), 7.34-7.23 (m, overlap, 5H, Ph), 5.00 (dt, J = 7.5, 
5.5, 1H,-CHCH2Ph), 3.74 (s, 3H, -CO2CH3), 3.28 (dd, J= 13.9, 5.5, 1H, -
CH2Ph), 3.19 (dd, J= 13.9, 7.6 Hz, 1H, -CH2Ph). 
 
ESI-MS m/z 323 ([M+Na]+), HR ESI-MS found 323.1013 C16H16N2NaO4 
1. mCPBA, DCM
(1d) (2d)
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requires 323.1002 (error 3.32 ppm). 
 
6.1.9 Synthesis of 6-cyanopicolinamide derivative 3a 
 
 
To a 50 ml round bottom flask containing 2a (0.2 g, 1.00 mmol) dimethyl sulfate 
(3 ml) was added and the reaction was placed under nitrogen and heated at 
60˚C for β4 h with stirring. The reaction was allowed to cool to room 
temperature then ether (25 ml) was added and left to stir for 1 h. The reaction 
was left to settle for 12 h. The ether was decanted off and the remaining oil was 
washed with ether and decanted again and any remaining solvent removed by 
rotary evaporation. Distilled water was added (10 ml) and the solution 
neutralised with NaHCO3, to this was then added NaCN (0.1g, 2.00 mmol) and 
the reaction stirred for 5 mins, during which time a yellow oil was produced. 
Extraction into DCM (3 x 30 ml), followed by drying (MgSO4) and evaporation 
produced the nitrile derivative 3a as a light purple solid (0.16 g, 77% yield).  
 
1H NMR [400 MHz, CDCl3]: δH = 7.96 (t, J = 7.9, 1H, Py), 7.90 (dd, J = 8.0, 1.3, 
1H, Py), 7.75 (dd, J = 7.9, 1.3, 1H, Py), 3.58 (q, J = 7.1, 2H, -CH2CH3 ), 3.40 (q, 
J = 7.1, 2H, -CH2CH3), 1.29 (t, J = 7.1, 3H, -CH2CH3), 1.32 (t, J = 7.1 Hz, 3H, -
CH2CH3). 
 
ESI-MS m/z 226 ([M+Na]+), HR ESI-MS found 226.0951 C11H13NaN3O requires 
226.0951 (error 0.06 ppm). 
  
1. (MeO)2SO2
2. NaHCO3, NaCN, H2O 
(2a) (3a)
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6.1.10 Synthesis of 6-cyanopicolinamide derivative 3b 
 
 
This compound was prepared in an identical manner to 3a, except 2b was used 
instead of 2a giving 3b as a white solid (76 % yield).  
 
1H NMR [400 MHz, CDCl3]: δH = 8.43 (dd, J = 8.9, 1.0, 1H, Py), 8.28 (br s, 1H, -
CONH), 8.06 (t, J = 7.9, 1H, Py), 7.87 (dd, J = 7.9, 1.0, 1H, Py), 4.30 (d, J = 
5.8, 2H, -NHCH2CO2), 3.82 (s, 3H, -CO2CH3). 
 
ESI-MS m/z 242 ([M+Na]+), HR ESI-MS found 242.0529 C10H9N3NaO3 requires 
242.0536 (error 2.80 ppm). 
 
6.1.11 Synthesis of 6-cyanopicolinamide derivative 3c 
 
 
This compound was prepared in an identical manner to 3a, except 2c was used 
instead of 2a giving 3c as a white solid (77 % yield).  
 
1H NMR [400 MHz, CDCl3]: δH = 8.42 (dd, J = 8.0, 1.1, 1H, Py), 8.25 (br d, J = 
1.(MeO)2SO2
2.NaHCO3, NaCN, H2O 
(2b) (3b)
1.(MeO)2SO2
2.NaHCO3, NaCN, H2O 
(2c) (3c)
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8.9, 1H, -CONH), 8.05 (t, J = 7.9, 1H, Py), 7.87 ( dd, J = 7.7, 1.1, 1H, Py), 4.73 
(dd, J = 9.2, 5.1, 1H, -NHCH), 3.97 (s, 3H, -CO2CH3), 2.34 (m, 1H, -CH(CH3)2), 
1.04 (d, J = 1.7, 3H, -CH(CH3)2), 1.03 (d, J = 1.7 Hz, 3H, -CH(CH3)2). 
 
ESI-MS m/z 284 ([M+Na]+), HR ESI-MS found 284.1017 C13H15N3NaO3 
requires 284.1006 (error 3.96 ppm). 
 
6.1.12 Synthesis of 6-cyanopicolinamide derivative 3d 
 
 
This compound was prepared in an identical manner to 3a, except 2d was used 
instead of 2a giving 3d as a colourless oil (74 % yield).  
 
1H NMR [400 MHz, CDCl3]: δH = 8.38 (dd, J = 8.0, 1.1, 1H, Py), 8.22 (br d, J= 
8.2, 1H, -CONH), 8.03 (t, J = 7.9, 1H, Py), 7.84 ( dd, J = 7.8, 1.1, 1H, Py), 7.35-
7.19 (m, overlap, 5H, Ph), 5.05 (dt, J = 8.3, 5.9, 1H,-CHCH2Ph), 3.77 (s, 3H, -
CO2CH3), 3.29 (dd, J = 13.9, 5.9, 1H, -CH2Ph), 3.23 (dd, J = 13.9, 5.8 Hz, 1H, -
CH2Ph). 
 
ESI-MS m/z 332 ([M+Na]+), HR ESI-MS found 332.0991 C17H15N3NaO3 
requires 332.1006 (error 4.35 ppm). 
  
1.(MeO)2SO2
2.NaHCO3, NaCN, H2O 
(2d) (3d)
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6.1.13 Synthesis of picolinamide-6-thioamide derivative 4a 
 
 
To a solution of the nitrile derivative 3a (0.1 g, 0.49 mmol) in ethanol (20 ml), 
triethylamine (1.0 g, 9.9 mmol) was added and H2S slowly bubbled through the 
solution which turned yellow after a few minutes. The solution was then left to 
stand at room temperature for 48 h during which time a precipitate was 
produced. Filtration gave the thioamide 4a as a light yellow powder (0.9 g, 78% 
yield).  
 
1H NMR [400 MHz, CDCl3]: δH = 9.31 (br s, 1H, -NH2), 8.76 (dd, J = 7.8, 1.0, 
1H, Py), 7.96 (t, J = 7.8, 1H, Py), 7.71 (dd, J = 7.8, 1.0, 1H, Py), 7.67 (br s, 1H, 
-NH2), 3.60 (q, J = 7.1, 2H, -CH2CH3 ), 3.30 (q, J = 7.1, 2H, -CH2CH3), 1.30 (t, J 
=7.1, 3H, -CH2CH3), 1.18 (t, J = 7.1 Hz, 3H, -CH2CH3). 
 
ESI-MS m/z 260.1 ([M+Na]+), HR ESI-MS found 260.0820 C11H15N3NaOS 
requires 260.0828  (error 2.92 ppm). 
  
1.H2S, Et3N, EtOH
(4a)(3a)
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6.1.14 Synthesis of picolinamide-6-thioamide derivative 4b 
 
 
This compound was prepared in an identical manner to 4a, except 3b was used 
instead of 3a giving 4b as a yellow powder (92 % yield). 
 
1H NMR [400 MHz, CDCl3]: δH = 9.08 (br s, 1H, -NH2), 8.89 (dd, J = 7.9, 1.0, 
1H, Py), 8.39 (dd, J = 7.9, 1.0, 1H, Py), 8.12 (br s, 1H, -CONH), 8.04 (t, J = 7.9, 
1H, Py), 7.71 (brs, 1H, -NH2), 4.31 (d, J = 5.4 Hz, 2H, -NHCH2CO2), 3.84 (s, 
3H, -CO2CH3). 
 
ESI-MS m/z 253 ([M+H]+), HR ESI-MS found 253.0510 C10H11N3O3S requires 
253.0516 (error 2.37 ppm). 
 
6.1.15 Synthesis of picolinamide-6-thioamide derivative 4c 
 
 
This compound was prepared in an identical manner to 4a, except 3c was used 
instead of 3a giving 4c as a yellow powder (60 % yield).  
1.H2S, Et3N, EtOH
(4b)(3b)
1.H2S, Et3N, EtOH
(4c)(3c)
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1H NMR [400 MHz, CDCl3]: δH = 9.06 (br s, 1H, -NH2), 8.88 (dd, J = 7.9, 1.1, 
1H, Py), 8.38 (dd, J = 7.8, 1.1, 1H, Py), 8.16 (br d, J = 8.8, 1H, -CONH), 8.04 (t, 
J = 7.8, 1H, Py), 7.76 (br s, 1H, -NH2), 4.77 (dd, J = 8.8, 5.0, 1H, -NHCH), 3.81 
(s, 3H, -CO2CH3), 2.34 (m, 1H, -CH(CH3)2), 1.03 (d, J = 7.0 Hz, 3H, -
CH(CH3)2), 1.02 (d, J = 7.0 Hz, 3H, -CH(CH3)2). 
 
ESI-MS m/z 318 ([M+Na]+), HR ESI-MS found 318.0893 C13H17N3NaO3S 
requires 318.0883 (error 3.21 ppm). 
 
6.1.16 Synthesis of picolinamide-6-thioamide derivative 4d 
 
 
This compound was prepared in an identical manner to 4a, except 3d was used 
instead of 3a giving  4d as a yellow powder (87 % yield).  
 
1H NMR [400 MHz, CDCl3]: δH = 8.86 (dd, J = 7.8, 1.1, 1H, Py), 8.75 (br s, 1H, -
NH2), 8.36 (dd, J = 7.8, 1.1, 1H, Py), 8.03 (t, J = 7.8, 1H, Py), 7.99 (br d, J= 8.2, 
1H, -CONH), 7.53 (br s, 1H, -NH2), 7.26-7.10 (m, overlap, 5H, Ph), 5.10 (dt, J = 
8.1, 5.2, 1H, -CHCH2Ph), 3.80 (s, 3H, -CO2CH3), 3.34 (dd, J = 13.8, 5.2, 1H, -
CH2Ph), 3.27(dd, J = 13.8, 5.2 Hz, 1H, -CH2Ph). 
 
ESI-MS m/z 366 ([M+Na]+), HR ESI-MS found 366.0870 C17H17N3NaO3S 
requires 366.0883 (error 3.41 ppm). 
  
1.H2S, Et3N, EtOH
(4d)(3d)
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6.1.17 Synthesis of L1 
 
 
To a solution of 1,3-di(α-dibromoacetyl)benzene (6) (0.05 g, 0.16 mmol) in 
ethanol (25 ml) was added the thioamide 4a (0.08 g, 0.34 mmol) and the 
reaction refluxed for 3 h. On cooling a white precipitate formed, which was 
isolated by filtration, followed by washing with EtOH (2 x 2 ml) and Et2O (2 x 2 
ml) (0.064 g, 67 % yield).  
 
1H NMR [400 MHz, CDCl3]: δH = 8.60 (t, J = 1.6, 1H, Ph), 8.42 (dd, J =7.8, 1.0, 
2H, Py), 8.02 (dd, J = 7.7, 1.6, 2H, Ph), 7.95 (t, J = 7.8, 2H, Py), 7.75 (dd, J = 
7.8, 1.0, 2H, Py), 7.74 (s, 2H, tz), 7.58 (t, J = 7.7, 1H, Ph), 3.63 (q, J = 7.1, 4H, -
CH2CH3 ), 3.51 (q, J = 7.0, 4H, -CH2CH3), 1.38 (t, J = 7.0, 6H, -CH2CH3), 1.32 
(t, J = 7.0 Hz, 6H, -CH2CH3). 
 
13C NMR [100 MHz, CDCl3]: δC = 168.5 (Q), 167.6 (Q), 156.5 (Q), 154.7 (Q), 
149.7 (Q), 138.1 (CH), 134.9 (Q), 129.3 (CH), 126.3 (CH), 124.7 (CH), 124.3 
(CH), 120.4 (CH), 116.1 (CH), 43.6 (CH2), 40.6 (CH2), 14.6 (CH3), 12.8 (CH3). 
(6)
1. EtOH
(4a)
(L1)
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IR (solid, v/cm-1) 3086, 2976, 2932, 1620, 1569, 1489, 1476, 1465, 1444, 1426, 
1377, 1320, 1116, 1081, 1028, 828, 776, 758. 
 
ESI-MS m/z 619 ([M+Na]+), HR ESI-MS found 619.1932 C32H32N6NaO2S2 
requires 619.1920 (error 1.88 ppm). 
 
6.1.18 Synthesis of L2 
 
 
This compound was prepared in an identical manner to L1, except 4b was used 
instead of 4a giving L2 as a cream powder (66 % yield). 
 
1H NMR (400 MHz, CDCl3): δH = 8.62 (t, J = 1.6, 1H, Ph), 8.55 (dd, J =7.7, 1.0, 
2H, Py), 8.51 (br t, J = 5.4, 2H, -CONH), 8.26 (dd, J = 7.7, 1.0, 2H, Py), 8.05 
(m, overlap, 4H, Py, Ph), 7.79 (s, 2H, tz), 7.59 (t, J = 7.8, 1H, Ph), 4.36 (d, J = 
5.4 Hz, 4H, -CH2-), 3.86 (s, 6H, -CO2CH3).  
 
1. EtOH
(6)(4b)
(L2)
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13C NMR [100 MHz, CDCl3]: δC = 170.2 (Q), 167.6 (Q), 163.8 (Q), 156.7 (Q), 
150.2 (Q), 148.9 (Q), 138.7 (CH), 134.8 (Q), 129.4 (CH), 126.4 (CH), 124.3 
(CH), 123.2 (CH), 122.6 (CH), 116.2 (CH), 52.6 (CH3), 41.4 (CH2). 
 
IR (solid, v/cm-1) 3385, 3108, 2954, 1747, 1679, 1590, 1568, 1521, 1446, 1374, 
1281, 1215, 1089, 1026, 998, 939, 833, 786, 773, 762, 754, 732, 664. 
 
ESI-MS m/z 629 ([M+H]+), HR ESI-MS found 629.1282 C30H25N6O6S2 requires 
629.1272 (error 1.74 ppm). 
 
6.1.19 Synthesis of L3 
 
 
This compound was prepared in an identical manner to L1, except 4c was used 
instead of 4a. The reaction was monitored via TLC until the starting material 
was consumed. Purifcation via column chromatography (Al2O3, 1% MeOH in 
DCM) gave L3 as a yellow solid (42 % yield).  
 
1H NMR [400 MHz, CDCl3]: δH = 8.63 (t, J = 1.0, 1H, Ph), 8.59 (br d, J = 8.9, 
2H, -CONH), 8.54 (dd, J = 7.8, 1.0, 2H, Ph), 8.24 (dd, J = 7.6, 1.0, 2H, Py), 
8.05 (t, J = 7.6, 2H, Py), 8.04 (dd, J = 7.6, 1.0, 2H, Py), 7.78 (s, 2H, tz), 7.60 (t, 
(6)
1. EtOH
(4c)
(L3)
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J = 7.8, 1H, Ph), 4.78 (dd, J = 8.9, 4.7, 2H, -NHCH), 3.83 (s, 6H, -CO2CH3), 
2.41 (m, 2H, -CH(CH3)2), 1.11 (d, J = 1.6, 6H, -CH(CH3)2), 1.09 (d, J = 1.5 Hz, 
6H, -CH(CH3)2).  
 
ESI-MS m/z 735 ([M+Na]+), HR ESI-MS found 735.2027 C36H36N6NaO6S2 
requires 735.2030 (error 0.39 ppm). 
 
6.1.20 Synthesis of L4 
 
 
This compound was prepared in an identical manner to L1, except 4d was used 
instead of 4a giving L4 as a white powder (67 % yield). 
  
1H NMR [400 MHz, CDCl3]: δH = 8.62 (t, J = 1.6, 1H, Ph), 8.53 (dd, J = 7.8, 1.0, 
2H, Py), 8.47 (br d, J = 8.0, 2H, -CONH), 8.23 (dd, J = 7.8, 1.0, 2H, Py), 8.05 (t, 
J = 7.8, 2H, Py), 8.04 (dd, J = 7.7, 1.6, 2H, Ph), 7.78 (s, 2H, tz), 7.59 (t, J = 7.7, 
1H, Ph), 7.38-7.29 (m, overlap, 10H, Ph), 5.09 (dt, J = 8.0, 5.9, 2H,-CHCH2Ph), 
3.80 (s, 6H, -CO2CH3), 3.32 (d, J = 5.9 Hz, 4H, -CH2Ph).  
 
(6)
1. EtOH
(4d)
(L4)
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13C NMR [100 MHz, CDCl3]: δC = 171.8 (Q), 167.7 (Q), 163.3 (Q), 156.7 (Q), 
150.1 (Q), 149.0 (Q), 138.7 (CH), 135.9 (Q), 134.9 (Q), 129.4 (CH), 129.4 (CH), 
128.8 (CH), 127.3 (CH), 126.4 (CH), 124.3 (CH), 123.1 (CH), 122.5 (CH) 116.2 
(CH), 53.4 (CH) 52.5 (CH3), 38.2 (CH2). 
 
IR (solid, v/cm-1) 3393, 3061, 2952, 1742, 1683, 1607, 1588, 1568, 1516, 1454, 
1441, 1366, 1280, 1202, 1179, 1103, 1073, 1026, 997, 767, 744, 702. 
 
ESI-MS m/z 831 ([M+Na]+), HR ESI-MS found 831.2029 C44H36N6NaO6S2 
requires 831.2030 (error 0.10 ppm). 
 
6.2 Preparation of phenyl-spacer ligands (L6 - L14) 
6.2.1 Synthesis of 3, 3'-Bis (2-bromoacetyl) biphenyl (8) 
 
γ,γ’- Diacetylbiphenyl (7) ( 0.24 g, 1.0 mmol) was dissolved in acetic acid (25 
ml) and set to stir at 80 ˚C under an atmosphere of dinitrogen. Bromine (0.γβ g, 
2.0 mmol) was diluted using acetic acid to give approximately 1 ml (approx. 0.9 
ml acetic acid) to allow slow addition to the reaction over 1 h. The reaction was 
monitored via TLC (SiO2, 1% MeOH in DCM); once the starting material was 
consumed the reaction was allowed to cool then poured over deionised water 
(30 ml) and NaHCO3 (0.1 g) was added to neutralise the reaction. The product 
was extracted into DCM (3 x 30 ml) and the combined organic layers dried 
(MgSO4). Removal of solvent left a crude product as a yellow-orange oil.  
Purification via column chromatography (SiO2, DCM) gave 8 as an off-white 
solid (145 mg, 37 % yield). 
(7)
1. Br2, CH3COOH
(8)
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1H NMR [400 MHz, CDCl3]: δH = 8.24 (br t, J= 1.7, 2H), 8.02 (dt, J= 7.8, 1.4, 
2H), 7.88 (dq, J= 7.7, 1.8, 1.1, 2H), 7.63 (t, J= 7.7 Hz, 2H), 4.52 (s, 4H, -CH2-
Br). 
 
ESI-MS m/z 416 ([M+Na]+), HR ESI-MS found 416.9099 C16H12Br2NaO2 
requires 416.9096 (error 0.89 ppm). 
 
6.2.2 Synthesis of L6 
 
 
To a solution of β,β’-bipyridine-6-thioamide (9) (0.072 g, 0.33 mmol) in ethanol 
(25 ml) was added the α-bromoacetyl (8) (0.06 g, 0.15 mmol) and the reaction 
refluxed for 8 h, during which time a precipitate was produced. This was 
isolated by filtration, whilst hot, followed by washing with EtOH and Et2O (2 x 2 
ml). The compound was isolated as the H.Br salt; to obtain the free ligand the 
product was suspended in concentrated ammonia (0.88 S.G., 10 ml) for 24 h. 
Filtration and washing with d.H2O, EtOH and Et2O (2 x 2 ml) gave the ligand, 
L6, as a cream powder (0.066 g, 70 % yield).  
 
L6
(9)
1. EtOH
(8)
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1H NMR [400 MHz, DMSO-d6]: δH= 8.77 (dt, J= 4.7, 0.7, 2H, Pyterm), 8.57 (s, 
2H, Tz), 8.52 (m, overlap, 4H, Pyterm, Py), 8.47 (s, 2H, Ph), 8.49 (dd, J= 7.7, 
0.8, 2H, Py), 8.18  (m, overlap, 4H, Py, Ph), 8.10 (dt, J=7.7, 1.7, 2H, Pyterm), 
7.83 (d, J= 7.9, 2H, Ph), 7.67 (t, J= 7.7, 2H, Ph), 7.57 (ddd, J= 7.4, 4.8, 1.0 Hz, 
2H, Pyterm).  
 
13C NMR [100 MHz, CDCl3]: δC = 169.3 (Q), 156.6 (Q), 155.7 (Q), 155.4 (Q), 
150.7 (Q), 149.2 (CH), 141.8 (Q), 138.1 (CH), 137.0 (CH), 135.1 (Q), 129.3 
(CH), 127.3 (CH), 125.5 (CH), 125.4 (CH), 124.1 (CH), 121.8 (CH), 121.3 (CH), 
119.8 (CH), 115.7 (CH). 
 
IR (solid, v/cm-1) 3060, 2360, 2337, 1601, 1581, 1562, 1475, 1454, 1431, 1080, 
1013, 776, 738, 732, 717, 693, 637. 
 
ESI-MS m/z 629 ([M+H]+), HR ESI-MS found 629.1577 C38H25N6S2 requires 
629.1577 (error 0.01ppm). 
 
6.2.3 Synthesis of 12 
 
 
To a 50 ml round bottom flask 1,3-dibromobenzene (10) (0.17 g, 0.7 mmol), 3-
acetyl phenylboronic acid (11) (0.3 g, 2.0 mmol), sodium carbonate (0.08 g, 
0.76 mmol), nBu4NBr (0.03 g, 0.09 mmol) and bis(triphenylphosphine) 
palladium chloride (0.01 g, 2 mol %) was suspended in deionised water (10 ml) 
and ethanol (10 ml). The reaction was left to stir at 70˚C for 20 h, and was 
monitored via TLC (SiO2, 1% MeOH in DCM). The ethanol was removed by 
rotary evaporation to allow extraction into DCM (3 x 30ml); the combined 
organic layers were dried over MgSO4. Filtration and evaporation provided a 
(10)
1. [Pd(PPh3)2Cl2]
EtOH:H2O
(12)(11)
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crude product that was purified via column chromatography (SiO2, 1% MeOH in 
DCM) producing the desired product, 12, as a cream solid (0.12 g, 54 % yield). 
 
1H NMR [400 MHz, CDCl3]: δH = 8.24 (t, J= 1.7, 2H, Ph), 7.98 (dt, J=7.8, 1.2, 
2H, Ph), 7.87 (dq, J=7.7, 1.2, 2H, Ph), 7.84 (t, J= 1.7 1H, Phcent), 7.65 (dt, J= 
7.6,  2H, Phcent), 7.59 (t, J=7.7, 2H, Ph), 7.58 (t, J=7.5 Hz, 1H, Phcent), 2.69 (s, 
6H, -CH3). 
 
ESI-MS m/z 337 ([M+Na]+), HR ESI-MS found 337.1199 C22H18NaO2 requires 
337.1199 (error 0.07ppm). 
 
6.2.4 Synthesis of 13 
 
 
This compound was produced in a similar manner to 3,3'-bis(2-
bromoacetyl)biphenyl (8), except 12 was used in place of γ,γ’- diacetylbiphenyl 
(7). The reaction was monitored via TLC (SiO2, 1% MeOH in DCM). Purification 
via column chromatography (SiO2, DCM) gave the desired product, 13, as an 
orange solid (63 % yield). 
 
1H NMR [400 MHz, CDCl3]: δH = 8.27 (t, J= 1.7, 2H, Ph), 8.01 (dq, J= 7.8,1.6, 
1.2, 2H, Ph), 7.91 (dq, J= 7.8, 1.8, 1.1, 2H, Ph), 7.83 (t, J= 1.1, 1H, Phcent), 7.66 
(dt, J= 7.8, 1.2 Hz, 2H, Phcent), 7.63-7.59 (m, overlap, 3H, Ph, Phcent), 4.53 (s, 
4H, -CH2-Br). 
 
ESI-MS m/z 493 ([M+Na]+), HR ESI-MS found 492.9419 C22H16Br2NaO2 
requires 492.9409 (error 1.97 ppm). 
  
1. Br2, CH3COOH
(12) (13)
184 
 
6.2.5 Synthesis of L7 
 
 
To a solution of β,β’-bipyridine-6-thioamide (9) (0.075 g, 0.35 mmol) in ethanol 
(25 ml) was added the α-bromoacetyl (13) (0.075 g, 0.16 mmol) and the 
reaction refluxed for 8 h, during which time a precipitate was produced. This 
was isolated by filtration, whilst hot, followed by washing with EtOH and Et2O (2 
x 2 ml). The compound was isolated as the H.Br salt; to obtain the free ligand 
the product was suspended in concentrated ammonia (0.88 S.G., 10 ml) for 24 
h. Filtration and washing with d.H2O, EtOH and Et2O (2 x 2 ml) gave the 
desired ligand, L7, as a light brown powder (0.08 g, 71 % yield). 
 
1H NMR [400 MHz, CDCl3]: δH = 8.71 (dq, J= 4.8, 1.7, 0.9, 2H, Pyterm), 8.61 (d, 
J= 8.0, 2H, Pyterm), 8.49 (dd, J= 7.8. 0.9, 2H, Py), 8.37 (dd, J= 7.8. 0.9, 2H, Py), 
8.35 (t, J= 1.6, 2H, Ph), 8.05 (dt, J= 7.8. 1.4, 2H, Ph), 8.01 (t, J= 1.6, 1H, 
Phcent), 7.96 (t, J= 7.8, 2H, Py), 7.90 (dt, J= 7.7, 1.8, 2H, Pyterm), 7.74 (s, 2H, 
Tz), 7.73 (dd, J= 7.3, 1.7, 2H, Phcent), 7.70 (dt, J= 8.0, 1.2, 2H, Ph), 7.64-7.58 
(m, overlap, 3H, Phcent, Ph), 7.37 (ddd, J= 7.5. 4.8, 1.2 Hz, 2H, Pyterm).  
 
1. EtOH
(13) (9)
(L7)
185 
 
13C NMR [125 MHz, CDCl3]: δC = 169.3 (quaternary, Q), 156.6 (Q), 155.6 (Q), 
155.3 (Q), 150.7 (Q), 149.0 (CH), 141.9 (Q), 141.8 (Q), 138.0 (CH), 137.1 (CH), 
135.2 (Q), 129.2 (CH), 127.2 (CH), 126.5 (CH), 126.4 (CH), 125.4 (CH), 124.0 
(CH), 121.8 (CH), 121.3 (CH), 119.8 (CH), 115.6 (CH).  
 
ESI-MS m/z 705 ([M+H]+), HR ESI-MS found 705.1894 C44H29N6S2 requires 
705.1890 (error 0.55 ppm). 
6.2.6 Synthesis of 15 
 
 
This compound was produced in an analogous fashion to compound 12, except 
2,6-dibromopyridine (14) was used in place of 1,3-dibromobenzene (10). The 
reaction was monitored via TLC (SiO2, 1 % MeOH in DCM). Purification via 
column chromatography (SiO2, 1 % MeOH in DCM) gave 15 as a yellow oil (95 
% yield).  
 
1H NMR [400 MHz, CDCl3]: δH = 8.74 (t, J= 1.7, 2H, Ph), 8.41 (dq, J= 7.8, 1.6, 
1.3, 2H, Ph), 8.05 (dt, J= 7.7, 1.3, 2H, Ph), 7.92 (t, J= 7.8, 1H, Py), 7.82 (d, J= 
7.8, 2H, Py), 7.64 (t, J= 7.7 Hz, 2H, Ph), 2.73 (s, 6H, -CH3).  
6.2.7 Synthesis of 16 
 
 
This compound was produced in an identical manner to 3,3'-bis(2-
bromoacetyl)biphenyl (8), except 15 was used in place of γ,γ’-diacetylbiphenyl 
1. Br2, CH3COOH
(15) (16)
(14)
1. [Pd(PPh3)2Cl2] 
EtOH:H2O
(15)(11)
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(7). The reaction was monitored via TLC (SiO2, DCM). Purification via column 
chromatography (SiO2, DCM) gave 16 as an off-white solid (62 % yield).  
 
1H NMR [400 MHz, CDCl3]: δH = 8.77 (d, J = 1.6, 2H, Ph), 8.44 (dd, J = 7.7, 0.9, 
2H, Ph), 8.07 (dd, J = 7.7, 1.1, 2H, Ph), 7.93 (t, J = 7.8, 1H, Py), 7.82 (d, J =  
7.7, 2H, Py), 7.66 (dt, J = 7.8, 1.5 Hz, 2H, Ph), 4.56 (s, 4H, -CH2-Br).  
 
6.2.8 Synthesis of L8 
 
 
To a solution of β,β’-bipyridine-6-thioamide (9) (0.06 g, 0.28 mmol) in ethanol 
(25 ml) was added the α-bromoacetyl (16) (0.057 g, 0.12 mmol) and the 
reaction refluxed for 8 h, during which time a precipitate was produced. This 
was isolated by filtration, whilst hot, followed by washing with EtOH and Et2O (2 
x 2 ml). The compound was isolated as the H.Br salt; to obtain the free ligand 
the product was suspended in concentrated ammonia (0.88 S.G., 10 ml) for 24 
h. Filtration and washing with d.H2O, EtOH and Et2O (2 x 2 ml) gave the 
desired ligand, L8, as a white powder (0.052 g, 61 % yield).  
1. EtOH
(16) (9)
(L8)
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(17)
1. NaH, THF
2. MeI
(18)
 
1H NMR [400 MHz, DMSO-d6]: δH = 9.09 (s, 2H, Ph), 8.69 (dq, J= 4.8, 0.8, 2H, 
Pyterm), 8.53 (s, 2H, Tz), 8.42 (dd, J= 7.8, 0.8, 2H, Py), 8.39 (d, J= 7.9, 2H, 
Pyterm), 8.31 (d, J= 8.1, 2H, Ph), 8.25 (dd, J=7.7, 0.8, 2H, Py), 8.21 (d, J= 8.0, 
2H, Ph), 8.16 (d, J= 6.6, 1H, Pycent), 8.11 (t J= 6.2, 2H, Pycent), 8.00 (t, J= 7.8, 
2H, Py), 7.97 (dt, J=7.7, 0.7, 2H, Pyterm), 7.71 (t, J= 7.7, 2H, Ph), 7.47 (ddd, J= 
7.6, 4.8, 1.1 Hz, 2H, Pyterm). 
 
The poor solubility of the ligand precluded 13C NMR analysis 
 
ESI-MS m/z 706 ([M+H]+), HR ESI-MS found 706.1844 C43H27N7S2 requires 
706.1842 (error 0.30 ppm). 
 
6.2.9 Synthesis of 1,3-dibromo-2-methoxy-5-methylbenzene (18)171 
 
 
A two necked round bottom flask charged with 2,6-dibromomethyl phenol (1.0 
g, 3.8 mmol) and sodium hydride (60%, 0.3 g, 7.5 mmol), was placed under an 
atmosphere of dinitrogen, and anhydrous THF (20 ml) was added. To this 
methyliodide (1ml) was added with care and the reaction was monitored via 
TLC (SiO2, 3:7 ethyl acetate: petroleum ether 40-60). Once all the starting 
material was consumed (48 h) methanol was added to the reaction (to react 
with any unreacted sodium hydride). The reaction was concentrated and d.H2O 
(40 ml) added, extracted into DCM (3 x 30 ml), the combined organic layers 
dried (MgSO4) and solvent removed by rotary evaporation. Separation and 
purification via column chromatography (SiO2, 1:9 ethyl acetate: petroleum 
ether 40-60) gave 18 as a fine pink solid (0.76 g, 71 % yield). 
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1H NMR [400 MHz, DMSO-d6]: δH = 7.32 (s, 2H, Ph), 3.86 (s, 3H, -OCH3), 2.29 
(s, 3H, -ArCH3).  
6.2.10 Synthesis of 19 
 
 
This compound was produced in an identical manner to compound 12, except 
1,3-dibromo-2-methoxy-5-methylbenzene (18) was used in place of 1,3-
dibromobenzene (11). The reaction was monitored via TLC (SiO2, 1 % MeOH 
in DCM). Purification via column chromatography (SiO2, 1 % MeOH in DCM) 
gave compound 19 as a white powder (60 % yield).  
 
1H NMR [500 MHz, CDCl3]: δH = 8.20 (t, J= 1.6, 2H, Ph), 7.97 (dt, J= 7.8, 1.5, 
2H, Ph), 7.85 (dt, J= 7.6, 1.5, 2H, Ph), 7.56 (t, J= 7.6 Hz, 2H, Ph), 7.21 (s, 2H, 
Phcent), 3.12 (s, 3H, -O-CH3), 2.67 (s, 6H, -CH3), 2.43 (s, 3H, -ArCH3). 
 
ESI-MS m/z 381 ([M+Na]+), HR ESI-MS found 381.1464 C24H22NaO3 requires 
381.1461 (error 0.73 ppm). 
  
(18)
1. [Pd(PPh3)2Cl2] 
EtOH:H2O
(19)(11)
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6.2.11 Synthesis of 20 
 
 
This compound was produced in an identical manner to compound 8, except 19 
was used in place of γ,γ’-diacetylbiphenyl (7). The reaction was monitored via 
TLC (SiO2, 0.5 % MeOH in DCM). Purification via column chromatography 
(SiO2, 0.5 % MeOH in DCM) gave compound 20 as a white powder (44 % 
yield). 
 
1H NMR [500 MHz, CDCl3]: δH = 8.23 (t, J= 1.6, 2H, Ph), 8.00 (dt, J= 7.8, 1.3, 
2H, Ph), 7.89 (dt, J= 7.8, 1.3, 2H, Ph), 7.58 (t, J= 7.8 Hz, 2H, Ph), 7.22 (s, 2H, 
Phcent), 4.53 (s, 4H, -CH2-Br), 3.13 (s, 3H, -O-CH3), 2.44 (s,3H, -ArCH3). 
 
ESI-MS m/z 536 ([M+Na]+), HR ESI-MS found 536.9671 C24H20Br2 NaO3 
requires 536.9671 (error 0.10 ppm). 
  
1. Br2, CH3COOH
(19) (20)
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6.2.12 Synthesis of L9 
 
 
To a solution of β,β’-bipyridine-6-thioamide (9) (0.069 g, 0.32 mmol) in ethanol 
(25 ml) was added the α-bromoacetyl (20) (0.075 g, 0.15 mmol) and the 
reaction refluxed for 8 h, during which time a precipitate was produced. This 
was isolated by filtration, whilst hot, followed by washing with EtOH and Et2O (2 
x 2 ml). NaHCO3(aq) (30 ml) was added to the resulting yellow powder, and the 
product was extracted into DCM (3 x 30 ml). The combined organic layers were 
dried (MgSO4) and concentrated followed by purification via column 
chromatography (Al2O3, DCM). This gave the desired ligand, L9, as a light 
yellow powder (0.069 g, 65 % yield). 
 
1H NMR [500 MHz, DMSO-d6]: δH = 8.75 (dq, J= 4.7, 0.9, 2H, Pyterm), 8.50 (dt, 
J= 7.9, 1.0, 2H, Pyterm), 8.49 (dd, J= 7.8, 0.9, 2H, Py), 8.43 (s, 2H, Tz), 8.33 (dd, 
J= 7.8, 0.9, 2H, Py), 8.28 (br s, 2H, Ph), 8.15 (t, J= 7.8, 2H, Py), 8.12 (dt, J= 
1. EtOH
(20) (9)
(L9)
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6.7, 2, 2H, Ph), 8.06 (dt, J= 7.7, 1.8, 2H, Pyterm), 7.61-7.60 (m, overlap, 4H, Ph), 
7.53 (dq, J= 7.5, 4.8, 1.2 Hz, 2H, Pyterm), 7.32 (s, 2H, Phcent), 3.21 (s, 3H, -
OCH3), 2.44 (s, 3H, -ArCH3).  
 
13C NMR [125 MHz, CDCl3/CD3OD]: δC = 169.1 (quaternary, Q), 156.8 (Q), 
155.2 (2 x Q), 152.9 (Q), 150.9 (Q), 148.7 (CH), 139.4 (Q), 138.1 (CH), 137.5 
(CH), 135.3 (Q), 134.5 (Q), 133.7 (Q), 131.1 (CH), 129.3 (CH), 128.6 (CH), 
127.3 (CH), 125.2 (CH), 124.1 (CH), 121.9 (CH), 121.6 (CH), 119.9 (CH), 115.5 
(CH), 60.8 (OCH3), 20.8 (CH3).  
 
ESI-MS m/z 749 ([M+H]+), HR ESI-MS found 749.2145 C46H33N6OS2 requires 
749.2152 (error 0.89 ppm). 
 
6.2.13 Synthesis of 23172 
 
 
In a 250 ml round bottom flask charged with 2-(2-methoxyethoxy)ethanol (5 g, 
0.04 mol) (22) pyridine was added (15 ml) and the mixture set to stir in an ice 
bath and left to cool (approx. 20 minutes).  Once cool p-toluenesulfonyl chloride 
(21) (8 g, 0.04 mol) was added slowly over 2 h. After the complete addition of 
the p-toluenesulfonyl chloride the reaction was left to stir at RT for 24 h. 
Deionised water (100 ml) was added to the reaction flask producing an oil, this 
was left to stand at RT for 24 h. The water was decanted off; ether (100 ml) 
was added to the remaining oil. This was then washed with d.H2O, HCl (2 M) 
and NaCl
 (aq) (100 ml). The solvent was dried (MgSO4) and the solvent 
removed, giving the desired product, 23, as a viscous colourless oil.  
 
(22) (23)(21)
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1. NaH, THF
(17) (23) (24)
1H NMR [400 MHz, CDCl3]: δH = 7.80 (d, J= 8.3, 2H), 7.34 (d, J= 8.1, 2H), 4.17 
(t, J= 4.9, 2H, -CH2), 3.69 (t, J= 4.9 Hz, 2H, -CH2), 3.58 (m, 2H, -CH2), 3.48 (m, 
2H, -CH2), 3.35 (s, 3H, -CH3), 2.45 (s, 3H, -ArCH3).  
 
6.2.14 Synthesis of 24 
 
 
A two necked round bottom flask charged with 2,6-dibromo-4-methylphenol 
(17) (1.36 g, 5.1 mmol) and sodium hydride (0.12 g, 5.1 mmol) was placed 
under an atmosphere of dinitrogen, to this was added anhydrous THF ( 35 ml). 
This was left to stir at room temperature for 1h. After this time 2-(2-
methoxyethoxy)ethyl 4-methylbenzenesulfonate (23) (0.71 g, 2.6 mmol) was 
added to the reaction and set to stir at 80  C. The reaction was monitored via 
TLC (SiO2, 2 % MeOH in DCM); once all the benzenesulfonate (23) was 
consumed methanol was added to the reaction whilst under N2(g) (to react with 
any unreacted sodium hydride). The reaction was concentrated and NaHCO3(aq) 
(50 ml) added to the reaction and the product extracted into ether (3 x 30 ml). 
The combined organic layers were dried (MgSO4) and the solvent removed by 
rotary evaporation. Separation and purification via column chromatography 
(SiO2, 2 % MeOH in DCM) gave 24 as a green oil (0.52 g, 56 % yield). 
 
1H NMR [400 MHz, CDCl3]: δH = 7.31 (s, 2H, Ph), 4.18 (t, J= 5.0, 2H, -CH2), 
3.94 (t, J= 5.2, 2H, -CH2), 3.78 (t, J= 4.5, 2H, -CH2), 3.60 (t, J= 4.5 Hz, 2H, -
CH2), 3.41 (s, 3H, -CH3), 2.28 (s, 3H, -ArCH3). 
 
ESI-MS m/z 388 ([M+Na]+), HR ESI-MS found 388.9358 C12H16Br2NaO3 
requires 388.9358 (error 1.09 ppm).  
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1. [Pd(PPh3)2Cl2] 
EtOH: H2O
(24)(11) (25)
6.2.15 Synthesis of 25 
 
 
This compound was produced in an identical manner to compound 12, except 
compound 24 was used in place of 1,3-dibromobenzene (10). The reaction was 
monitored via TLC (SiO2, 1:1 ethyl acetate: petroleum ether 40-60). Purification 
via column chromatography (SiO2, 1:1 ethyl acetate: petroleum ether 40-60) 
gave compound 25 as a yellow oil (89 % yield). 
 
1H NMR [400 MHz, CDCl3]: δH = 8.21 (s, 2H, Ph), 7.95 (d, J= 7.7, 2H, Ph), 7.89 
(d, J= 7.6, 2H, Ph), 7.53 (t, J= 7.7, 2H, Ph), 7.22 (s, 2H, Phcent), 3.35 (t, J= 5.0 
Hz, 2H, -CH2), 3.28-3.26 (m, overlap, 5H, -CH2, -CH3), 3.18-3.14 (m, overlap, 
4H, 2 x -CH2), 2.68 (s, 6H, -CH3), 2.43 (s, 3H, -ArCH3). 
 
ESI-MS m/z 469 ([M+Na]+), HR ESI-MS found 469.2001 C28H30NaO5 requires 
469.1985 (error 3.32 ppm). 
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6.2.16 Synthesis of 26 
 
 
This compound was produced in an identical manner to compound 8, except 
that compound 25 was used in place of 3,γ’-diacetylbiphenyl (7). The reaction 
was monitored via TLC (SiO2, 1:1 ethyl acetate: petroleum ether 40-60). 
Purification via column chromatography (SiO2, 1:1 ethyl acetate: petroleum 
ether 40-60) gave compound 26 as a yellow oil (89 % yield).  
 
1H NMR [400 MHz, CDCl3]: δH = 8.25 (s, 2H, Ph), 7.99 (d, J= 7.8, 2H, Ph), 7.92 
(d, J= 7.7, 2H, Ph), 7.57 (t, J= 7.7, 2H, Ph), 7.22 (s, 2H, Phcent), 4.55 (s, 4H, -
CH2Br), 3.36 (t, J= 4.8 Hz, 2H, -CH2), 3.29-3.26 (m, overlap, 5H, -CH2, -CH3), 
3.19-3.15 (m, overlap, 4H, 2 x -CH2), 2.43 (s, 3H, -ArCH3). 
 
ESI-MS m/z 625 ([M+Na]+), HR ESI-MS found 625.0206 C28H28Br2NaO5 
requires 625.0196 (error 1.60 ppm). 
  
1. Br2, CH3COOH
(25) (26)
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1. EtOH
(L10)
(26) (9)
6.2.17 Synthesis of ligand L10 
 
 
To a solution of β,β’-bipyridine-6-thioamide (9) (0.098 g, 0.46 mmol) in ethanol 
(25 ml) was added the α-bromoacetyl (26) (0.125 g, 0.21 mmol) and the 
reaction refluxed for 8 h; the reaction was monitored via TLC (Al2O3, 1 % 
MeOH in DCM). Upon completion the solvent was removed by rotary 
evaporation followed by purification via coulum chromatography (Al2O3, 1 % 
MeOH in DCM) giving the final ligand, L10, as a fine white solid once completely 
dry (0.09 g, 51 % yield).  
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(27)
1. [Pd(PPh3)2Cl2] 
EtOH:H2O
(28)(11)
1H NMR [400 MHz, CDCl3]: δH = 8.72 (dt, J= 4.8, 0.8, 2H, Pyterm), 8.61 (d, J= 
8.0, 2H, Pyterm), 8.50 (dd, J= 7.8, 0.9, 2H, Py), 8.37 (dd, J= 7.8, 0.9, 2H, Py), 
8.28 (t, J= 1.5, 2H, Ph), 8.05 (dt, J= 7.7, 1.4, 2H, Ph), 7.97 (t, J= 7.8, 2H, Py), 
7.90 (dt, J= 7.7, 1.7, 2H, Pyterm), 7.73 (s, 2H, Tz), 7.69 (dt, J= 7.8, 1.3, 2H, Ph), 
7.54 (t, J= 7.7, 2H, Ph), 7.36 (ddd, J= 7.8, 4.8, 1.1, 2H, Pyterm), 7.31 (s, 2H, 
Phcent), 3.53 (t, J= 4.8, 2H, -CH2), 3.28 (t, J= 4.8 Hz, 2H, -CH2), 3.21-3.16 (m, 
overlap, 7H, 2 x -CH2, -CH3), 2.48 (s, 3H, -ArCH3). 
 
13C NMR [125 MHz, CDCl3/CD3OD]: δC = 169.1 (quaternary, Q), 156.7 (Q), 
155.5 (Q), 155.3 (Q) 151.9 (Q), 150.7 (Q), 149.1 (CH), 139.3 (Q), 138.1 (CH), 
137.2 (CH), 135.5 (Q), 134.5 (Q), 133.8 (Q), 131.1 (CH), 129.6 (CH), 128.6 
(CH), 127.4 (CH), 125.2 (CH), 124.1 (CH), 121.8 (CH), 121.4 (CH), 119.8 (CH), 
115.6 (CH), 72.1 (OCH2), 71.7 (OCH2), 69.9 (OCH2), 69.8 (OCH2), 58.9 
(OCH3), 20.9 (ArCH3). 
 
ESI-MS m/z 837 ([M+H]+), HR ESI-MS found 837.2661 C50H41N6O3S2 requires 
837.2676 (error 1.75 ppm).  
6.2.18 Synthesis of 28 
 
 
This compound was produced in an identical manner to compound 12, except 
2,6-dibromo-p-toluidine (27) was used in place of 1,3-dibromobenzene (10). 
The reaction was monitored via TLC (SiO2, 3:7 ethyl acetate : petroleum ether 
40-60). Purification via column chromatography (SiO2, 1:2 ethyl acetate : 
petroleum ether 40-60) gave 28 as a yellow oil (49 % yield). 
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1. Br2, CH3COOH
(28) (29)
 
1H NMR [400 MHz, CDCl3]: δH = 8.10 (s, 2H, Ph), 7.97 (d, J= 7.8, 2H, Ph), 7.74 
(d, J= 7.7, 2H, Ph), 7.57 (t, J= 7.7 Hz, 2H, Ph), 7.00 (s, 2H, Phcent), 3.64 (br s, 
2H, -NH2), 2.66 (s, 6H,-CH3), 2.34 (s, 3H, -ArCH3). 
 
ESI-MS m/z 366 ([M+Na]+), HR ESI-MS found 366.1465 C23H21NNaO2 requires 
366.1464 (error 0.24 ppm).  
 
6.2.19 Synthesis of 29 
 
 
This compound was produced in an identical manner to compound 8, except 28 
was used in place of γ,γ’-diacetylbiphenyl (7). The reaction was monitored via 
TLC (SiO2, 3:7 ethyl acetate: petroleum ether 40-60). Purification via column 
chromatography (SiO2, 3:7 ethyl acetate: petroleum ether 40-60) gave 
compound 29 as a dark yellow oil (38 % yield). 
 
1H NMR [400 MHz, CDCl3]: δH = 8.22 (s, 2H, Ph), 8.00 (d, J=7.3, 2H, Ph), 7.79 
(d, J=7.0, 2H, Ph), 7.61 (t, J=7.7 Hz, 2H, Ph), 7.01 (s, 2H, Phcent), 4.50 (s, 4H, -
CH2Br), 3.69 (br s, 2H, -NH2), 2.34 (s, 3H, -ArCH3). 
 
ESI-MS m/z 499 ([M+H]+), HR ESI-MS found 499.9854 C23H20Br2NO2 requires 
499.9855 (error 0.33 ppm). 
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6.2.20 Synthesis of L11 
 
 
To a solution of β,β’-bipyridine-6-thioamide (9) (0.052 g, 0.24 mmol) in ethanol 
(β5 ml) was added the α-bromoacetyl (29) (0.06 g, 0.12 mmol) and the reaction 
refluxed for 8 h, during which time a precipitate was produced. This was 
isolated by filtration, whilst hot, followed by washing with EtOH and Et2O (2 x 2 
ml). The compound was isolated as the H.Br salt; to obtain the free ligand the 
product was suspended in concentrated ammonia (0.88 S.G., 10 ml) for 24 h. 
Filtration and washing with d.H2O, EtOH and Et2O (2 x 2 ml) gave the ligand, 
L11, as an off-white powder (0.026 g, 30 % yield).  
 
1H NMR [400 MHz, CDCl3]: δH = 8.72 (dd, J= 4.8, 0.8, 2H, Pyterm), 8.61 (d, J= 
8.6, 2H, Pyterm), 8.50 (dd, J= 7.8, 0.9, 2H, Py), 8.35 (dd, J= 7.8, 0.9, 2H, Py), 
8.19 (s, 2H, Ph), 8.04 (dt, J= 7.0, 1.8, 2H, Ph), 7.97 (t, J= 7.8, 2H, Py), 7.90 (dt, 
J= 7.8, 1.8, 2H, Pyterm), 7.70 (s, 2H, Tz), 7.60-7.53 (m, overlap, 4H, Ph), 7.37 
(ddd, J= 7.4, 4.8, 1.2 Hz, 2H, Pyterm), 7.10 (s, 2H, Phcent), 3.84 (br s, 2H, -NH2), 
2.39 (s, 3H, -ArCH3). 
 
1. EtOH
(29) (9)
(L11)
199 
 
(27)
Acetic anhydride 
(30)
ESI-MS m/z 734 ([M+H]+), HR ESI-MS found 734.2150 C45H31N7S2 requires 
734.2155 (error 0.66 ppm). 
7.2.21 Synthesis of 30173 
 
 
In a 50 ml round bottom flask 2,6-dibromo-p-toluidine (27) (1.0 g, 3.77 mmol) 
was dissolved in acetic anhydride (10 ml) and the reaction was set to stir at 60 
˚C for 1 h. After this time the reaction was left to stand at RT for 48 h. Over this 
time a crystalline solid was produced. The excess acetic anhydride was 
decanted off; the remaining solid was suspended in ether. This ether was 
decanted off, leaving the desired product 30 as a colourless crystalline solid 
(0.6 g, 70% yield). 
 
1H NMR [400 MHz, DMSO-d6]: δH = 7.41 (s, 2H, Ph), 6.92 (br s, 1H, -NH), 2.32 
(s, 3H, -ArCH3) 2.23 (s, 3H, -CH3).  
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6.2.22 Synthesis of 31 
 
 
This compound was produced in an identical manner to compound 12, except 
N-(2,6-dibromo-4-methylphenyl)acetamide (30) was used in place of 1,3-
dibromobenzene (10). The reaction was monitored via TLC (SiO2, 2:3 ethyl 
acetate: petroleum ether 40-60). Purification via column chromatography (SiO2, 
2:3 ethyl acetate: petroleum ether 40-60) gave compound 31 as a white solid 
(79 % yield).  
 
1H NMR [400 MHz, CDCl3]: δH = 8.00 (s, 2H, Ph), 7.96 (d, J= 7.8, 2H, Ph), 7.62 
(d, J= 7.6, 2H, Ph), 7.52 (t, J= 7.6 Hz, 2H, Ph), 7.24 (s, 2H, Phcent), 6.58 (s, 1H, 
-NH), 2.63 (s, 6H, -CH3), 2.45( s, 3H, -ArCH3), 1.68 (s, 3H, -CH3). 
 
ESI-MS m/z 408 ([M+Na]+), HR ESI-MS found 408.1571 C25H23NNaO3 requires 
408.1570 (error 0.20 ppm). 
  
1. [Pd(PPh3)2Cl2] 
EtOH:H2O
(31)(30)(11)
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6.2.23 Synthesis of 32 
 
 
This compound was produced in an identical manner to compound 8, except 31 
was used in place of γ,γ’-diacetylbiphenyl (7). The reaction was monitored via 
TLC (SiO2, 2:3 ethyl acetate: petroleum ether 40-60). Purification via column 
chromatography (SiO2, 2:3 ethyl acetate: petroleum ether 40-60) gave 32 as a 
white solid (58 % yield). 
 
1H NMR [400 MHz, CDCl3]: δH = 8.02 (t, J= 1.6, 2H, Ph), 7.99 (dt, J= 7.7, 1.6, 
2H, Ph), 7.67 (dt, J= 7.6, 1.6, 2H, Ph), 7.56 (t, J= 7.7 Hz, 2H, Ph), 7.24 (s, 2H, 
Phcent), 6.56 (s, 1H, -NH), 4.47 (s, 4H, -CH2Br), 2.49 (s, 3H, -ArCH3), 1.70 (s, 
3H, -CH3). 
 
ESI-MS m/z 563 ([M+Na]+), HR ESI-MS found 563.9788 C25H21Br2NNaO3 
requires 563.9780 (error 1.40 ppm). 
  
1. Br2, CH3COOH
(31) (32)
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6.2.24 Synthesis of L12 
 
 
To a solution of β,β’-bipyridine-6-thioamide (9) (0.079 g, 0.37 mmol) in ethanol 
(β5 ml) was added the α-bromoacetyl (32) (0.100 g, 0.18 mmol) and the 
reaction refluxed for 8 h, during which time a precipitate was produced. This 
was isolated by filtration followed by washing with EtOH and Et2O (2 x 2 ml). 
The compound was isolated as the H.Br salt; to obtain the free ligand the 
product was suspended in concentrated ammonia (0.88 S.G., 10 ml) for 24 h. 
Filtration and washing with d.H2O, EtOH and Et2O (2 x 2 ml) gave the desired 
ligand as an off-white powder. (0.125 g, 84 % yield).  
 
1H NMR [400 MHz, CDCl3]: δH = 8.71 (d, J= 4.8, 2H, Pyterm), 8.60 (d, J= 7.9, 
2H, Pyterm), 8.48 (d, J= 7.7, 2H, Py), 8.34 (d, J= 7.4, 2H, Py), 8.15 (s, 2H, Ph), 
8.03 (d, J= 7.8, 2H, Ph), 7.96 (t, J= 7.8, 2H, Py), 7.90 (dt, J= 7.8, 1.7, 2H, 
Pyterm), 7.69 (s, 2H, Tz), 7.55 (t, J= 7.5, 2H, Ph) 7.45 (d, J= 7.6 Hz, 2H, Ph), 
1. EtOH
(32) (9)
(L12)
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7.39-7.33 (m, overlap, 4H, Pyterm, Phcent), 6.59 (s, 1H, -NH), 2.49 (s, 3H, -
ArCH3), 1.75 (s, 3H, -CH3). 
 
ESI-MS m/z 776 (M + H+), HR ESI-MS found 776.2263 C47H34N7OS2 requires 
776.2261 (error 0.25 ppm). 
 
6.2.25 Synthesis of N-(2,6-dibromo-4-methyl-phenyl)benzamide (33) 
 
 
To a solution of 27 (0.67 g, 2.53 mmol) in DCM (25 ml) pyridine (0.20 g, 2.53 
mmol) was added. This was set to stir at room temperature then a solution of 
benzoyl chloride (0.36 g, 2.53 mmol) in DCM (1 ml) was added drop-wise over 
a period of 1 h. The reaction was monitored by TLC (SiO2, 1:1 ethyl acetate: 
petroleum ether 40-60).  Upon completion DCM (25 ml) was added to the 
reaction, this was then washed with deionised water followed by NaHCO3(aq) 
and finally washed with HCl (2 M) (2 x 30 ml). The resulting solution was dried 
(MgSO4) and the solvent evaporated. Purification via column chromatography 
(SiO2, 3:7 ethyl acetate: petroleum ether 40-60) gave 33 as a white powder 
(0.82 g, 88 % yield). 
 
1H NMR [400 MHz, CDCl3]: δH= 7.98 (d, J= 7.4, 2H, Bz), 7.60 (t, J= 7.3 Hz, 1H, 
Bz), 7.53 (m overlap, 3H, -NH, Bz), 7.47 (s, 2H, Ph), 2.36 (s, 3H, -ArCH3). 
 
1. Benzoyl Chloride 
(27) (33)
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(11)
EtOH:H2O 
1. [Pd(PPh3)2Cl2] 
(33) (34)
ESI-MS m/z 389 ([M+Na]+), HR ESI-MS found 389.9094 C14H11Br2NNaO 
requires 389.9099 (error 1.41 ppm).  
 
6.2.26 Synthesis of 34 
 
 
This compound was produced in an identical manner to compound 12, except 
N-(2,6-dibromo-4-methyl-phenyl) benzamide (33) was used in place of 1,3-
dibromobenzene (10). The reaction was monitored via TLC (SiO2, 1:1 ethyl 
acetate: petroleum ether 40-60). Upon completion the solvent was removed 
and NaHCO3 (aq) (20 ml) added. This was extracted first with 1% MeOH in DCM 
(3 x 30 ml) followed by 3 % MeOH in DCM (3 x 30 ml) and finally 5 % MeOH in 
DCM (3 x 30 ml). The combined organic layers were dried over MgSO4, filtered 
and evaporated. Once all the solvent had been removed DCM (≈ 2 ml) was 
added to the reaction and upon standing a precipitate was produced. This was 
isolated via filtration to give the desired compound, 34, as a light grey powder 
(48 % yield). 
 
1H NMR [400 MHz, DMSO-d6]: δH = 9.82 (s, 1H, -NH), 8.06 (t, J= 1.6, 2H, Ph), 
7.86 (dt, J= 7.8, 1.4, 2H, Ph), 7.71 (dt, J= 7.7, 1.4, 2H, Ph), 7.53-7.47 (m, 
overlap, 4H, Ph, Bz), 7.42 (tt, J= 7.4, 1.5, 1H, Bz), 7.34 (s, 2H, Phcent), 7.42 (t, 
J= 7.3 Hz, 2H, Bz), 2.51 (s, 6H, -CH3), 2.46 (s, 3H, -ArCH3). 
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(35)
1. Br2, CH3COOH
(34)
ESI-MS m/z 470 ([M+Na]+), HR ESI-MS found 470.1712 C30H25NNaO3 requires 
470.1727 (error 3.05 ppm). 
 
6.2.27 Synthesis of 35 
 
 
This compound was produced in a similar manner to compound 8, except 34 
was used in place of γ,γ’-diacetylbiphenyl (7). The reaction was monitored via 
TLC (SiO2, 2:3 ethyl acetate: petroleum ether 40-60) unitl the starting materal 
was consumed (approximately 3 h).  After this time the reation was allowed to 
cool, then poured over NaHCO3(aq) (30 ml), extracted using 1% MeOH in DCM 
(2 x 30 ml), 3% MeOH in DCM (2 x 30 ml) and 5% MeOH in DCM (2 x 30 ml). 
The combined organic layers were dried (MgSO4), filtered and the solvent 
removed by rotory evaporation. After this  DCM (5 ml) was added to the flask, 
upon reduction of solvent a precipitate was produced. Collection via filtration 
gave a crude orange-brown solid. 
 
Note: Due to solubility probems this compound was not purified, thus 
characterisation of this compound cannot be reported. 
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1. EtOH
(35) (9)
(L13)
6.2.28 Synthesis of L13 
To a solution of β,β’-bipyridine-6-thioamide (9) (0.071 g, 0.33 mmol) in ethanol 
(β5 ml) was added the α-bromoacetyl (35) (0.10 g, 0.17 mmol) and the reaction 
heated under reflux for 8 h. The reaction was allowed to cool, which resulted in 
the production of a precipitate. This was isolated by filtration, followed by 
washing with EtOH and Et2O (2 x 2 ml) giving the ligand, L13, as a cream 
powder (0.039 g, 45 % yield). 
 
1H NMR [500 MHz, DMSO-d6]: δH = 9.90 (s, 1H, -NH), 8.76 (dq, J= 4.8, 0.9 2H, 
Pyterm), 8.52-8.49 (m, overlap, 4H, Py, Pyterm), 8.35 (dd, J= 7.8, 1.0, 2H, Py), 
8.33 (s, 2H, Ph), 8.30 (s, 2H, Tz), 8.16 (t, J= 7.8, 2H, Py), 8.08 (dt, J= 7.7, 1.8, 
2H, Pyterm), 8.01 (dt, J= 7.3, 1.7, 2H, Ph), 7.64 (dd, J= 7.1, 1.3, 2H, Bz), 7.57-
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7.49 (m, overlap, 6H, Pyterm, Ph), 7.42 (s, 2H, Phcent), 7.28 (t, J= 7.4, 1H, Bz), 
7.13 (t, J= 7.9 Hz, 2H, Bz), 2.63 (s, 3H, -ArCH3). 
 
ESI-MS m/z 838 ([M+H]+), HR ESI-MS found 838.2439 C52H36N7OS2 requires 
838.2417 (error 2.63 ppm)  
6.2.29 Synthesis of 36 
 
 
This compound was produced in an identical manner to compound 12, except 
2,6-dibromo-4-methylphenol (17) was used in place of 1,3-dibromobenzene 
(10). The reaction was monitored via TLC (SiO2, 1:3 ethyl acetate: petroleum 
ether 40-60). Purification via column chromatography (SiO2, 1:3 ethyl acetate: 
petroleum ether 40-60) gave compound 36 as a yellow oil (65 % yield). 
 
1H NMR [400 MHz, CDCl3]: δH = 8.13 (t, J= 7.7, 2H, Ph), 7.98 (dt, J= 7.7, 1.5, 
2H, Ph), 7.78 (dt, J= 7.7, 1.5, 2H, Ph), 7.58 (t, J= 7.8 Hz, 2H, Ph), 7.14 (s, 2H, 
Phcent), 5.15 (s, 1H, -OH), 2.65 (s, 6H, -CH3), 2.05 (s, 3H, -ArCH3). 
 
ESI-MS m/z 367 ([M+Na]+), HR ESI-MS found 367.1302 C23H20NaO3 requires 
367.1304 (error 0.60 ppm). 
  
(17)
1. [Pd(PPh3)2Cl2] 
EtOH:H2O
(36)(11)
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6.2.30 Synthesis of 37 
 
 
This compound was produced in an identical manner to compound 8, except 36 
was used in place of γ,γ’-diacetylbiphenyl (7). The reaction was monitored via 
TLC (SiO2, 1 % MeOH in DCM). Purification via column chromatography (SiO2, 
1 % MeOH in DCM) gave compound 37 as an off-white powder (89 % yield).  
 
1H NMR [400 MHz, CDCl3]: δH = 8.17 (t, J= 1.6,  2H, Ph), 8.02 (dd, J= 7.8, 1.2, 
2H, Ph), 7.82 (dd, J= 7.7, 1.1, 2H, Ph), 7.62 (t, J= 7.8 Hz, 2H, Ph), 7.15 (s, 2H, 
Phcent), 5.08 (s, 1H, -OH), 4.50 (s, 4H, -CH2Br), 2.40 (s, 3H, -ArCH3). 
 
ESI-MS m/z 523 ([M+Na]+), HR ESI-MS found 522.9520 C23H18Br2NaO3 
requires 522.9515 (error 0.90 ppm). 
 
1. Br2, CH3COOH
(36) (37)
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6.2.31 Synthesis of 38 
 
 
To a solution of β,β’-bipyridine-6-thioamide (9) (0.113 g, 0.53 mmol) in ethanol 
(β5 ml) was added the α-bromoacetyl (37) (0.120 g, 0.24 mmol) and the 
reaction refluxed for 8 h during which time a precipitate was produced. This 
was isolated by filtration, followed by washing with EtOH and Et2O (2 x 2 ml). 
The compound was isolated as the H.Br salt; to obtain the free ligand the 
product was suspended in concentrated ammonia (0.88 S.G., 10 ml) for 24 h. 
Filtration and washing with d.H2O, EtOH and Et2O (2 x 2 ml) gave the desired 
product as a light brown powder (79 % yield). 
 
1H NMR [500 MHz, CDCl3]: δH = 8.71 (dq, J= 4.8, 0.9, 2H, Pyterm), 8.60 (dt, J= 
7.9, 0.9, 2H, Pyterm), 8.48 (dd, J= 7.9, 1.0, 2H, Py), 8.35 (dd, J= 7.8, 1.0, 2H, 
Py), 8.24 (br s, 2H, Ph), 8.06-8.04 (m, 2H, Ph), 7.96 (t, J= 7.8, 2H, Py), 7.89 (dt, 
J= 7.7, 1.7, 2H, Pyterm), 7.69 (s, 2H, Tz), 7.60-7.59 (m, overlap, 4H, 2 x Ph), 
7.36 (ddd, J= 7.5, 4.8, 1.2 Hz, 2H, Pyterm), 7.24 (s, 2H, Phcent), 5.45 (s, 1H, -
OH), 2.42 (s, 3H, -ArCH3). 
1. EtOH
(37) (9)
(38)
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(38)
1. NaH, DMF
2. Benzyl Bromide
(L14)
 
ESI-MS m/z 735 ([M+H]+), HR ESI-MS found 735.1994 C45H31N6OS2 requires 
735.1995 (error 0.19 ppm). 
 
6.2.32 Synthesis of L14 
 
 
A two necked round bottom flask charged with 38 (0.14 g, 0.19 mmol) and 
sodium hydride (0.04 g, 0.95 mmol), was placed under an atmosphere of N2(g), 
to this anhydrous DMF (5 ml) was added. This was left to stir at 80  C for 1h. 
After this time benzyl bromide (0.07 g, 0.38 mmol) was added to the reaction 
and set to stir at 80  C. The reaction was monitored via TLC (Al2O3, 1% hexane 
in DCM); once all the starting material had been consumed methanol was 
added to the reaction whilst under N2(g) (to react with any unreacted sodium 
hydride). The reaction was concentrated and NaHCO3(aq) (30 ml) added and the 
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reaction extracted into DCM (3 x 30 ml). The combined organic layers were 
dried (MgSO4) and the solvent removed by rotary evaporation. Separation and 
purification via column chromatography (Al2O3, 1% hexane in DCM) gave L14 
as a fine cream powder once dry (0.052 g, 56 % yield) 
 
1H NMR [400 MHz, CDCl3]: δH = 8.72 (dq, J= 4.8, 0.8  2H, Pyterm), 8.62 (d, J= 
7.9, 2H, Pyterm), 8.50 (dd, J= 7.9, 0.8, 2H, Py), 8.36 (dd, J= 7.7, 0.9, 2H, Py),  
8.31 (t, J= 1.6, 2H, Ph), 8.09 (d, J= 7.8, 2H, Ph), 7.98 (t, J= 7.8, 2H, Py), 7.91 
(dt, J= 7.7, 1.8, 2H, Pyterm), 7.71 (d, J= 7.8, 2H, Ph), 7.62 (s, 2H, Tz), 7.56 (t, J= 
7.7, 2H, Ph), 7.37 (ddd, J= 7.5, 4.8, 1.1, 2H, Pyterm), 7.36 (s, 2H, Phcent), 7.08 (t, 
J= 7.2, 1H, Bn), 7.03 (t, J= 7.2, 2H, Bn), 6.79 (d, J= 6.9 Hz, 2H, Bn), 4.29 (s, 
2H, O-CH2-), 2.50 (s, 3H, -ArCH3). 
 
13C NMR [125 MHz, CDCl3]: δC= 169.2 (quaternary, Q), 156.7 (Q), 155.7 (Q), 
155.4 (Q), 151.4 (Q), 150.8 (Q), 149.2 (CH), 139.2 (Q), 138.0 (CH), 137.0 (CH), 
136.7 (Q), 135.8 (Q), 134.5 (Q), 134.1 (Q), 131.0 (CH), 129.7 (CH), 128.7 (CH), 
128.6 (CH), 128.0 (CH), 127.7 (CH), 127.5 (CH), 125.3 (CH), 124.1 (CH), 121.7 
(CH), 121.3 (CH), 119.8 (CH), 115.6 (CH), 75.0 (CH2, Bn), 21.0 (CH3).  
 
ESI-MS m/z 825 ([M+H]+), HR ESI-MS found 825.2455 C52H37N6OS2 requires 
825.2465 (error 1.24 ppm).
 
 
6.3 Preparation of (L15- L17) 
6.3.1 Synthesis of 8-hydroxyquinoline-2-carbothioamide 40 
  
 
To a solution of 8-hydroxyquinoline-2-carbonitrile (39) (1.0 g, 5.9 mmol) in 
ethanol (20 ml), triethylamine (1.0 g, 9.9 mmol) was added and H2S(g) slowly 
(39) (40)
1. H2S, Et3N, EtOH
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bubbled through the solution which turned yellow after a few minutes. The 
solution was then left to stand at room temperature for 48 h during which time a 
precipitate was produced. Filtration gave the thioamide, 40, as a dark yellow 
powder (1.1 g, 91 % yield).  
 
1H NMR [400 MHz, CDCl3]: δH = 9.21 (br s, 1H, -NH2), 8.85 (d, J = 8.7, 1H, Py), 
8.32 ( d, J = 8.7, 1H, Py), 7.76 (br s, 1H, -NH2), 7.63 (s,1H, -OH), 7.59 (t, J = 
8.0, 1H, Ph), 7.44 (dd, J = 8.3, 1.0 Hz, 1H, Ph), 7.27 (m, overlap with solvent 
peak, 1H, Ph). 
 
ESI-MS m/z 227 ([M+Na]+), HR ESI-MS found 227.0253 C10H8N2NaOS 
requires 227.0250 (error 1.55 ppm).  
 
6.3.2 Synthesis of 42 
 
Diacetyl cresol (41) ( 0.2 g, 1.0 mmol) was dissolved in acetic acid (25 ml) and 
set to stir at 80 ˚C under an atmosphere of N2(g). Bromine (0.33 g, 2.0 mmol) 
was diluted to 1 ml with acetic acid (approx. 0.9 ml) to allow slow addition to the 
reaction. The reaction was monitored via TLC (SiO2, 1% hexane in DCM) once 
the starting material was consumed the reaction was allowed to cool to room 
temperature, then poured over deionised water (30 ml) and NaHCO3 (0.1 g) 
was added to neutralise the reaction. The product was extracted into DCM (3 x 
30 ml) and the combined organic layers dried over MgSO4. Removal of the 
solvent left the crude product as an orange oil. Purification via column 
chromatography (SiO2, 1 % hexane in DCM) gave the desired product as an 
off-white solid (42). (0.15 g, 41 % yield)  
 
(41) (42)
1. Br2, CH3COOH
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(40)
1. EtOH
(42) (L15)
1H NMR [400 MHz, CDCl3]: δH = 12.78 (s, 1H, -OH), 7.89 (s, 2H, Ph), 4.60 (s, 
4H, -CH2Br), 2.39 (s, 3H, Ar-CH3). 
 
ESI-MS m/z 370 ([M+Na]+), HR ESI-MS found 370.8889 C1H10Br2NaO3 
requires 370.8889 (error 0.07 ppm).  
 
6.3.3 Synthesis of L15  
 
To a solution of 8-hydroxyquinoline-2-carbothioamide (40) (0.058 g, 0.28 mmol) 
in ethanol (β5 ml) the α-bromoacetyl, 42, (0.045 g, 0.13 mmol) was added and 
the solution refluxed for 5 h. After this time the resulting yellow precipitate was 
filtered, washed with ethanol (2 ml) and ether (2 ml) giving the bromide salt of 
the ligand. This was suspended in ammonia (0.88 S.G., 10 ml) and left for 12 h. 
Filtration and washing with d.H2O, EtOH and Et2O (2 x 2 ml) gave L15 as a light 
yellow powder (0.056 g, 78 % yield)  
 
1H NMR [400 MHz, DMSO-d6]: δH = 12.59 (s, 1H, -OH), 9.98 (s, 2H, -OH), 8.59 
(s, 2H, Tz), 8.54 (d, J = 8.6, 2H, Py), 8.40 (d, J = 8.6, 2H, Py), 8.04 (s, 2H, 
Phcent), 7.52-7.49 (m, overlap, 4H, 2 x Ph), 7.21 (dd, J = 6.6, 2.3 Hz, 2H, Ph), 
2.45 (s, 3H, Ar-CH3). 
 
13C NMR [100 MHz, CDCl3]: δC= 167.8 (quaternary, Q), 153.8 (Q), 153.2 (Q), 
151.5 (Q), 148.5 (Q), 138.6 (Q), 138.2 (CH), 129.9 (Q), 129.2 (CH), 129.0 (CH), 
128.6 (Q), 120.4 (Q), 120.3 (Q), 118.5 (CH), 118.1 (CH), 113.2 (CH), 20.9 (-
CH3). 
 
ESI-MS m/z 583 ([M+Na]+), HR ESI-MS found 583.0869 C31H20N4NaO3S2 
requires 583.0869 (error 0.07 ppm) 
214 
 
6.3.4 Synthesis of L16 
 
 
To a 50 ml round bottom flask charged with β,β’-bipyridine-6-thioamide (9) 
(0.β0γ g, 0.94 mmol) and the α-bromoacetyl, 42, (0.15 g, 0.43 mmol) was 
added DMF (10 ml) and the resulting solution was heated at 80 ˚C for 24 h. 
After this time the resulting yellow precipitate was filtered, washed with ethanol 
and ether (2 x 2 ml) giving the bromide salt of the ligand. This compound was 
suspended in ammonia (0.88 S.G., 10 ml) and left for 24 h. Filtration and 
washing with d.H2O, EtOH and Et2O (2 x 2 ml) gave L16 as a fine yellow solid 
(0.21 g, 84 % yield).  
 
1H NMR [500 MHz, DMSO-d6]: δH = 12.33 (s, 1H, -OH), 8.77 (dq, J = 4.7, 1.8, 
0.9, 2H, Pyterm), 8.54-8.52 (m, overlap, 4H, Py, Pyterm ), 8.51 (s, 2H, Tz), 8.34 
(dd, J = 7.7, 1.0, 2H, Py), 8.21 (t, J = 7.7, 2H, Py), 8.07 (dt, J = 7.7, 1.8, 2H, 
Pyterm), 8.02 (s, 2H, Ph), 7.54 (ddd, J= 7.5. 4.8, 1.2 Hz, 2H, Pyterm), 2.47 (s, 3H, 
Ar-CH3).  
 
The poor solubility of the ligand precluded 13C NMR analysis. 
 
IR (solid, v/cm-1) 3138, 3117, 2982, 1580, 1571, 1560, 1526, 1514, 1480, 1452, 
1429, 1297, 1275, 1252, 1144, 1091, 1076, 1027,1016, 852, 823, 776, 740, 
730, 688, 652. 
 
ESI-MS m/z 605 ([M+Na]+), HR ESI-MS found 605.1183 C33H22N6NaOS2 
requires 605.1189 (error 0.96 ppm)  
  
(9) (42) (L16)
1. EtOH
215 
 
1. mCPBA, DCM
(43) (44)
6.3.5 Synthesis of 6’-cyano-β,β’-bipyridine-N-oxide (44)169 
 
 
To a solution of 6-cyano-β,β’-bipyridine (43) (0.2 g, 1.1 mmol) in DCM (25 ml), 
mCPBA (0.27 g, 1.2 mmol, (77%)) was added slowly, over a period of 2 h after 
which the reaction was allowed to stir for 8 h. The solvent was removed by 
rotary evaporation and the resulting solid purified via column chromatography 
(Al2O3, 1% MeOH in DCM). This gave the desired compound, 44, as a cream 
solid (0.17 g, 78 % yield) 
 
1H NMR [400 MHz, CDCl3]: δH = 9.27 (dd, J = 8.3, 1.0, 1H, PyN-oxide), 8.33 (dd, J 
= 6.4, 0.9, 1H, Py), 8.27 (dd, J = 8.0, 2.1, 1H, PyN-oxide), 7.99 (t, J = 8.0, 1H, Py), 
7.75 (dd, J = 6.4, 0.9, 1H, Py), 7.43 (dt, J = 7.8, 1.3, 1H, PyN-oxide), 7.36 (ddd, J 
= 8.0, 5.9, 2.2 Hz, 1H, PyN-oxide). 
 
ESI-MS m/z 220 ([M+Na]+), HR ESI-MS found 220.0480 C11H7N3NaO requires 
220.0481 (error 0.46 ppm). 
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1. H2S, Et3N, EtOH
(45)(44)
6.3.6 Synthesis of Synthesis of N-oxide-β,β’-bipyridine-6’-thioamide (45)169 
 
 
This compound was produced in a similar manner to 8-hydroxyquinoline-2-
carbothioamide (40), except 6’-cyano-β,β’-bipyridine-N-oxide (44) was used in 
place of 8-hydroxyquinoline-2-carbonitrile (39). Filtration of the resulting 
precipitate gave 45 as a yellow powder (88 % yield).  
 
1H NMR [400 MHz, CDCl3]: δH = 9.50 (br s, 1H, -NH2), 8.97 (dd, J = 8.0, 0.7, 
1H, PyN-oxide), 8.78 (dd, J = 7.9, 0.7, 1H, PyN-oxide), 8.36 (dd, J = 6.4, 0.7, 1H, 
Py), 8.04 (dd, J = 8.0, 2.1, 1H, Py), 8.01 (t, J = 7.5, 1H, Py), 7.76 (br s, 1H, -
NH2), 7.41 (dt, J = 7.7, 1.2 Hz, 1H, PyN-oxide), 7.35 (m, 1H, PyN-oxide). 
 
ESI-MS m/z 254 ([M+Na]+), HR ESI-MS found 254.0371 C11H9N3NaOS 
requires 254.0359 (error 4.79 ppm). 
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6.3.7 Synthesis of L17169 
 
 
To a solution of N-oxide-β,β’-bipyridine-6’-thioamide (45) (0.073 g, 0.31 mmol) 
in DMF (5 ml) the α-bromoacetyl, 42, (0.050 g, 0.14 mmol) was added and the 
solution heated at 80 ˚C for 8 h. After this time the resulting yellow precipitate 
was filtered, washed with ethanol and ether (2 x 2 ml) giving the bromide salt of 
the ligand. This compound was suspended in ammonia (0.88 S.G., 10 ml) and 
left for 24 h. Filtration and washing with d.H2O, EtOH and Et2O (2 x 2 ml) gave 
L17 as a fine yellow powder (0.053 g, 62 % yield).  
 
IR (solid, v/cm-1) 3112, 2955, 2359, 2343, 1738, 1675, 1581, 1567, 1515, 1490, 
1450, 1494, 1393, 1292, 1285, 1231, 1211, 1155, 1023, 1011, 773, 760,736. 
 
Note: Due to poor solubility of this compound in organic solvents no NMR could 
be recorded. 
(42) (L17)(45)
1. EtOH
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6.4 Synthesis of complexes 
 
For each ligand a selection of different metal ions, generally as the perchlorate, 
tetrafluoroborate or triflate salt, were employed in each case to investigate their 
coordination chemistry. The complexes reported here are those which 
produced crystals of sufficient quality for X-ray diffraction. 
6.4.1 Synthesis of [Zn5(L1)5](CF3SO3)10 
To a suspension of L1 (5 mg, 0.008 mmol) in acetonitrile (1 ml) was added 
Zn(CF3SO3)2 (3 mg, 0.08 mmol) and the suspension sonicated until all the 
ligand had dissolved. Ethyl acetate was then slowly allowed to diffuse into the 
solution giving colourless crystals, which were filtered and dried under vacuum 
(0.04 g, 50%). NMR and mass spectroscopy data are discussed in the text. 
Found: C, 42.9; H, 3.7; N, 12.2%. Calculated for C170H160N30F30O40S20Zn5: C, 
42.5; H, 3.4; N, 11.9%.  
 
All the other ligand complexes (L2–L4) were synthesised in an identical manner. 
[Zn5(L2)5](CF3SO3)10 (yield = 45%) Found: C, 39.3; H, 2.7; N, 11.9%. 
Calculated for C160H120N30O60S20F30Zn5: C, 38.7; H, 2.4; N, 11.5%. 
[Zn5(L3)5](CF3SO3)10 (yield = 50%) Found: C, 42.6; H, 3.8; N, 7.4%. Calculated 
for C190H180N30O60S20F30Zn5: C, 42.4; H, 3.4;N, 7.8%. [Zn5(L4)5](CF3SO3)10 
(yield = 55%) Found: C, 47.5; H, 3.2; N, 10.1%. Calculated for 
C230H180N30O60S20F30Zn5: C, 47.1; H, 3.1; N, 9.7%. 
 
6.4.2 Synthesis of the complex [Cu2(L6)2](ClO4)4 
To a suspension of L6 (5.0 mg, 0.008 mmol) in acetonitrile (2 ml) was added 
Cu(ClO4)2.6H2O (2.9 mg, 0.008 mmol) and the suspension sonicated until all 
the ligand had dissolved giving a light green solution. Filtration followed by the 
slow diffusion of diethyl ether vapour into the acetonitrile solution resulted in the 
formation of green crystals of [Cu2(L6)2](ClO4)4. ESI-MS m/z 1683 
corresponding to {[Cu2(L6)2](ClO4)3}+. [Cu2(L6)2](ClO4)4 (yield = 72 %). 
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6.4.3 Synthesis of the complex [Fe2(L7)2](ClO4)4 
To a suspension of L7 (5.0 mg, 0.007 mmol) in nitromethane (2 ml) was added 
Fe(ClO4)2.6H2O (2.6 mg, 0.007 mmol) and the suspension sonicated until all 
the ligand had dissolved giving a deep purple solution. Filtration followed by the 
slow diffusion of diethyl ether vapour into the nitromethane solution resulted in 
the formation of purple crystals of [Fe2(L7)2](ClO4)4. ESI-MS m/z 1819 
corresponding to {[Fe2(L7)2](ClO4)3}+. [Fe2(L7)2][ClO4]4 (yield = 75 %). Found: C, 
54.3; H, 2.6; N, 9.6%. Calculated for C89H59Cl4Fe2N13O18S4: C, 54.0; H, 3.0; N, 
9.2%. 
 
6.4.4 Synthesis of the complex [Hg2(L8)2](ClO4)4 
To a suspension of L8 (5.0 mg, 0.007 mmol) in nitromethane (2 ml) was added 
Hg(ClO4)2.6H2O (3.6 mg, 0.007 mmol) and the suspension sonicated until all 
the ligand had dissolved giving a pale yellow solution. Filtration followed by the 
slow diffusion of diisopropyl ether vapour into the nitromethane solution 
resulted in the formation of colourless crystals of [Hg2(L8)2](ClO4)4. ESI-MS m/z 
2111 corresponding to {[Hg2(L8)2](ClO4)3}+. [Hg2(L8)2](ClO4)4 (yield = 44 %). 
 
6.4.5 Synthesis of L9 complexes 
6.4.5.1 Synthesis of the complex [Co2(L9)2](BF4)4 
To a suspension of L9 (5.0 mg, 0.007 mmol) in nitromethane (2 ml) was added 
Co(BF4)2.6H2O (2.3 mg, 0.007 mmol) and the suspension sonicated until all the 
ligand had dissolved giving an orange solution. Filtration followed by the slow 
diffusion of chloroform vapour into the nitromethane solution resulted in the 
formation of orange crystals of [Co2(L9)2](BF4)4. ESI-MS m/z 1876 
corresponding to {[Co2(L9)2](BF4)3}+. [Co2(L9)2][BF4]4 (yield = 45 %). Found: C, 
56.4; H, 2.9; N, 9.0 %. Calculated for C92H64B4Co2F16N12O2S4: C, 56.3; H, 3.3; 
N, 8.6 % 
 
6.4.5.2 Synthesis of the complex [Cd2(L9)2](ClO4)4 
To a suspension of L9 (5.0 mg, 0.007 mmol) in acetonitrile (2 ml) was added 
Cd(ClO4)2.6H2O (2.8 mg, 0.007 mmol) and the suspension sonicated until all 
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the ligand had dissolved giving a pale yellow solution. Filtration followed by 
layering with diethyl resulted in the formation X-ray quality crystals of 
[Cd2(L9)2](ClO4)4. ESI-MS m/z 2022 corresponding to {[Cd2(L9)2](ClO4)}+. 
[Cd2(L9)2][ClO4]4 (yield = 63 %). Found: C, 51.8; H, 3.0; N, 8.1%. Calculated for 
C94H67Cd2Cl4N13O18S4: C, 52.2; H, 3.1; N, 8.4%. 
 
6.4.6 Synthesis of the complex [Fe2(L10)2](ClO4)4 
To a suspension of L10 (5.0 mg, 0.006 mmol) in acetonitrile (2 ml) was added 
Fe(ClO4)2.6H2O (2.2 mg, 0.007 mmol) and the suspension sonicated until all 
the ligand had dissolved giving a deep purple solution. Filtration followed by the 
slow diffusion of chloroform vapour into the acetonitrile solution resulted in the 
formation of purple crystals of [Fe2(L10)2](ClO4)4. ESI-MS m/z 2084 
corresponding to {[Fe2(L10)2](ClO4)3}+. [Fe2(L10)2](ClO4)4 (yield = 75%). Found: 
C, 52.5; H, 3.2; N, 6.8%. Calculated for C101H81Cl7Fe2N12O22S4: C, 52.7; H, 3.6; 
N, 7.3%.  
 
6.4.7 Synthesis of the complex [Cd2(L11)2](ClO4)4 
To a suspension of L11 (5.0 mg, 0.007 mmol) in nitromethane (2 ml) was added 
Cd(ClO4)2.6H2O (2.9 mg, 0.007 mmol) and the suspension sonicated until all 
the ligand had dissolved. To this was added camphorsulfonic acid* (1.6 mg, 
0.007
 
mmol) giving a pale yellow solution. Filtration followed by the slow 
diffusion of dichloromethane vapour into the nitromethane solution resulted in 
the formation of yellow crystals of [Cd2(L11)2](ClO4)4. ESI-MS m/z 1990 
corresponding to {[Cd2(L11)2](ClO4)3}+.. [Cd2(L11)(L11+H)](ClO4)5 (yield = 48%). 
Found: C, 49.0; H, 2.7; N, 8.7 %. Calculated for C90H63Cd2Cl5N14O20S4: C, 49.3; 
H, 2.9; N, 9.0%. 
 
6.4.8 Synthesis of the complex [Zn2(L12)2](ClO4)4 
To a suspension of L12 (5.0 mg, 0.006 mmol) in nitromethane (2 ml) was added 
Zn(ClO4)2.6H2O (2.4 mg, 0.006 mmol) and the suspension sonicated until all 
the ligand had dissolved giving a colourless solution. Filtration followed by the 
slow diffusion of dichloromethane vapour into the nitromethane solution 
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resulted in the formation of colourless crystals of [Zn2(L12)2](ClO4)4. ESI-MS m/z 
1981 corresponding to {[Zn2(L12)2](ClO4)3}+. [Zn2(L12)2](ClO4)4 (yield = 46%). 
 
6.4.9 Synthesis of the complex [Zn2(L13)2](ClO4)4 
To a suspension of L13 (5.0 mg, 0.006 mmol) in nitromethane (2 ml) was added 
Zn(ClO4)2.6H2O (2.2 mg, 0.006 mmol) and the suspension sonicated until all 
the ligand had dissolved giving a colourless solution. Filtration followed by the 
slow diffusion of dichloromethane vapour into the nitromethane solution 
resulted in the formation of colourless crystals of [Zn2(L13)2](ClO4)4. ESI-MS m/z 
2105 corresponding to {[Zn2(L13)2](ClO4)3}+. [Zn2(L13)2](ClO4)4 (yield = 57 %). 
 
6.4.10 Synthesis of the complex [Cd2(L14)2](ClO4)4 
To a suspension of L14 (5.0 mg, 0.006 mmol) in acetonitrile (2 ml) was added 
Cd(ClO4)2.6H2O (2.5 mg, 0.006 mmol) and the suspension sonicated until all 
the ligand had dissolved giving a colourless solution. Filtration followed by the 
slow diffusion of dichloromethane vapour into the acetonitrile solution resulted 
in the formation of colourless crystals of [Cd2(L14)2](ClO4)4. ESI-MS m/z 2173 
corresponding to {[Cd2(L14)2](ClO4)3}+.[Cd2(L14)2][ClO4]4 (yield = 55 %). Found: 
C, 55.2; H, 3.4; N, 7.1%. Calculated for C104H72Cd2Cl4N12O18S4: C, 54.9; H, 3.2; 
N, 7.4%. 
 
6.4.11 Synthesis of the complex [Cd2(L10)2][Cd2(L12-H)2])(ClO4)10 
To a suspension of L10 (5.0 mg, 0.006 mmol) and L11 (4.4 mg, 0.006 mmol) in 
nitromethane (2 ml) was added Cd(ClO4)2.6H2O (5.0 mg, 0.012 mmol) and the 
suspension sonicated until all the ligand had dissolved. To this was added 
camphorsulfonic acid* (1.4 mg, 0.006 mmol) giving a colourless solution. 
Filtration followed by the slow diffusion of dichloromethane vapour into the 
nitromethane solution resulted in the formation of large colourless crystals of 
[Cd2(L10)2][Cd2(L12-H)2])(ClO4)10.. [[Cd2(L10)2][Cd2(L11- H)2]](ClO4)10 (yield = 62 
%). Found: C, 48.8; H, 2.9; N, 7.5%. Calculated for C190H148Cd4Cl10N26O48S8: 
C, 49.3; H, 3.2; N, 7.9%. 
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* Camphorsulfonic acid is used as it’s a non-hygroscopic solid which is easy to 
weigh accurately and is soluble in a wide variety of solvents. 
 
6.4.12 Synthesis of the complex [(L15)2Eu2(H2O)2](CF3SO3)4 
To a suspension of L15 (5.0 mg, 0.010 mmol) in nitromethane (2 ml) was added 
Eu(CF3SO3)3 (5.9 mg, 0.010 mmol) and the suspension sonicated until all the 
ligand had dissolved giving a yellow solution. Filtration followed by the slow 
diffusion of chloroform vapour into the nitromethane solution resulted in the 
formation of yellow crystals of [(L15)2Eu2(H2O)2](CF3SO3)4. ESI-MS m/z 1869 
corresponding to {[(L15)2Eu2](CF3SO3)3}+. [(L15)2Eu2](CF3SO3)4 (yield = 64%). 
Found C, 37.2; H, 2.0; N, 4.9%. Calculated for C67H41Cl3Eu2F12N8O18S8: C, 
37.6; H, 1.8; N, 5.2%. 
 
6.4.13 Synthesis of the complex [(L16)2La2(H2O)2(CF3SO3)2](CF3SO3)4 
To a suspension of L16 (5.0 mg, 0.009 mmol) in nitromethane (2 ml) was added 
La(CF3SO3)3 (5.0 mg, 0.009 mmol) and the suspension sonicated until all the 
ligand had dissolved giving a yellow solution. Filtration followed by the slow 
diffusion of diisopropyl ether vapour into the nitromethane solution resulted in 
the formation of X-ray quality crystals of [(L16)2La2(H2O)2(CF3SO3)2](CF3SO3)4. 
ESI-MS m/z 1887 corresponding to {[(L16)2La2](CF3SO3)3}+. [(L16)2La2] 
](CF3SO3)4 (yield = 50%). Found: C, 40.1; H, 2.0; N, 7.8%. Calculated for 
C70H46F12La2N12O16S8: C, 40.5; H, 2.2; N, 8.1% 
 
6.4.14 Synthesis of the complex [(L17)2Tb2](CF3SO3)4 
To a suspension of L17 (5.0 mg, 0.008 mmol) in nitromethane (2 ml) was added 
Tb(CF3SO3)3 (4.9 mg, 0.008 mmol) and the suspension sonicated until all the 
ligand had dissolved giving a yellow solution. Filtration followed by the slow 
diffusion of diethyl ether vapour into the nitromethane solution resulted in the 
formation of X-ray quality crystals of [(L17)2Tb2](CF3SO3)4. ESI-MS m/z 1991 
corresponding to {[(L17)2Tb2](CF3SO3)3}+. [(L17)2Tb2](CF3SO3)4 (yield = 59%). 
Found C, 38.4; H, 1.8; N, 7.9%. Calculated for C71H45F12N13O20S8Tb2: C, 38.7; 
H, 2.1; N, 8.3%.  
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Appendix 1: Crystal data tables 
 
In general single crystal X-ray diffraction data was collected at 150(2) K on a 
Bruker Apex Duo diffractometer equipped with a graphite monochromated 
Mo(Kα) radiation source and a cold stream of Nβ gas. Solutions were 
generated by conventional heavy atom Patterson or direct methods and refined 
by full-matrix least squares on all F2 data, using SHELXS-97 and SHELXL 
software respectively.5 Absorption corrections were applied based on multiple 
and symmetry-equivalent measurements using SADABS.6 A number of crystal 
structures contained anion and/or solvent disorder this was modelled 
depending on the requirements of the data.  
 
For example within [Zn5(L1)5](CF3SO3)10 a number of triflate anions and 
terminal diethylamide fragments were refined with geometric similarity restraints 
(SAME and SIMU). Additionally four triflate anions were modelled using two-
component disorder models. Each component was treated as a rigid body 
(AFIX 9). The unit cell contained large amounts of diffuse electron density, 
presumably due to highly disordered interstitial solvent. However, attempts at 
modelling this were unsuccessful and the relevant scattering contributions were 
thus removed using the SQUEEZE routine in PLATON.  
 
Generally anion and/or solvent disorder was modelled in two positions using 
the part instructions and constrained using DELU, SIMU, SADI and ISOR 
instructions in the least squares refinements. Specifically, for [Fe2(L7)2][ClO4]4 
the terminal phenyl spacer showed slight positional disorder resulting in large 
anisotropic displacement parameters. For simplicity five carbon atoms were 
constrained using DELU and SIMU constrains and one was further constrained 
using ISOR. Additionally [Cd2(L9)2][ClO4]4 contained a substitution disorder 
comprising of a molecule of acetonitrile and a water molecule and these were 
modelled in two positions using the part instruction and were both constrained 
                                            
5
 SHELXTL Program System, Vers. 5.1, Bruker Analytical X-ray Instruments Inc., Madison, WI, 
1998. 
6
 G. M. Sheldrick, SADABS: A Program for Absorption Correction with the Siemens SMART 
System, University of Göttingen (Germany), 1996 
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using DELU and SIMU and the bond lengths of the acetonitrile molecule 
constrained using DFIX.  
 
The crystals of [Zn2(L9)2][CF3SO3]2 decomposed rapidly and despite exhaustive 
attempts to collect data and growing the crystals under different conditions 
(changing solvents, counter ions and temperature) only very poorly diffracting 
crystals were formed. However, despite this data was collected and a gross 
molecular structure was obtained but contained sever disorder of a triflate 
counter ion and solvent molecules and to obtain data of reasonable quality the 
diffuse electron density was removed using the solvent mask facility in Olex2,7 
resulting in very large voids in the crystal structure. The solvent mask removed 
a total of 611.4 electrons in the unit cell which corresponds to triflate anion and 
one ethyl acetate and nitromethane solvent molecules per helicate complex 
(which corresponds to a total of 612 electrons in the unit cell). Given the 
obvious problems associated with extensive anion disorder in this crystal 
structure any structural discussion has been omitted manuscript apart from 
being confident that the gross solution is correct and that the complex is 
isostructural with [Co2(L9)2][BF4]4 (i.e. a meso-helicate). 
 
For the one-dimensional chain [[Cd2(L10)2][Cd2(L11-H)2]](ClO4)10 the crystals of 
this species
 
diffracted poorly
 
so data was limited to 2theta = 50. The glycol 
chain was refined isotropically as a satisfactory anisotropic disordered model 
could not be found. The majority of the solvent water positions, one CH2Cl2 and 
two ClO4 anions were refined isotropically. The C-Cl distances of one CH2Cl2 
and the Cl-O distances of one ClO4 were restrained to be chemically 
reasonable. 
  
                                            
7
 O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard and H. Puschmann, OLEX2: a 
complete structure solution, refinement and analysis program. J. Appl. Cryst. (2009). 
42, 339-341. 
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Table A1. Crystallographic data of L1 complex [Zn5(L1)5]10+ 
  
Compound [Zn5(L1)5](CF3SO3)10.  
Formula C230H270F30N40O60S20Zn5 
M 6092.91 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions 
a (Å) 
b (Å) 
c (Å) 
α (˚) 
ȕ (˚) 
Ȗ (˚) 
V (Å3) 
 
20.3776(13) 
21.5461(15) 
28.7397(19) 
79.876(2)  
85.013(2) 
77.697(2) 
12120.6(1) 
Z 2 
ρcalc (Mg cm-1) 1.669 
F(000) 6300 
Crystal dimensions (mm) 0.5, 0.2, 0.2 
Reflections collected 131442 
Range 1.44 ≤ θ ≥ βγ.γ7˚ 
hkl range indices -ββ ≤ h ≥ ββ, -β4 ≤ k ≥ βγ, -γ1≤ l ≥ γβ 
Unique reflections  35025 
Rint 0.0667 
Rw 0.2819 
R
 
0.1032 
Reflections with I > βσ(I) 22284 
GOF 1.069 
Refined parameters 2360 
Restraints 369 
Largest peak and hole (e Å-3) 1.417, -1.425   
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Table A2. Crystallographic data of L6 complex [Cu2(L6)2]4+ 
  
Compound [Cu2(L6)2][ClO4]4 
Formula C84.37 H62.06 Cl4 Cu2 N16.18 O16 S4 
M 1955.71 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions 
a (Å) 
b (Å) 
c (Å) 
α (˚) 
ȕ (˚) 
Ȗ (˚) 
V (Å3) 
 
15.2185(8)  
17.9346(11)  
18.4590(12)  
112.4660(10)  
94.9120(10)  
98.333(2)  
4551.5(5) 
Z 2 
ρcalc (Mg cm-1) 1.427 
F(000) 1999 
Crystal dimensions (mm) 0.3, 0.25, 0.1 
Reflections collected 104298 
Range 1.88 ≤ θ ≥ γ1.γ7˚ 
hkl range indices -β1 ≤ h ≥ ββ, -β5 ≤ k ≥ β5, -β6≤ l ≥ β6 
Unique reflections  28137  
Rint 0.0566 
Rw 0.2031 
R
 
0.0687 
Reflections with I > βσ(I) 16524 
GOF 1.02 
Refined parameters 1224 
Restraints 85 
Largest peak and hole (e Å-3) 1.680, -0.707   
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Table A3. Crystallographic data of L7 complex [Fe2(L7)2]4+ 
  
Compound [Fe2(L7)2][ClO4]4 
Formula C45H31Cl2FeN7O10S2 
M 1020.64 
Crystal system Orthorhombic 
Space group Cmca 
Unit cell dimensions 
a (Å) 
b (Å) 
c (Å) 
α (˚) 
ȕ (˚) 
Ȗ (˚) 
V (Å3) 
 
45.5093(11)  
22.2219(5) 
17.1211(4) 
90 
90 
90 
17314.6(7) 
Z 16 
ρcalc (Mg cm-1) 1.566 
F(000) 8352 
Crystal dimensions (mm) 0.5, 0.4, 0.2 
Reflections collected 46105 
Range 1.79 ≤ θ ≥ β8.4β˚ 
hkl range indices -60 ≤ h ≥ 60, -β9 ≤ k ≥ β5, -ββ≤ l ≥ 15 
Unique reflections  10977 
Rint 0.0544 
Rw 0.1368 
R
 
0.0552 
Reflections with I > βσ(I) 6702 
GOF 1.019 
Refined parameters 620 
Restraints 48 
Largest peak and hole (e Å-3) 1.129, -0.828 
239 
 
Table A4. Crystallographic data of L8 complex [Hg2(L8)2]4+ 
  
Compound [Hg2(L8)2][ClO4]4 
Formula C89H63Cl4Hg2N17O22S4 
M 2393.78 
Crystal system Monoclinic 
Space group P2(1)/c 
Unit cell dimensions 
a (Å) 
b (Å) 
c (Å) 
α (˚) 
ȕ (˚) 
Ȗ (˚) 
V (Å3) 
 
17.5144(7)  
26.3233(10)  
19.1644(7)  
90 
98.5960(10)  
90 
8736.2(6) 
Z 4 
ρcalc (Mg cm-1) 1.82 
F(000) 4736 
Crystal dimensions (mm) 0.3, 0.3, 0.2 
Reflections collected 83581 
Range 1.66 ≤ θ ≥ β7.88˚ 
hkl range indices -βγ ≤ h ≥ βγ, -γ4 ≤ k ≥ γ4, -β5≤ l ≥ β5 
Unique reflections  20762 
Rint 0.0579 
Rw 0.0569 
R
 
0.0324 
Reflections with I > βσ(I) 15429 
GOF 0.999 
Refined parameters 1274 
Restraints 18 
Largest peak and hole (e Å-3) 1.131, -0.793 
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Table A5. Crystallographic data of L9 complex [Zn2(L9)2]4+ 
  
Compound [Zn2(L9)2][CF3SO3]4 
Formula C101 H75 F12 N13 O18 S8 Zn2 
M 1926.81 
Crystal system monoclinic 
Space group C 2/c 
Unit cell dimensions 
a (Å) 
b (Å) 
c (Å) 
α (˚) 
ȕ (˚) 
Ȗ (˚) 
V (Å3) 
 
40.525(4) 
24.073(2) 
12.188(1) 
90 
105.746(2) 
90 
11443.7(18) 
Z 4 
ρcalc (Mg cm-1) 1.1183 
F(000) 3951.1988 
Crystal dimensions (mm) 0.30, 0.15, 0.15 
Reflections collected 53010 
Range 1.74 ≤ θ ≥ β8.46˚ 
hkl range indices -54 ≤ h ≥ 5β, 0 ≤ k ≥ γβ, 0 ≤ l ≥ 16 
Unique reflections  14217 
Rint 0.0675 
Rw 0.2050 
R
 
0.0635 
Reflections with I > βσ(I) 6799 
GOF 0.9818 
Refined parameters 578 
Restraints 0 
Largest peak and hole (e Å-3) 0.7212, -0.9532 
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Table A6. Crystallographic data of L9 complex [Co2(L9)2]4+ 
  
Compound [Co2(L9)2][BF4]4 
Formula C96 H68 B4 Cl12 Co2 F16 N12 O2 S4 
M 2440.36 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions 
a (Å) 
b (Å) 
c (Å) 
α (˚) 
ȕ (˚) 
Ȗ (˚) 
V (Å3) 
 
11.2403(4) 
14.2668(6) 
15.9890(6) 
97.9160(10) 
102.7040(10) 
91.6320(10) 
2472.85(16) 
Z 1 
ρcalc (Mg cm-1) 1.639 
F(000) 1230 
Crystal dimensions (mm) 0.30, 0.30, 0.15 
Reflections collected 56159 
Range 1.γβ ≤ θ ≥ γ0.51˚ 
hkl range indices -16 ≤ h ≥ 16, -β0 ≤ k ≥ β0, -ββ≤ l ≥ ββ 
Unique reflections  14975 
Rint 0.0518 
Rw 0.1684 
R
 
0.0611 
Reflections with I > βσ(I) 9866 
GOF 1.041 
Refined parameters 669 
Restraints 0 
Largest peak and hole (e Å-3) 1.469, -1.185 
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Table A7. Crystallographic data of L9 complex [Cd2(L9)2]4+ 
  
Compound [Cd2(L9)2][ClO4]4 
Formula C201H152Cd4Cl8N33O38S8 
M 4627.24 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions 
a (Å) 
b (Å) 
c (Å) 
α (˚) 
ȕ (˚) 
Ȗ (˚) 
V (Å3) 
 
12.6829(8)  
16.4451(10)  
25.0185(14)  
94.6030(10)  
101.5490(10)  
97.467(2)  
5038.7(5) 
Z 1 
ρcalc (Mg cm-1) 1.525 
F(000) 2349 
Crystal dimensions (mm) 0.2, 0.2, 0.1 
Reflections collected 112792 
Range 1.4γ ≤ θ ≥ γ0.0γ˚ 
hkl range indices -17 ≤ h ≥ 17, -βγ ≤ k ≥ βγ, -γ5≤ l ≥ γγ 
Unique reflections  29420 
Rint 0.0807 
Rw 0.1302 
R
 
0.0591 
Reflections with I > βσ(I) 16062 
GOF 1.018 
Refined parameters 1360 
Restraints 30 
Largest peak and hole (e Å-3) 1.095, -0.989   
243 
 
Table A8. Crystallographic data of L10 complex [Fe2(L10)2]4+ 
  
Compound [Fe2(L10)2][ClO4]4 
Formula C108H90Cl16Fe2N14O22S4 
M 2743.08 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions 
a (Å) 
b (Å) 
c (Å) 
α (˚) 
ȕ (˚) 
Ȗ (˚) 
V (Å3) 
 
11.7211(6)  
13.4503(8)  
21.2922(12)  
104.0930(10)  
96.2950(10)  
110.1670(10)  
2986.2(3) 
Z 1 
ρcalc (Mg cm-1) 1.525 
F(000) 1400 
Crystal dimensions (mm) 0.50, 0.26, 0.03 
Reflections collected 55213 
Range 1.69 ≤ θ ≥ β8.7β˚ 
hkl range indices -15 ≤ h ≥ 14, -17 ≤ k ≥ 17, -β8≤ l ≥ β8 
Unique reflections  14883 
Rint 0.0774 
Rw 0.1325 
R
 
0.0596 
Reflections with I > βσ(I) 8603 
GOF 1.016 
Refined parameters 751 
Restraints 0 
Largest peak and hole (e Å-3) 1.518, -1.128 
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Table A9. Crystallographic data of L11 complex [Cd2(L11)(L11-H)]5+ 
 
  
Compound [Cd2(L11)(L11-H)2](ClO4)5 
Formula C94.86H75.57Cd2Cl13N14.86O22.71 S4 
M 2600.83 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions 
a (Å) 
b (Å) 
c (Å) 
α (˚) 
ȕ (˚) 
Ȗ (˚) 
V (Å3) 
 
13.8209(7) 
18.3351(9) 
21.5994(10) 
95.0080(10) 
92.1730(10) 
107.4850(10) 
5188.8(4) 
Z 2 
ρcalc (Mg cm-1) 1.665 
F(000) 2622.8 
Crystal dimensions (mm) 0.40, 0.3, 0.01 
Reflections collected 118786 
Range 1.43 ≤ θ ≤ 30.51 
hkl range indices -19≤h≤19, -β6≤k ≤β6, -γ0≤l≤γ0 
Unique reflections  31560 
Rint 0.0580 
Rw 0.1514 
R
 
0.0588 
Reflections with I > βσ(I) 20025 
GOF 1.045 
Refined parameters 1401 
Restraints 52 
Largest peak and hole (e Å-3) 1.888, -1.980 
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Table A10. Crystallographic data of L12 complex [Zn2(L12)2]4+ 
  
Compound [Zn2(L12)2][ClO4] 
Formula C24 H18 Cl N4 O5.5 S Zn0.5 
M 550.65 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions 
a (Å) 
b (Å) 
c (Å) 
α (˚) 
ȕ (˚) 
Ȗ (˚) 
V (Å3) 
 
12.5839(5) 
12.9897(6) 
19.7481(8) 
85.377(1) 
82.463(1) 
68.636(1) 
2978.4(2) 
Z 4 
ρcalc (Mg cm-1) 1.2279 
F(000) 1130.2089 
Reflections collected 55104 
Range 1.68 ≤ θ ≥ β7.88˚ 
hkl range indices -16 ≤ h ≥ 16, -17 ≤ k ≥ 17, -β5 ≤ l ≥ β5 
Unique reflections  14123 
Rint 0.0538 
R
 
0.048156 
Reflections with I > βσ(I) 9827 
GOF 1.013791 
Refined parameters 661 
Restraints 0 
Largest peak and hole (e Å-3) 1.086330, -0.891055 
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Table A11. Crystallographic data of L13 complex [Zn2(L13)2]4+ 
 
  
Compound [Zn2(L13)2][ClO4]4 
Formula C114.956 H94 Cl22.333 N15.789 O22.579 S4 Zn2 
M 3108.71 
Crystal system Triclinic 
Space group P -1 
Unit cell dimensions 
a (Å) 
b (Å) 
c (Å) 
α (˚) 
ȕ (˚) 
Ȗ (˚) 
V (Å3) 
 
14.4009(7) 
20.9146(11) 
22.4441(12) 
80.955(1) 
84.776(1) 
83.257(1) 
6611.5(6) 
Z 2 
ρcalc (Mg cm-1) 1.5614 
F(000) 3167.1135 
Crystal dimensions (mm) 0.5, 0.3, 0.2 
Reflections collected 120152 
Range 1.4γ ≤ θ ≥ β8.β8˚ 
hkl range indices -19 ≤ h ≥ 19, -β7 ≤ k ≥ β7, -β9 ≤ l ≥ β9 
Unique reflections  32500 
Rint 0.0712 
R
 
0.0665 
Reflections with I > βσ(I) 18703 
GOF 1.0786 
Refined parameters 1699 
Restraints 174 
Largest peak and hole (e Å-3) 2.0134, -1.4919 
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Table A12. Crystallographic data of L14 complex [Cd2(L14)2]4+ 
 
Compound [Cd2(L14)2][ClO4]4 
Formula C110.95 H82.43 Cd2 Cl4 N15.47 O18 S4 
M 2415.24 
Crystal system Monoclinic 
Space group P 1 21/c  
Unit cell dimensions 
a (Å) 
b (Å) 
c (Å) 
α (˚) 
ȕ (˚) 
Ȗ (˚) 
V (Å3) 
 
21.7000(11) 
12.4488(6) 
22.2200(11) 
90 
117.0500(10) 
90 
5345.9(5) 
Z 2 
ρcalc (Mg cm-1) 1.500 
F(000) 2457 
Crystal dimensions (mm) 0.4, 0.15, 0.12 
Reflections collected 53131 
Range 1.84 ≤ θ ≥ β8.γγ˚ 
hkl range indices -β8 ≤ h ≥ β8, -8 ≤ k ≥ 16, -β9 ≤ l ≥ β9 
Unique reflections  13301 
Rint 0.0618 
Rw 0.1503 
R
 
0.0546 
Reflections with I > βσ(I) 8746 
GOF 1.023 
Refined parameters 734 
Restraints 60 
Largest peak and hole (e Å-3) 2.560, -0.920   
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Table A13. Crystallographic data of L10 and L11 complex [Cd2(L10)2][Cd2(L11-
H)2]10+ 
Compound [[Cd2(L10)2][Cd2(L11-H)2]]10+ 
Formula C98H93Cd2Cl10N13O30.50S4 
M 2648.39 
Crystal system Monoclinic 
Space group P2(1)/c 
Unit cell dimensions 
a (Å) 
b (Å) 
c (Å) 
α (˚) 
ȕ (˚) 
Ȗ (˚) 
V (Å3) 
 
13.3018(3) 
20.7598(4) 
44.2313(9) 
90 
91.2640(10) 
90 
12211.2(4) 
Z 4 
ρcalc (Mg cm-1) 1.441 
F(000) 5384 
Crystal dimensions (mm) 0.50, 0.18, 0.07 
Reflections collected 104867 
Range 1.35 ≤ θ ≤ 25.00 ˚ 
hkl range indices -15≤h≤15, -β46≤k ≤β4, -5β≤l≤5β 
Unique reflections  21329 
Rint 0.0686 
Rw 0.3254 
R
 
0.1202 
Reflections with I > βσ(I) 13700 
GOF 2.239 
Refined parameters 1304 
Restraints 6 
Largest peak and hole (e Å-3) 2.296, -1.509 
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Table A14. Crystallographic data of L15 complex [(L15)2Eu2]4+ 
 
Compound [(L15)2Eu2](CF3SO3)4 
Formula C70.907H44Cl7.561Eu2F12N10.386O24.773S8 
M 2494.35 
Crystal system Monoclinic 
Space group C2/c 
Unit cell dimensions 
a (Å) 
b (Å) 
c (Å) 
α (˚) 
ȕ (˚) 
Ȗ (˚) 
V (Å3) 
 
22.4400(4)  
17.4669(3)  
23.2350(5)  
90 
91.603 
90 
9103.6(3) 
Z 4 
ρcalc (Mg cm-1) 1.671 
F(000) 4934.5601 
Crystal dimensions (mm) 0.25, 0.25, 0.15 
Reflections collected 53586 
Range 1.71 ≤ θ ≥ γ0.0γ˚ 
hkl range indices -γ1 ≤ h ≥ γ1, -β4 ≤ k ≥ β4, -γβ≤ l ≥ γβ 
Unique reflections  13292  
Rint 0.0396 
Rw 0.0831 
R
 
0.0345 
Reflections with I > βσ(I) 10278 
GOF 1.059 
Refined parameters 567 
Restraints 31 
Largest peak and hole (e Å-3) 1.342, -1.296   
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Table A15. Crystallographic data of L16 complex [(L16)2La2]4+ 
 
Compound [(L16)2La2](CF3SO3)4 
Formula C36.50 H27.50 F6 La N7.50 O11 S4 
M 1128.31 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions 
a (Å) 
b (Å) 
c (Å) 
α (˚) 
ȕ (˚) 
Ȗ (˚) 
V (Å3) 
 
14.3142(13)  
17.3019(16)  
17.810(2)  
88.810(3)  
89.053(3)  
70.987(5)  
4169.1(7) 
Z x 
ρcalc (Mg cm-1) 1.798 
F(000) 2248 
Crystal dimensions (mm) 0.20, 0.20, 0.10 
Reflections collected 28806 
Range 1.50 ≤ θ ≥ β4.81˚ 
hkl range indices -16 ≤ h ≥ 16, -β0 ≤ k ≥ β0, -β0≤ l ≥ β0 
Unique reflections  14150 
Rint 0.0736 
Rw 0.0886 
R
 
0.0494 
Reflections with I > βσ(I) 8826 
GOF 0.954 
Refined parameters 1210 
Restraints 78 
Largest peak and hole (e Å-3) 0.954, -0.977 
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Table A16. Crystallographic data of L17 complex [(L17)2Tb2]4+ 
 
Compound [(L17)2Tb2](CF3SO3)4 
Formula C75.10 H57.29 F12 N17.10 O27.75 S8 Tb2 
M 2445.45 
Crystal system Monoclinic 
Space group P2(1)/n 
Unit cell dimensions 
a (Å) 
b (Å) 
c (Å) 
α (˚) 
ȕ (˚) 
Ȗ (˚) 
V (Å3) 
 
19.1137(8)  
20.0995(8)  
24.0305(10)  
90 
99.2700(10)  
90 
9111.4(6) 
Z 4 
ρcalc (Mg cm-1) 1.783 
F(000) 4862 
Crystal dimensions (mm) 0.30, 0.20, 0.20 
Reflections collected 88947 
Range 1.48 ≤ θ ≥ β7.88˚ 
hkl range indices -β5 ≤ h ≥ β5, -β6 ≤ k ≥ β6, -γ1≤ l ≥ γ1 
Unique reflections  21738 
Rint 0.0602 
Rw 0.1299 
R
 
0.0508 
Reflections with I > βσ(I) 15968 
GOF 1.053 
Refined parameters 1493 
Restraints 633 
Largest peak and hole (e Å-3) 2.554, -1.750 
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Appendix 2: Crystal packing 
A2.1. Packing of L1 complex [Zn5(L1)5]10+ 
A2.2 Packing of L6 complex [Cu2(L6)2]4+ 
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A2.3. Packing of L7 complex [Fe2(L7)2]4+ 
 
 
A2.4. Packing of L8 complex [Hg2(L8)2]4+ 
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A2.5. Packing of L9 complex [Co2(L9)2]4+ 
 
A2.6. Packing of L9 complex [Cd2(L9)2]4+ 
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A2.7. Packing of L10 complex [Fe2(L10)2]4+ 
 
A2.8. Packing of L11 complex [Cd2(L11)(L11-H)]5+ 
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A2.9. Packing of L13 complex [Zn2(L13)2]4+ 
 
A2.10. Packing of L14 complex [Cd2(L14)2]4+ 
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A2.11. Packing of L15 complex [(L15)2Eu2]4+ 
 
A2.12. Packing of L16 complex [(L16)2La2]4+ 
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A2.13. Packing of L17 complex [(L17)2Tb2]4+ 
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Appendix 3: Publications 
 
